
<html lang="en"     class="pb-page"  data-request-id="0b0eebd6-0c3e-495a-b20b-f45df3fb5746"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm401274b;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2013.56.issue-22;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Characterization of a Novel Dihydroisoxazole Class of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Potentiators" /></meta><meta name="dc.Creator" content="Nandini C.  Patel" /></meta><meta name="dc.Creator" content="Jacob  Schwarz" /></meta><meta name="dc.Creator" content="Xinjun J.  Hou" /></meta><meta name="dc.Creator" content="Dennis J.  Hoover" /></meta><meta name="dc.Creator" content="Longfei  Xie" /></meta><meta name="dc.Creator" content="Anton J.  Fliri" /></meta><meta name="dc.Creator" content="Randall J.  Gallaschun" /></meta><meta name="dc.Creator" content="John T.  Lazzaro" /></meta><meta name="dc.Creator" content="Dianne K.  Bryce" /></meta><meta name="dc.Creator" content="William E.  Hoffmann" /></meta><meta name="dc.Creator" content="Ashley N.  Hanks" /></meta><meta name="dc.Creator" content="Dina  McGinnis" /></meta><meta name="dc.Creator" content="Eric S.  Marr" /></meta><meta name="dc.Creator" content="Justin L.  Gazard" /></meta><meta name="dc.Creator" content="Mihály  Hajós" /></meta><meta name="dc.Creator" content="Renato J.  Scialis" /></meta><meta name="dc.Creator" content="Raymond S.  Hurst" /></meta><meta name="dc.Creator" content="Christopher L.  Shaffer" /></meta><meta name="dc.Creator" content="Jayvardhan  Pandit" /></meta><meta name="dc.Creator" content="Christopher J.  O’Donnell" /></meta><meta name="dc.Description" content="Positive allosteric modulators (“potentiators”) of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (AMPAR) enhance excitatory neurotransmission and may improve the cognitive d..." /></meta><meta name="Description" content="Positive allosteric modulators (“potentiators”) of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (AMPAR) enhance excitatory neurotransmission and may improve the cognitive d..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 11, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401274b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401274b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401274b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401274b" /></link>
        
    
    

<title>Discovery and Characterization of a Novel Dihydroisoxazole Class of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Potentiators | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401274b" /></meta><meta property="og:title" content="Discovery and Characterization of a Novel Dihydroisoxazole Class of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Potentiators" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0010.jpeg" /></meta><meta property="og:description" content="Positive allosteric modulators (“potentiators”) of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (AMPAR) enhance excitatory neurotransmission and may improve the cognitive deficits associated with various neurological disorders. The dihydroisoxazole (DHI) series of AMPAR potentiators described herein originated from the identification of 7 by a high-throughput functional activity screen using mouse embryonic stem (mES) cell-derived neuronal precursors. Subsequent structure-based drug design using X-ray crystal structures of the ligand-binding domain of human GluA2 led to the discovery of both PF-04725379 (11), which in tritiated form became a novel ligand for characterizing the binding affinities of subsequent AMPAR potentiators in rat brain homogenate, and PF-04701475 (8a), a prototype used to explore AMPAR-mediated pharmacology in vivo. Lead series optimization provided 16a, a functionally potent compound lacking the potentially bioactivatable aniline within 8a, but retaining desirable in vitro ADME properties." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401274b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401274b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401274b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401274b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401274b&amp;href=/doi/10.1021/jm401274b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9180-9191</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4012438" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401287m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Characterization of a Novel Dihydroisoxazole Class of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Potentiators</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nandini+C.++Patel">Nandini C. Patel</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacob++Schwarz">Jacob Schwarz</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xinjun+J.++Hou">Xinjun J. Hou</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+J.++Hoover">Dennis J. Hoover</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Longfei++Xie">Longfei Xie</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anton+J.++Fliri">Anton J. Fliri</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Randall+J.++Gallaschun">Randall J. Gallaschun</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+T.++Lazzaro">John T. Lazzaro</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dianne+K.++Bryce">Dianne K. Bryce</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+E.++Hoffmann">William E. Hoffmann</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ashley+N.++Hanks">Ashley N. Hanks</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dina++McGinnis">Dina McGinnis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+S.++Marr">Eric S. Marr</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Justin+L.++Gazard">Justin L. Gazard</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mih%C3%A1ly++Haj%C3%B3s">Mihály Hajós</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Renato+J.++Scialis">Renato J. Scialis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raymond+S.++Hurst">Raymond S. Hurst</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+L.++Shaffer">Christopher L. Shaffer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jayvardhan++Pandit">Jayvardhan Pandit</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++O%E2%80%99Donnell">Christopher J. O’Donnell</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Pfizer Worldwide Research and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div><div class="corresp-info"><strong>*</strong>(C.J.O.) Tel: (860) 715-4118. E-mail: <a href="/cdn-cgi/l/email-protection#34575c465d47405b445c51461a5e1a5b505b5a5a5158587444525d4e51461a575b59"><span class="__cf_email__" data-cfemail="cba8a3b9a2b8bfa4bba3aeb9e5a1e5a4afa4a5a5aea7a78bbbada2b1aeb9e5a8a4a6">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>(J.P.) Tel: (860) 441-3738. E-mail: <a href="/cdn-cgi/l/email-protection#85efe4fcf3e4f7e1ede4ebabf5e4ebe1ecf1c5f5e3ecffe0f7abe6eae8"><span class="__cf_email__" data-cfemail="ddb7bca4abbcafb9b5bcb3f3adbcb3b9b4a99dadbbb4a7b8aff3beb2b0">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401274b&amp;href=/doi/10.1021%2Fjm401274b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9180–9191</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 11, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 August 2013</li><li><span class="item_label"><b>Published</b> online</span>11 November 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 November 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401274b" title="DOI URL">https://doi.org/10.1021/jm401274b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9180%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNandini%2BC.%2BPatel%252C%2BJacob%2BSchwarz%252C%2BXinjun%2BJ.%2BHou%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D22%26contentID%3Djm401274b%26title%3DDiscovery%2Band%2BCharacterization%2Bof%2Ba%2BNovel%2BDihydroisoxazole%2BClass%2Bof%2B%25CE%25B1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2Bacid%2B%2528AMPA%2529%2BReceptor%2BPotentiators%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9191%26publicationDate%3DNovember%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401274b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1395</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401274b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Characterization of a Novel Dihydroisoxazole Class of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Potentiators&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nandini&quot;,&quot;last_name&quot;:&quot;C. Patel&quot;},{&quot;first_name&quot;:&quot;Jacob&quot;,&quot;last_name&quot;:&quot;Schwarz&quot;},{&quot;first_name&quot;:&quot;Xinjun&quot;,&quot;last_name&quot;:&quot;J. Hou&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;J. Hoover&quot;},{&quot;first_name&quot;:&quot;Longfei&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Anton&quot;,&quot;last_name&quot;:&quot;J. Fliri&quot;},{&quot;first_name&quot;:&quot;Randall&quot;,&quot;last_name&quot;:&quot;J. Gallaschun&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;T. Lazzaro&quot;},{&quot;first_name&quot;:&quot;Dianne&quot;,&quot;last_name&quot;:&quot;K. Bryce&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;E. Hoffmann&quot;},{&quot;first_name&quot;:&quot;Ashley&quot;,&quot;last_name&quot;:&quot;N. Hanks&quot;},{&quot;first_name&quot;:&quot;Dina&quot;,&quot;last_name&quot;:&quot;McGinnis&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;S. Marr&quot;},{&quot;first_name&quot;:&quot;Justin&quot;,&quot;last_name&quot;:&quot;L. Gazard&quot;},{&quot;first_name&quot;:&quot;Mihály&quot;,&quot;last_name&quot;:&quot;Hajós&quot;},{&quot;first_name&quot;:&quot;Renato&quot;,&quot;last_name&quot;:&quot;J. Scialis&quot;},{&quot;first_name&quot;:&quot;Raymond&quot;,&quot;last_name&quot;:&quot;S. Hurst&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;L. Shaffer&quot;},{&quot;first_name&quot;:&quot;Jayvardhan&quot;,&quot;last_name&quot;:&quot;Pandit&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. O’Donnell&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;9180-9191&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401274b&quot;},&quot;abstract&quot;:&quot;Positive allosteric modulators (“potentiators”) of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (AMPAR) enhance excitatory neurotransmission and may improve the cognitive deficits associated with various neurological disorders. The dihydroisoxazole (DHI) series of AMPAR potentiators described herein originated from the identification of 7 by a high-throughput functional activity screen using mouse embryonic stem (mES) cell-derived neuronal precursors. Subsequent structure-based drug design using X-ray crystal structures of the ligand-binding domain of human GluA2 led to the discovery of both PF-04725379 (11), which in tritiated form became a novel ligand for characterizing the binding affinities of subsequent AMPAR potentiators in rat brain homogenate, and PF-04701475 (8a), a prototype used to explore AMPAR-mediated pharmacology in vivo. Lead series optimization provided 16a, a functionally potent compound lacking the potentially bioactivatable aniline within 8a, but retaining desirab&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401274b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401274b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401274b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401274b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401274b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401274b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401274b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401274b&amp;href=/doi/10.1021/jm401274b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401274b" /></input><a href="/doi/pdf/10.1021/jm401274b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401274b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401274b%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DPatel%26date%3D2013%26atitle%3DDiscovery%2Band%2BCharacterization%2Bof%2Ba%2BNovel%2BDihydroisoxazole%2BClass%2Bof%2B%25CE%25B1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2Bacid%2B%2528AMPA%2529%2BReceptor%2BPotentiators%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D22%26spage%3D9180%26epage%3D9191%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jmcmar.2013.56.issue-22/production/jmcmar.2013.56.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Positive allosteric modulators (“potentiators”) of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (AMPAR) enhance excitatory neurotransmission and may improve the cognitive deficits associated with various neurological disorders. The dihydroisoxazole (DHI) series of AMPAR potentiators described herein originated from the identification of <b>7</b> by a high-throughput functional activity screen using mouse embryonic stem (mES) cell-derived neuronal precursors. Subsequent structure-based drug design using X-ray crystal structures of the ligand-binding domain of human GluA2 led to the discovery of both PF-04725379 (<b>11</b>), which in tritiated form became a novel ligand for characterizing the binding affinities of subsequent AMPAR potentiators in rat brain homogenate, and PF-04701475 (<b>8a</b>), a prototype used to explore AMPAR-mediated pharmacology in vivo. Lead series optimization provided <b>16a</b>, a functionally potent compound lacking the potentially bioactivatable aniline within <b>8a</b>, but retaining desirable in vitro ADME properties.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glutamate, which mediates the majority of excitatory neurotransmission in the mammalian brain, is released from presynaptic terminals to activate a variety of glutamatergic receptors on a diverse population of neurons and glia. Ionotropic glutamate receptors comprise three postsynaptic subtypes differentiated by their unique responses to the selective agonists α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate (NMDA), and kainate.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Activated AMPA receptors (AMPARs) depolarize neuronal membranes leading to increased NMDA receptor-mediated Ca<sup>2+</sup>-gating<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> that affects synaptic morphology and function<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> believed to underlie learning and memory.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Thus, AMPAR activation has been proposed to ease the cognitive deficits of diseases such as schizophrenia and Alzheimer’s disease.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Unlike orthosteric agonists, AMPAR positive allosteric modulators (“potentiators”) lack intrinsic activity. However, in the presence of glutamate, they augment agonism by modulating the biophysical properties of the receptor. It has been demonstrated that AMPAR potentiators binding at different allosteric sites can attenuate either receptor deactivation (increasing synaptic current amplitude) or both receptor deactivation and desensitization (increasing and prolonging synaptic current). Consistent with AMPAR potentiators having these effects on synaptic currents, they have been shown to reduce the threshold and elevate the ceiling of long-term potentiation, increase the task-specific firing activity of hippocampal neurons, and enhance stimulation-induced hippocampal theta-oscillation; all of which have been proposed to represent a pro-cognitive profile.<a onclick="showRef(event, 'cit3b ref5'); return false;" href="javascript:void(0);" class="ref cit3b ref5">(3b, 5)</a> These observations are supported by the nootropic effects of AMPAR potentiators in both animal models<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and in some but not all small clinical trials.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In addition to cognitive enhancement, AMPAR potentiators have shown activity in other neurodisease animal models of anxiety, attention-deficit hyperactivity disorder, Parkinson’s disease, and depression.<a onclick="showRef(event, 'cit6b ref8'); return false;" href="javascript:void(0);" class="ref cit6b ref8">(6b, 8)</a></div><div class="NLM_p">AMPARs have four subunits organized as a dimer of dimers.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> For each subunit, its extracellular portion contains an amino-terminal domain (ATD) and a ligand-binding domain (LBD), while its transmembrane portion comprises three alpha helices (TM1, TM3, and TM4) and a re-entrant hairpin loop (TM2) on the intracellular side of the membrane. The intracellular C-terminus of the receptor has been shown to possess interaction sites for a variety of proteins involved in receptor trafficking and synaptic plasticity. There are four subtypes of AMPAR subunits (GluA1–4) that are functionally organized as hetero- or homotetramers; additional structural diversity is conferred by RNA editing and alternative RNA splicing generating flip (i) and flop (o) variants for each subunit.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The flip/flop cassette, in a sequence-dependent manner, regulates the rate of channel closing and desensitization.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">There are many solved cocrystal structures of the AMPAR LBD with bound potentiators.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The membrane-proximal LBD has a bilobate structure, which has been shown to adopt open and closed conformations depending on whether it is bound to antagonists or agonists, respectively.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Glutamate binding to the LBD triggers lobe closure to initiate the gating cascade. AMPAR potentiators bind at the LBD dimer interface and preferentially stabilize the LBD in its active (closed) conformation. Different modes of allosteric activation are possible as indicated by experiments demonstrating that potentiators can differentially affect receptor deactivation and desensitization to enhance receptor signaling.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">A diverse array of chemotypes (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), distinguished by their receptor interactions, have been reported to potentiate AMPARs.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> One group of compounds, characterized by the benzamides (represented by <b>1</b>, CX516),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> the benzothiadiazines (<b>2</b>, S18986),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and the trifluomethyltetrahydroindazole carboxamides (<b>3</b>, GSK732973),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> attenuates receptor deactivation with minimal to modest effects on receptor desensitization. Another group, exemplified by the phenethylsulfonamides (<b>4</b>, LY451646),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> the heterocyclic carboxylic acids (<b>5</b>, LY2059346),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and the amino indane sulfonamides (<b>6</b>, GSK729327),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> has a primary affect of impeding receptor desensitization.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative structures of AMPAR potentiator chemotypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Considering the structural diversity and multiple binding modes of allosteric AMPAR potentiators, opportunities remain to identify and explore new molecules to expand the knowledgebase of this pharmacological class. The highlighted molecules (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) were reportedly discovered by using homotetrameric AMPAR functional assays to elucidate structure–activity relationships (SAR) and, for the phenethylsulfonamides, to identify a radioligand for in vitro AMPAR binding assays.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, because of the AMPAR complexities emphasized previously and because it is unclear which subunit combination(s) affords an optimal therapeutic agent, we used a functional assay employing mouse embryonic stem (mES) cell-derived neurons to profile compounds against a native constellation of AMPAR subtypes and their associated proteins to generate amalgamated pharmacologic values.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The assay was specifically configured for the identification of AMPAR potentiators. In this article, we disclose a new molecular class of potentiators identified in a high-throughput screen (HTS) of the Pfizer compound file utilizing this assay. Specifically, we discuss the medicinal chemistry strategy, guided by X-ray crystal structures of the AMPAR LBD-bound HTS lead followed by iterative structure-based drug design (SBDD) with the careful consideration of physicochemical properties that confer favorable absorption, distribution, metabolism, and excretion (ADME) characteristics, which identified both a novel radioligand to establish a proprietary AMPAR potentiator binding assay and a novel prototype to explore the in vivo pharmacology of this class. The developed binding assay and the in vivo characterization of the prototype compound are also disclosed.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17583" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17583" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Discovery of a Novel AMPAR Radioligand</h3><div class="NLM_p">An HTS of the Pfizer screening library using a fluorometric imaging plate reader (FLIPR)-based mES cell-derived neuronal precursors functional assay<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> identified DHI (<i>S</i>)-<b>7</b> (EC<sub>50</sub> of 4.4 μM) as an AMPAR potentiator, which was originally prepared during the identification of novel structural motifs to replace the oxolidinone of the linezolid structural class (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> With a molecular weight (MW) of 305 amu, calculated logP (clogP) of 2.0, topological polar surface area (TPSA) of 54 Å<sup>2</sup>, <b>7</b> seemed a favorable starting point for molecular optimization considering the physicochemical properties associated with orally administered small molecule drugs targeting the central nervous system (CNS).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> From an in vitro ADME perspective,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a><b>7</b> had good permeability (<i>P</i><sub>app</sub> of 35 × 10<sup>–6</sup> cm/s), no P-glycoprotein (P-gp) liability (MDR1-transfected MDCK Efflux Ratio (ER) of 0.98), and modest human liver microsome-projected clearance (<i>CL</i><sub>int,app</sub> = 26 μL/min/mg). Accordingly, the goal of SAR studies initiating from <b>7</b> was to improve functional potency while maintaining optimal CNS-centric physicochemical and ADME properties.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structure of <b>7</b> (magenta) superimposed on the X-ray structure of <b>4</b> (cyan) in the symmetrical binding pocket of the human GluA2o LBD. Only one binding pose for each compound is shown for clarity. Analogous to the sulfonamide hydrogen of <b>4</b>, the amide hydrogen of <b>7</b> forms a hydrogen bond with the backbone carbonyl oxygen of Pro-494.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Crystal structures of the AMPAR LBD show a binding site for potentiators at the interface between two subunits of the LBD.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The binding site straddles a crystallographic 2-fold axis of symmetry, which relates two subunits of the LBD, and can accommodate either two ligands bound symmetrically (e.g., cyclothiazide<a onclick="showRef(event, 'cit27b'); return false;" href="javascript:void(0);" class="ref cit27b">(27b)</a>) or a single ligand bound asymmetrically that is able to bind in two different orientations with equal affinity. A 1.5 Å resolution X-ray cocrystal structure with <b>4</b> was determined internally at the time of the HTS campaign, and this structural information was incorporated into the hit optimization strategy. Initially, the cocrystal structure of the GluA2o LBD and <b>4</b> was used as a computational docking model for the binding of <b>7</b>. Since <b>7</b> is chiral and at the time of its discovery it was unknown which enantiomer would be preferred by the receptor, each enantiomer was individually modeled using an internal proprietary docking program<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> to understand its interaction with the LBD. Through multisampling docking simulation it was determined that the original <i>S</i>-enantiomer identified from the HTS aligned well with <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) and provided the best fit in the binding pocket. The acetamide of <b>7</b> occupied the hydrophobic pocket formed by Ile-481, Leu-751, and Val-750, with its amide hydrogen forming a hydrogen bond with the backbone carbonyl of Pro-494. In this docking model, the pyrrolidine of <b>7</b> overlays with the nitrile of <b>4</b> and approaches Asn-754. For confirmation, the X-ray structure of <b>7</b> bound to the glutamate-bound LBD of human GluA2o was determined at 2.1 Å resolution (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), and it clearly showed <b>7</b> occupying the allosteric site at the dimer interface of two LBD subunits. As with <b>4</b>, <b>7</b> binds equally in two symmetrical orientations. Its acetamide projects into one deep pocket, similar to the sulfonamide in <b>4</b>.</div><div class="NLM_p">This structure immediately suggested design ideas to improve the potency of <b>7</b>. First, it was hypothesized that replacing the acetamide with a sulfonamide would better fill the hydrophobic pocket to produce a more functionally potent compound while maintaining desirable drug-like properties. The initial replacement of the acetamide of <b>7</b> with the isopropyl sulfonamide of <b>4</b> to give <b>8</b> afforded a 100-fold improvement in activity as a racemate. Following enantiopurification of <b>8</b>, functional analysis showed its <i>S</i>-enantiomer (PF-04701475, <b>8a</b>), which had acceptable physicochemical and in vitro ADME properties, to be most potent (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Attempts to expand the SAR of the acetamide region of <b>7</b> through small amide and sulfonamide libraries, along with exploring its replacement with simple carbamates and ureas, was largely unfruitful. Notably, functional activity was lost (i.e., EC<sub>50</sub> > 32 μM) upon such substitutions but retained by low molecular weight sulfonamide or amide moieties.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. ADME Properties</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">mES, all values represent an average of a 9-point concentration–response curve run in triplicate.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">mES, maximal efficacy was normalized to the average response to AMPA (100 μM) in the presence of cyclothiazide (32 μM), which was defined as 100%.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Predicted hepatic clearance (<i>CL</i><sub>H</sub>) from a human liver microsomal stability assay.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">LC–MS/MS-based quantification of the absorptive apparent permeability (<i>P</i><sub>app,A→B</sub>) of a potentiator (2 μM) across a population of Madin Darby Canine Kidney (MDCK) cells with reduced transporter expression.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">The ratio of secretory (<i>P</i><sub>app,B→A</sub>) to absorptive (<i>P</i><sub>app,A→B</sub>) apparent permeabilities of a potentiator (2 μM) in human multidrug resistance protein-1-transfected MDCK cells (MDR1-MDCK).</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">This compound was tested in 4 other trials of the assay, but the data was excluded from the mean as the range of concentrations tested did not allow for either the asymptotic maximum or minimum to be achieved. ND = not determined.</p></div></div><div></div></div><div class="NLM_p">Modeling <b>8a</b> into the crystal structure of <b>7</b> bound to AMPAR suggested its pyrrolidine was making important interactions within the binding pocket, and this was confirmed as pyrrolidine-lacking <b>9</b> was inactive (EC<sub>50</sub> > 32 μM). Des-fluoro analogue <b>10</b> was slightly less potent than <b>8</b>, indicating that the aryl fluorine might regulate only a minor interaction with the binding pocket as supported by the cocrystal structure. Furthermore, it appeared that the second hydrophobic pocket within the binding site could be accessed through pyrrolidine substitution, which might confer greater functional potency. This speculation was explored by placing an acetamide at the 3-position of the pyrrolidine to afford <b>11</b>, and it was confirmed by both the high functional potency of <b>11</b> (EC<sub>50</sub> < 10 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and its X-ray cocrystal structure (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) that the acetamide advantageously reached into the second (symmetry-related) binding pocket.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. A 1.85 Å resolution X-ray cocrystal structure of <b>11</b> showing the second (symmetric) hydrophobic pocket occupied by the acetamide substituent off the 3-position on the pyrrolidine ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Because of its high potency in functional activity in the mES assay, a tritiated form of <b>11</b> [<sup>3</sup>H]PF-04725379, with a specific activity of 44.2 Ci/mmol, was prepared to develop an AMPAR potentiator binding assay using cell membrane preparation from rat cortical tissues and modifying described methodology.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Since it is reported that glutamate enhances the binding of an AMPAR potentiator radioligand, saturations were performed with <span class="smallcaps smallerCapital">l</span>-glutamate (500 μM).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Saturation binding studies determined a <i>K</i><sub>D</sub> of 4.8 nM (<i>n</i> = 2) and <i>B</i><sub>max</sub> of 22,220 CPM (<i>n</i> = 2) of <b>11</b> in rat cortical tissue. Subsequently, a competition binding assay was developed with <b>11</b>, and the <i>K</i><sub>i</sub> values derived from it helped further validate the enantiospecific functional activity of <b>8a</b> and <b>8b</b> and additional analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Optimization of the DHI Series to Improve ADME Properties</h3><div class="NLM_p">The design of <b>11</b> demonstrated that the structure-based design strategy of making a ligand that simultaneously occupies both LBD hydrophobic pockets can indeed lead to a highly potent AMPAR potentiator. However, its high MW (427 amu) and TPSA (109 Å<sup>2</sup>) resulted in poor permeablility (<i>P</i><sub>app</sub> of 3.9 × 10<sup>–6</sup> cm/s) and high P-gp liability (MDR1 ER of 12.1). As suggested by these in vitro ADME parameters, <b>11</b> was not brain penetrant in mice (brain-to-plasma compound concentration ratio (<i>C</i><sub>b</sub>:<i>C</i><sub>p</sub>) of 0.03) hindering its use to characterize the AMPAR-mediated pharmacology of this DHI class in vivo.</div><div class="NLM_p">Consequently, the SAR around <b>8a</b> was revisited, where replacements for its aniline moiety were first sought to derisk the well-documented concerns of idiosyncratic drug reactions associated with aniline-containing molecules.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The crystal structures of <b>4</b>, <b>7</b>, and <b>11</b> indicated that substituting the pyrrolidine with an aromatic ring could be accommodated within the AMPAR LBD. Accordingly, pyrrolidine replacement with a phenyl group (<b>12</b> vs <b>8</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) significantly decreased functional potency; however, replacing it with a 3-pyridyl group (<b>13</b>) maintained fairly similar potency. As expected from the modeling and potency of <b>11</b>, nitrile introduction at the meta or para positions of the distal aromatic ring (<b>14</b> and <b>15</b>) produced very little improvement in activity, whereas incorporation into the ortho position (<b>16</b>) accessed the hydrophilic pocket and hence increased potency. As with the pyrollidine analogues, the <i>S</i>-enantiomer (<b>16a</b>) was more potent. Moreover, using the newly developed radioligand binding assay, the functional activity of compound <b>16a</b> is most likely attributed to its potent binding to the AMPAR potentiator site, which is apparent in the docked model of <b>16a</b> into the LBD (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The enhanced potency of <b>16a</b> was complimented by its retention of desirable physicochemical and in vitro ADME properties (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Model of <b>16a</b> aligned with the X-ray crystal structure of <b>11</b> to demonstrate the interaction of the cyano group. Like the acetamide of <b>11</b>, the <i>ortho</i>-nitrile of <b>16a</b> optimally accessed the symmetric hydrophilic pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p">Attractive features of the DHI series include its readily scalable synthesis and its rapidly expandable chemical landscape via enabled parallel synthesis of commercially available aldehydes (<b>17a</b>–<b>d</b>). Treatment of <b>17a</b>–<b>d</b> with hydroxylamine hydrochloride under basic conditions followed by reaction with <i>N</i>-chlorosuccinimide afforded chlorooximes <b>18a</b>–<b>d</b> in 90–99% yield (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The DHI core was prepared via a 3 + 2 cycloaddition between <b>18</b> and Boc-protected allyl amine in the presence of triethylamine to afford <b>19</b> in 85–90% yield. Liberation of the primary amine using TFA or HCl followed by addition of isopropyl sulfonyl chloride gave the desired sulfonamide <b>21</b> in 45–85% yield. An improved sequence, which eliminated the deprotection step, utilized allyl isopropylsulfonamide (<b>20</b>) in the 3 + 2 cycloaddition to cleanly afford the DHI core <b>21</b> in 85–90% yield. Suzuki couplings performed under standard conditions (Pd, ligand, base, and solvent; e.g., Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, toluene/EtOH/H<sub>2</sub>O) on the aryl bromide <b>21b</b> provided the biaryl series (<b>12</b>–<b>16</b>) and nucleophilic aromatic substitution on the aryl fluoride derivative (<b>21a</b> and <b>c</b>) provided the corresponding pyrrollidines (<b>8</b>, <b>10</b>, and <b>11</b>). As mentioned previously, enantiopure material could be obtained by either chiral preparative HPLC on the final analogues or separation at the penultimate coupling intermediate. Unambiguous confirmation of the structure was achieved through X-ray crystallographic analysis of <b>8a</b> and penultimate intermediate <b>21</b>.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of the DHI Series<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NH<sub>2</sub>OH·HCl, NaOH, EtOH, 90–99%; (b) NCS, DMF, 92–99%; (c) Boc allylamine, Et<sub>3</sub>N, 85–90%; (d) TFA, DCM, 75%; (e) isopropyl sulfonyl chloride, DBU, DMAP, 45–85% yield; (f) allylisopropylsulfonamide (<b>20</b>), Et<sub>3</sub>N, DCM, RT, 20 h, 85–90%; (g) Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, toluene/EtOH/H<sub>2</sub>O, 80 °C, 20 h (Method A) or Xphos, Pd(OAc)<sub>2</sub>, KF, 1:1 MeOH/toluene (Method B), 40–75%; (h) pyrrolidine, K<sub>2</sub>CO<sub>3</sub>, 20–70%; (i) chiral separations using SFC on either Chiralpak AD-H or Chiralcel OJ-H columns, 4.6 mm × 25 cm, carbon dioxide–methanol (90:10 or 80:20, v/v) at 2.5 mL/min, 30 °C, UV detection at 254 nm.</p></p></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In Vivo Characterization of <b>8a</b></h3><div class="NLM_p">Upon its identification as the DHI prototype, <b>8a</b> was evaluated in a series of rodent assays to determine its neuropharmacokinetics and mechanism-mediated exposure–response relationships (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). By integrating the free drug hypothesis,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> the fact that interstitial fluid drug concentrations (<i>C</i><sub>ISF</sub>) dictate drug interaction with the extracellular ligand binding site of postsynaptic transmembrane proteins<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and that unbound brain compound concentration (<i>C</i><sub>b,u</sub>) is a valid <i>C</i><sub>ISF</sub> surrogate,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> a <i>C</i><sub>b,u</sub>-normalized AMPAR-mediated exposure–response continuum was defined for <b>8a</b> in rodents. This strategy provided a preliminary acute-dose rodent-based therapeutic index (TI) for <b>8a</b> in terms of its electrophysiological and biochemical effects relative to its convulsion threshold. Because of the known safety concerns of AMPAR overstimulation,<a onclick="showRef(event, 'cit34a cit34b'); return false;" href="javascript:void(0);" class="ref cit34a cit34b">(34a, 34b)</a> defining the single-dose rodent-based TI of an AMPAR potentiator is a key step in its progression to large animal safety and efficacy studies for determining interspecies exposure–response relationships, which will ultimately dictate the compound’s clinical viability.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Summary of the AMPAR-mediated pharmacological characterization of <b>8a</b> in rodents. Panel A: Convulsion-causing <i>C</i><sub>b,u</sub> in CD-1 mice (<i>N</i> = 8) and rats (<i>N</i> = 6); ○, individual animal; ▲, interanimal mean. Panel B: <b>8a</b> dose-dependently increased CD-1 mouse cerebellum cGMP; single doses were administered SC with a 0.5 h pretreatment time, with data expressed as mean ± SEM with <i>N</i> = 5–6/dose; ** <i>P</i> < 0.01, one-way ANOVA followed by post hoc Dunnett’s <i>t</i> test. Panels C and D: Summary of the dose–response relationship in the rat MK-801-disrupted cortical oscillation (panel C) and paired-pulse facilitation (panel D) assay following IV administration of <b>8a</b>; * <i>P</i> = 0.05 vs control condition, <b>#</b><i>P</i> < 0.05 vs MK-801 condition, two-tailed Student’s <i>t</i> test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>8a</b> had low unbound fractions in rat plasma (0.027) and brain homogenate (0.014). Using described methodology<a onclick="showRef(event, 'cit33b'); return false;" href="javascript:void(0);" class="ref cit33b">(33b)</a> following a single subcutaneous (SC) dose (0.2 mg/kg) to Sprague–Dawley rats, <b>8a</b> demonstrated an identical terminal half-life (0.40 h) in both plasma and brain, an AUC<sub>0–Tlast</sub>-derived total brain-to-total plasma compound concentration ratio (<i>C</i><sub>b</sub>:<i>C</i><sub>p</sub>) of 1.04, and a <i>C</i><sub>b,u</sub>-to-unbound plasma compound concentration (<i>C</i><sub>p,u</sub>) ratio (<i>C</i><sub>b,u</sub>:<i>C</i><sub>p,u</sub>) of 0.54. Consistent with it being a highly permeable compound that is not a substrate for P-gp (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) or breast cancer resistance protein (Pfizer, internal unpublished data), <b>8a</b> has net equilibrium at the blood–brain barrier in rats, which likely occurs in higher-order species.<a onclick="showRef(event, 'cit33b'); return false;" href="javascript:void(0);" class="ref cit33b">(33b)</a></div><div class="NLM_p">In CD-1 mice, general convulsions, occurring from 5 to 11 min postdose, were observed at both 0.32 (<i>N</i> = 2 of 6 animals) and 0.56 (<i>N</i> = 6/6) mg/kg, SC and corresponded to a mean (±SD) convulsion-causing <i>C</i><sub>b,u</sub> of 2.1 ± 1.1 nM. In Sprague–Dawley rats, convulsions, occurring from 13 to 23 min postdose, were observed in both the 0.32 (<i>N</i> = 1/5) and 0.56 (<i>N</i> = 5/5) mg/kg, SC groups at a mean <i>C</i><sub>b,u</sub> of 2.3 ± 0.4 nM. In rats, generalized tremors began in all animals ca. 10 min before full convulsion. Collectively (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A), <b>8a</b> had an essentially identical exposure-based convulsion threshold in both rats and mice.</div><div class="NLM_p last">Employing a modified version of a cerebellum cyclic guanosine monophosphate (cGMP) assay,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a><b>8a</b> increased cGMP levels in CD-1 mouse cerebellum with statistically significant elevations (<i>P</i> < 0.01, versus vehicle-treated animals) 0.5 h after receiving 0.32 mg/kg, SC (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B) at a mean <i>C</i><sub>b,u</sub> of 0.4 nM. The effects of <b>8a</b> on neurocircuitry function were quantified in urethane-anesthetized Sprague–Dawley rats following disruption of the cortical electroencephalogram and paired-pulse facilitation (PPF) by the NMDA receptor antagonist MK-801.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> This model, grounded in the NMDA receptor hypofunction hypothesis of schizophrenia,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> evaluates a compound’s ability to affect the monosynaptic projection from the hippocampus/subiculum to the medial prefrontal cortex that contributes to working memory,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and such dysfunction is implicated in the decreased cognitive performance of schizophrenia patients.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Intravenous bolus (IV) administration of <b>8a</b> at 0.003 mg/kg, but not 0.001 mg/kg, significantly reversed the MK-801-induced increase in the low delta component of the local field potential (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C) and decrease in PPF (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>D). After the 0.003 mg/kg bolus, these significant effects of <b>8a</b> began at ca. 5 min at a projected <i>C</i><sub>b,u</sub> of 0.004 nM based on linear dose–<i>C</i><sub>b,u</sub> extrapolation from a rat IV pharmacokinetics study (0.01 mg/kg). Holistically, the in vivo data suggest that increasing <b>8a</b><i>C</i><sub>b,u</sub> progresses sequentially to initial nootropic electrophysiological effects ca. 100-fold below cerebellar cGMP elevation, which occurs ca. 5-fold below generalized convulsion. From an acute-dose perspective, <b>8a</b> has a ca. 500-fold TI for convulsion relative to pro-cognitive pharmacodynamics in rats. These rat-based efficacy data, coupled with projected human pharmacokinetic parameters and assuming both the translatability of the rodent exposure–response relationship and no compression of the reported acute dose-based TI upon chronic administration, suggest a daily clinically efficacious dose of ca. 0.2 mg for <b>8a</b>.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A novel series of AMPAR potentiators with a DHI core was identified by a functional assay using mES cell-derived neurons. The impact on binding of various functional groups of the lead structure <b>7</b> was determined using SBDD aided by X-ray crystal structures of select AMPAR potentiators docked within the human GluA2o LBD. Series optimization to increase functional potency led to the identification of <b>11</b> whose tritiated form helped develop a proprietary radioligand binding assay for measuring potentiator binding to native AMPARs in rat cortical tissue. Simultaneously through a minimal number of design cycles, <b>8a</b> was identified for in vivo AMPAR-mediated pharmacological characterization in rodents, which suggested its exposure separation between desired and deleterious effects was sufficient for its preclinical progression. Finally, SBDD-guided optimization of primary pharmacology, with consideration of the physicochemical and in vitro ADME properties favorable for orally administered, brain-penetrant drugs, led to the discovery of <b>16a</b>, which showed that the potentially bioactivatable aniline within <b>8a</b> was not required for highly potent compounds.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> General Chemistry Procedure</h3><div class="NLM_p">All reagents and solvents were used as purchased from commercial sources. Reactions were carried out under nitrogen. Mass spectral data was collected on a Micromass ADM atmospheric pressure chemical ionization instrument (LRMS APCI). NMR spectra were generated on a Varian 400 and 500 MHz or Bruker 400 MHz instruments. Chemical shifts were recorded in ppm relative to tetramethylsilane (TMS) with multiplicities given as s (singlet), bs (broad singlet), d (doublet), t (triplet), dd (doublet of doublets), dt (double of triplets), and m (multiplet). High-resolution mass spectra (HRMS) Accurate Mass Spectrometry analyses were conducted on an Agilent 6220 TOF mass spectrometer (Agilent Technologies, Wilmington, DE) in positive on a Agilent ZORBAX, 3.0 mm × 50 mm, C18, 1.8 μm; Column Temperature 60 °C or negative on a Waters XBridge, 3.0 mm × 50 mm, C18, 2.5 μm; Column Temperature 60 °C in electrospray mode. The system was calibrated to greater than 1 ppm accuracy across the mass range prior to analyses according to manufacturer’s specifications. The samples were separated using UHPLC on an Agilent 1200 system prior to mass spectrometric analysis. The resulting spectra were automatically lockmass corrected and the target mass ions and any confirming adducts (Na<sup>+</sup>, NH<sub>4</sub><sup>+</sup>) were extracted and combined as a chromatogram. The mass accuracy was calculated for all observed isotopes against the theoretical mass ions derived from the chemical formula using MassHunter software (Agilent Technologies). Low resolution mass spectra were determined on a Waters/Micromass system. The X-ray diffraction measurements were carried out at 298 K on a Bruker SMART APEX CCD area detector system equipped with a graphite monochromator and sealed tube Cu radiation (1.54178 Å) source. Compound purity was determined by combustion analysis (Quantitative Technologies Inc.) where the analyses indicated by the symbols of the elements were within ±0.4% of the theoretical values or by high pressure liquid chromatography (HPLC) confirming it to be ≥95% or by a combination of the two methods. HPLC conditions utilized are as follows. Gradient: 0–1.5 min 5% acetonitrile (ACN)/water, 1.5–10 min 5–100% ACN/water, 10–11 min 100% ACN, 11–12.5 min 100–5% ACN/water; UV detector, 254 nM. Retention times (RT) are in minutes and purity is calculated as % total area. (Column: XBridge C18 5 μ (4.6 mm × 150 mm); mobile phase, flow rate of 1.5 mL/min with solvent containing 0.1% TFA.</div><div class="NLM_p last">Compound <b>8a</b>, >99% chemical purity, <a class="ref internalNav" href="#notes-7" aria-label="Supplemental Data">Supplemental Data</a>) and <i>N</i>-((<i>S</i>)-1-(3,5-[3<i>H</i>]-2-fluoro-4-((<i>S</i>)-5-((1-methylethylsulfonamido)methyl)-4,5-dihydroisoxazol-3-yl)phenyl)pyrrolidin-3-yl)acetamide ([<sup>3</sup>H]<b>11</b>), 98.5% radiochemical purity, 100% ee, 49 Ci/mmol) were synthesized and fully characterized by Neuroscience Chemistry at Pfizer Worldwide Research and Development (WRD, Groton, CT). Compound <b>8a</b> (Product No. PZ0215) and <b>11</b> (Product No. PZ0216) are commercially available from Sigma-Aldrich Corporation (St. Louis, MO).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Procedure for the SN<sub>2</sub>Ar</h3><div class="NLM_p">The dihydroisoxazole <b>21</b> (3.1 mmol), the corresponding pyrrolidine (17.6 mmol), and powdered potassium carbonate (4.0 mmol) were combined in a sealed tube and heated to 135–140 °C. The resulting melt was heated until the starting dihydroisoxazole was consumed (2–16 h depending on substrate). The reaction mixture was cooled to room temperature, diluted with water (10 vol), and extracted with ethyl acetate (3 × 10 vol). The combined organic layers were washed consecutively with water (2 × 10 vol), saturated sodium chloride solution (10 vol), dried over anhydrous magnesium sulfate and filtered. The solvent was removed under reduced pressure and the resulting solid purified via chromatography or crystallization to afford the desired product.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> <i>N</i>-((3-(3-Fluoro-4-(pyrrolidin-1-yl)phenyl)-4,5-dihydroisoxazol-5-yl)methyl)propane-2-sulfonamide (<b>8</b>)</h4><div class="NLM_p">The product was obtained from <b>21a</b> and pyrrolidine. The crude material was purified via flash chromatography (Isco silica gel, 5% MeOH/DCM) followed by crystallization from toluene to afford <b>8</b> in 78% yield as a white crystalline solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32 (dd, <i>J</i> = 14.93, 2.07 Hz, 1H), 7.21 (dd, <i>J</i> = 8.30, 2.07 Hz, 1H), 6.61 (t, <i>J</i> = 8.92 Hz, 1H), 4.79–4.89 (m, 1H), 4.67 (t, <i>J</i> = 6.43 Hz, 1H), 3.15–3.52 (m, 9H), 1.93–2.01 (m, 4H), 1.38 (dd, <i>J</i> = 6.84, 2.28 Hz, 6H).</div><div class="NLM_p">Separation of the enantiomers was done via a chiral chromatography (SFC chromatography on either Chiralcel OJ-H column, 4.6 mm × 25 cm, carbon dioxide–methanol (90:10 or 80:20, v/v) at 2.5 mL/min, 30 °C, UV detection at 254 nM) to afford (<b>8a</b> and <b>8b</b>) as white solids.</div><div class="NLM_p">Enantiomer 1: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32 (dd, <i>J</i> = 14.93, 2.07 Hz, 1H), 7.22 (dd, <i>J</i> = 8.30, 2.07 Hz, 1H), 6.60 (t, <i>J</i> = 8.92 Hz, 1H), 4.80–4.88 (m, 1H), 4.57 (t, <i>J</i> = 6.43 Hz, 1H), 3.45–3.51 (m, 4H), 3.16–3.44 (m, 5H), 1.94–2.01 (m, 4H), 1.38 (dd, <i>J</i> = 6.64, 2.49 Hz, 6H). HRMS (ESI-) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>17</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>3</sub>S 370.1595; found 370.1598.</div><div class="NLM_p last">Enantiomer 2: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.33 (dd, <i>J</i> = 15.14, 1.87 Hz, 1H), 7.22 (dd, <i>J</i> = 8.30, 2.07 Hz, 1H), 6.61 (t, <i>J</i> = 8.71 Hz, 1H), 4.80–4.89 (m, 1H), 4.52 (t, <i>J</i> = 6.22 Hz, 1H), 3.45–3.51 (m, 5H), 3.15–3.45 (m, 5H), 1.95–2.01 (m, 4H), 1.39 (dd, <i>J</i> = 6.84, 2.28 Hz, 6H). Calcd. for C<sub>17</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>3</sub>S: C, 55.27; H, 6.33; N,11.37. Found: C, 55.24; H, 6.78; N, 11.58. HRMS (ESI-) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>17</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>3</sub>S 370.1595; found 370.1597.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> <i>N</i>-((3-(4-(Pyrrolidin-1-yl)phenyl)-4,5-dihydroisoxazol-5-yl)methyl)propane-2-sulfonamide (<b>10</b>)</h4><div class="NLM_p last">The product was obtained from <b>21c</b> and pyrrolidine. The crude material was purified via flash chromatography (Isco silica gel, 10% MeOH/DCM) to afford the product in 22% yield as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.49–7.54 (m, 2H), 6.51–6.57 (m, 2H), 4.78–4.87 (m, 1H), 4.55 (t, <i>J</i> = 6.22 Hz, 1H), 3.15–3.50 (m, 9H), 2.03 (td, <i>J</i> = 6.64, 3.32 Hz, 4H), 1.37–1.41 (m, 6H). Calcd for C<sub>17</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>S: C, 58.09; H, 7.17; N, 11.96. Found: C, 57.62; H, 7.15; N, 11.71. HRMS (ESI-) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>17</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub>S 352.1689; found 352.1684.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> <i>N</i>-((3<i>S</i>)-1-(2-Fluoro-4-(5-((1-methylethylsulfonamido)methyl)-4,5-dihydroisoxazol-3-yl)phenyl)pyrrolidin-3-yl)acetamide (<b>11</b>)</h4><div class="NLM_p last">The product was obtained from <b>21a</b> and commercially available (<i>S</i>)-<i>N</i>-(pyrrolidin-3-yl)acetamide. The crude material was crystallized from toluene to afford the product in 68% yield as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36 (dd, <i>J</i> = 14.93, 2.07 Hz, 1H), 7.24 (dd, <i>J</i> = 8.50, 1.87 Hz, 1H), 6.63 (t, <i>J</i> = 8.71 Hz, 1H), 5.80 (d, <i>J</i> = 7.05 Hz, 1H), 4.81–4.91 (m, 1H), 4.49–4.67 (m, 2H), 3.60–3.75 (m, 2H), 3.47 (ddd, <i>J</i> = 13.79, 5.91, 3.53 Hz, 2H), 3.29–3.42 (m, 3H), 3.16–3.28 (m, 2H), 2.28 (dd, <i>J</i> = 13.89, 5.60 Hz, 1H), 2.00 (s, 3H), 1.92–1.99 (m, 1H), 1.38 (dd, <i>J</i> = 6.84, 3.53 Hz, 6H). Calcd for C<sub>19</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>4</sub>S: C, 53.51; H, 6.38; N, 13.14. Found: C, 53.51; H, 6.38; N, 13.09. HRMS (ESI-) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>19</sub>H<sub>28</sub>FN<sub>4</sub>O<sub>4</sub>S 427.1810; found 427.1805.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Procedure for the Suzuki Coupling</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Method A</h4><div class="NLM_p last">Sodium carbonate (0.25 mmol) was added to a solution of the bromide <b>21b</b> (0.05 mmol) in ethanol (1.0 mL) and water (0.2 mL). The solution was degassed for 15 min and a solution of Pd(PPh<sub>3</sub>)<sub>4</sub> (2.5 μmol) in toluene (0.1 mL) was added. The reaction mixture was heated to 80 °C and stirred for 20 h. The reaction mixture was cooled to room temperature and partitioned between ethyl acetate (3 × 2.5 mL) and 1 N sodium hydroxide (1.5 mL). The organic layer was washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, and the solvent removed under reduced pressure. The crude product was purified by column chromatography.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Method B</h4><div class="NLM_p last">Bromide <b>21b</b> (0.53 mmol), Xphos (0.05 mmol), KF (2.67 mmol), boronic acid (0.80 mmol), and palladium acetate (0.025 mmol) were combined in a 10 mL microwave vial. The vial was purged with N<sub>2</sub>/vacuum three times then a degassed 1:1 MeOH/toluene solution (2 mL) was added and heated at 130 °C for 50 min in the microwave. The solvent was removed under reduced pressure and diluted with saturated sodium bicarbonate (25 mL) and washed with dichloromethane (3 × 25 mL). The combined organic layers were dried over anhydrous magnesium sulfate and the solvent removed under reduced pressure. The crude product was purified by column chromatography.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-((3-(2-Fluoro-[1,1′-biphenyl]-4-yl)-4,5-dihydroisoxazol-5-yl)methyl)propane-2-sulfonamide (<b>12</b>)</h4><div class="NLM_p last">Prepared via Method A from <b>21b</b> and phenylboronic acid in 46% yield as an off white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.53–7.59 (m, 2H), 7.37–7.52 (m, 6H), 4.95 (dddd, <i>J</i> = 10.68, 7.36, 5.39, 3.53 Hz, 1H), 4.80 (t, <i>J</i> = 6.43 Hz, 1H), 3.28–3.56 (m, 4H), 3.15–3.27 (m, 1H), 1.36–1.42 (m, 6H).</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>-((3-(3-Fluoro-4-(pyridin-3-yl)phenyl)-4,5-dihydroisoxazol-5-yl)methyl)propane-2-sulfonamide (<b>13</b>)</h4><div class="NLM_p last">Prepared via Method A from <b>21b</b> and pyridin-3-ylboronic acid in 76% yield as an off white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.83 (br. s., 1H), 8.66 (d, <i>J</i> = 3.90 Hz, 1H), 7.95 (dd, <i>J</i> = 7.80, 1.56 Hz, 1H), 7.40–7.60 (m, 4H), 4.91–5.06 (m, 1H), 4.64 (t, <i>J</i> = 6.24 Hz, 1H), 3.29–3.60 (m, 4H), 3.23 (td, <i>J</i> = 13.66, 6.83 Hz, 1H), 1.34–1.45 (m, 6H). Calcd for C<sub>18</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>3</sub>S·1.6 H<sub>2</sub>O: C, 53.22; H, 5.76; N, 10.34. Found: C, 53.05; H, 5.02; N, 10.20. HRMS (ESI-) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>18</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>3</sub>S 378.1282; found 378.1285.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-((3-(4′-Cyano-2-fluoro-[1,1′-biphenyl]-4-yl)-4,5-dihydroisoxazol-5-yl)methyl)propane-2-sulfonamide (<b>14</b>)</h4><div class="NLM_p last">Prepared via Method B from <b>21b</b> and (4-cyanophenyl)boronic acid in 76% yield as an off white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.73–7.81 (m, 2H), 7.64–7.72 (m, 2H), 7.44–7.60 (m, 3H), 4.98 (dd, <i>J</i> = 4.98, 3.32 Hz, 1H), 4.54 (dd, <i>J</i> = 7.05, 5.81 Hz, 1H), 3.32–3.58 (m, 4H), 3.22 (quin, <i>J</i> = 6.84 Hz, 1H), 1.40 (dd, <i>J</i> = 6.84, 3.94 Hz, 6H). HRMS (ESI-) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>20</sub>H<sub>21</sub>FN<sub>3</sub>O<sub>3</sub>S 402.1282; found 402.1286.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>N</i>-((3-(3′-Cyano-2-fluoro-[1,1′-biphenyl]-4-yl)-4,5-dihydroisoxazol-5-yl)methyl)propane-2-sulfonamide (<b>15</b>)</h4><div class="NLM_p last">Prepared via Method B from <b>21b</b> and (3-cyanophenyl)boronic acid in 45% yield as a tan solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.86 (d, <i>J</i> = 1.24 Hz, 1H), 7.81 (qd, <i>J</i> = 7.88, 1.52 Hz, 1H), 7.70 (td, <i>J</i> = 7.88, 1.45 Hz, 1H), 7.44–7.62 (m, 4H), 4.97 (dddd, <i>J</i> = 10.73, 7.73, 4.77, 3.32 Hz, 1H), 4.51–4.58 (m, 1H), 3.31–3.58 (m, 4H), 3.22 (spt, <i>J</i> = 6.80 Hz, 1H), 1.40 (dd, <i>J</i> = 6.64, 3.73 Hz, 6H). Calcd. for C<sub>20</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>3</sub>S: C, 59.84; H, 5.02; N, 10.47. Found: C, 59.24; H, 5.17; N, 10.09. HRMS (ESI-) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>20</sub>H<sub>21</sub>FN<sub>3</sub>O<sub>3</sub>S 402.1282; Found 402.1283.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>N</i>-((3-(2′-Cyano-2-fluoro-[1,1′-biphenyl]-4-yl)-4,5-dihydroisoxazol-5-yl)methyl)propane-2-sulfonamide (<b>16</b>)</h4><div class="NLM_p">Prepared via Method B from <b>21b</b> and (2-cyanophenyl)boronic acid in 38% yield as an off white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.80 (dd, <i>J</i> = 7.88, 1.24 Hz, 1H), 7.66–7.72 (m, 1H), 7.46–7.58 (m, 5H), 4.97 (dddd, <i>J</i> = 10.68, 7.36, 5.60, 3.32 Hz, 1H), 4.69 (t, <i>J</i> = 6.43 Hz, 1H), 3.29–3.56 (m, 4H), 3.23 (spt, <i>J</i> = 6.84 Hz, 1H), 1.40 (dd, <i>J</i> = 6.84, 2.70 Hz, 6H). Calcd. for C<sub>20</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>3</sub>S: C, 59.84; H, 5.02; N, 10.47. Found: C, 59.25; H, 4.95; N, 10.23. HRMS (ESI-) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>20</sub>H<sub>21</sub>FN<sub>3</sub>O<sub>3</sub>S 402.1282; found 402.1281.</div><div class="NLM_p last">Separation of <b>16</b> was performed via a chiral chromatography (SFC chromatography on a Chiralpak AD-H column, 4.6 mm × 25 cm, carbon dioxide–methanol (90:10 or 80:20, v/v) at 2.5 mL/min, 30 °C, UV detection at 254 nM) to afford (<b>16a</b>) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.77–7.82 (m, 1H), 7.65–7.72 (m, 1H), 7.44–7.58 (m, 5H), 4.86–5.01 (m, 2H), 3.29–3.56 (m, 4H), 3.17–3.27 (m, 1H), 1.39 (dd, <i>J</i> = 6.84, 3.53 Hz, 6H). HRMS (ESI-) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> Calcd for C<sub>20</sub>H<sub>21</sub>FN<sub>3</sub>O<sub>3</sub>S 402.1282; found 402.1289.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> X-ray Crystallography</h3><div class="NLM_p last">GluR2-S1S2J flop protein was expressed, refolded, and purified essentially as previously reported<a onclick="showRef(event, 'cit27b'); return false;" href="javascript:void(0);" class="ref cit27b">(27b)</a> with 1 mM (<i>S</i>)-Glu present during all steps. It was crystallized in complex with (<i>S</i>)-Glu and potentiator compounds by the hanging-drop vapor-diffusion method at 4 °C. The protein solution contained 7 mg/mL GluR2-S1S2J, 10 mM (<i>S</i>)-Glu, 10 mM HEPES (pH 7.5), 20 mM NaCl, and 1 mM EDTA. Compound was added to a final concentration of 150 μM from a 30 mM DMSO stock. To this solution, an equal amount of reservoir solution containing 10% PEG 8000, 0.1 M ZnAc, and 0.1 M NaAc, pH 5.5, was added, and 2 μL drops of this mixture were allowed to equilibrate by vapor diffusion over a 1 mL reservoir. Crystals appeared in the drops in 3–5 days, were transferred to a cryoprotectant solution consisting of the crystallization buffer supplemented with 15% glycerol, and flash-frozen in liquid nitrogen. Because the modulators bind on the molecular 2-fold axis, two modulator molecules were modeled for each binding site, each with occupancies of 0.5. Data collection and refinement statistics are provided in the <a class="ref internalNav" href="#notes-7" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Rat Brain Homogenate Radioligand Binding Assay</h3><div class="NLM_p">Brains from 7 to 8 week old Sprague–Dawley rats were purchased from Pel-Freez Biologicals (Rogers, AR) and stored at −80 °C. The cortex was dissected, homogenized using a polytron in 50 mM Tris 7.4 and centrifuged (40,000<i>g</i> for 20 min). The resulting pellet was resuspended in 50 mM Tris 7.4 and centrifuged (40,000<i>g</i> for 20 min); this was repeated three times for a total of 4 washes, after which the pellet was resuspended in 30 mM Tris 7.4 at 100 mg/mL and stored at −80 °C. The multiple wash steps were performed to remove endogenous glutamate from the cortical tissue preparation.</div><div class="NLM_p">Saturation binding studies were performed by adding 175 μL of different concentrations of <b>11</b> in assay buffer (30 mM Tris HCl, pH 7.4) to a 96-well polypropylene plate. Twenty-five microliters of assay buffer or <i>N</i>-((3<i>R</i>,4<i>S</i>)-3-(2′-cyano-[1,1′-biphenyl]-4-yl)tetrahydro-2<i>H</i>-pyran-4-yl)propane-2-sulfonamide (<b>22</b>, PF-04697190)<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> was then added to each well. Compound <b>22</b> (100 μM in assay buffer, final concentration 10 μM) was used to determine nonspecific binding. <span class="smallcaps smallerCapital">l</span>-Glutamic acid (25 μL, 5 mM stock concentration, 500 nM final concentration) was added to each well unless indicated. The previously prepared rat cortical tissue was thawed and homogenized (100 mg/mL), then added (25 μL, 2.5 mg tissue, 0.25 mg/well final concentration) to each sample well. Plates were incubated for 2 h at 37 °C and then harvested onto uncoated Filtermat B filters (PerkinElmer Inc., Waltham, MA) using a Skatron filter harvester (Skatron Instruments Ltd., Newmarket, UK) and Tris wash buffer (50 mM, pH 7.4, 4 °C). Filters were dried overnight at room temperature, placed in scintillant bags and read using a Betaplate filtermat reader (PerkinElmer, Inc.).</div><div class="NLM_p last">Competition binding studies used similar methods. Compound <b>11</b> was added to each well (175 μL) at a concentration of approximately 1 nM; for each experiment, the precise stock solution concentration was determined by liquid scintillation counting. <span class="smallcaps smallerCapital">l</span>-Glutamic acid (25 μL) was added. Assay buffer, test compounds, or <b>22</b><a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> were added (25 μL) to negative control, sample, and positive control wells, respectively. Test compounds for competitive binding experiments were prepared as DMSO stock solutions (10 or 30 mM), then titrated for dose response studies, at 10-fold their final concentrations. Concentration–response data were fitted using a logistic four parameter fit model. The <i>K</i><sub>i</sub> for each compound was determined using the calculated IC<sub>50</sub> and the ligand concentration determined for each experiment using the Cheng–Prusoff equation.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> In Vivo Studies with <b>8a</b></h3><div class="NLM_p">Chemicals and solvents were supplied by Sigma-Aldrich Corporation (St. Louis, MO), Thermo Fisher Scientific (Waltham, MA), and Mallinckrodt Baker, Inc. (Phillipsburg, NJ). For control matrices, species-specific plasma was procured from Bioreclamation, Inc. (Hicksville, NY) and rat brain tissue was obtained at WRD. Male CD-1 mice and Sprague–Dawley rats were bought from Harlan Laboratories (Indianapolis, IN) or Charles River Laboratories, Inc. (Wilmington, MA), respectively. All studies were performed in accordance with the <i>Guide for the Care and Use of Laboratory Animals</i> (Institute of Laboratory Animal Resources, 1996) using protocols reviewed and approved by the WRD Institutional Animal Care and Use Committee. All blood samples were collected into EDTA-containing tubes and processed immediately to obtain plasma, and the collection of neuromatrices followed published techniques.<a onclick="showRef(event, 'cit33b'); return false;" href="javascript:void(0);" class="ref cit33b">(33b)</a> All biomatrices collected for <b>8a</b> quantification, which occurred using a described method,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> were stored at −70 °C until processing for bioanalysis.</div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Plasma and Brain Homogenate Nonspecific Binding</h4><div class="NLM_p last">Using a reported equilibrium dialysis procedure,<a onclick="showRef(event, 'cit33b'); return false;" href="javascript:void(0);" class="ref cit33b">(33b)</a> the unbound fraction (<i>f</i><sub>u</sub>) of <b>8a</b> (1 μM, <i>N</i> = 4/matrix) was determined in Sprague–Dawley rat plasma (<i>f</i><sub>u,p</sub>) and brain homogenate (<i>f</i><sub>u,b</sub>). The stability of <b>8a</b> in each biomatrix and the optimal dialysis time were determined separately prior to actual studies.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> In Vivo Pharmacokinetics</h4><div class="NLM_p last">Before in vivo pharmacology experiments, studies with <b>8a</b> characterizing its pharmacokinetics (peripheral and/or central) were conducted in rodents to determine total plasma (<i>C</i><sub>p</sub>) and/or brain (<i>C</i><sub>b</sub>) compound concentrations at select times after a specific dose, which allowed the correlation of pharmacodynamics to <i>C</i><sub>p</sub> and/or <i>C</i><sub>b</sub> in in vivo pharmacology experiments. Individual animal doses were calculated based on respective dose solution concentrations (mg/mL), pretreatment body weights (kg), and dose volume (mL/kg); the actual amount of dose solution administered to each animal was determined by weighing the loaded syringe before and after it was dispensed. All study animals were fasted overnight.</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Mouse</h4><div class="NLM_p last">A single dose (0.1 mg/kg) of <b>8a</b> in 5:5:90 (v/v/v) DMSO/cremophor EL/deionized H<sub>2</sub>O (0.01 mg/mL) was administered (10 mL/kg) subcutaneously (SC) to CD-1 (<i>N</i> = 2) mice. At 0.5 h postdose, animals were placed under isoflurane anesthesia for the collection of blood and brain samples.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Rat Intravenous Dose</h4><div class="NLM_p last">From jugular vein-cannulated Sprague–Dawley rats (<i>N</i> = 3) receiving a single bolus (1 mL/kg) intravenously (IV) of <b>8a</b> (0.01 mg/kg) in 2:98 (v/v) DMSO/10% hydroxypropyl-β-cyclodextrin, blood samples (0.5 mL) were serially collected just before dosing and at 0.083, 0.25, 0.5, 1, 2, 4, 6, 8, and 12 h postdose.</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Neuropharmacokinetics</h4><div class="NLM_p">Applying described methodology,<a onclick="showRef(event, 'cit33b'); return false;" href="javascript:void(0);" class="ref cit33b">(33b)</a> a single dose (0.2 mg/kg, SC) of <b>8a</b> in 20% hydroxypropyl-β-cyclodextrin (0.2 mg/mL) was injected (1 mL/kg) into each male Sprague–Dawley rat. Blood, cerebrospinal fluid (CSF), and brain samples were collected from each animal after euthanasia by CO<sub>2</sub> asphyxiation at 0.25, 0.5, 1, 2, 4, and 8 h postdose (<i>N</i> = 2/time point). </div><div class="NLM_p">Pharmacokinetic parameters were calculated by noncompartmental analyses using WinNonlin version 5.2 (Pharsight Corp., Mountain View, CA). The area under the matrix compound concentration–time curve (AUC<sub>0–Tlast</sub>) was calculated using the linear trapezoidal method, the elimination rate constant (<i>k</i><sub>el</sub>) was determined by linear regression of the log concentration versus time data during the last observable elimination phase, and half-life (<i>t</i><sub>1/2</sub>) was calculated as 0.693/<i>k</i><sub>el</sub>. Both <i>C</i><sub>max</sub> and <i>T</i><sub>max</sub> were taken directly from the matrix compound concentration versus time data, and AUC<sub>0–Tlast</sub>-based interneurocompartmental ratios were calculated.<a onclick="showRef(event, 'cit33b'); return false;" href="javascript:void(0);" class="ref cit33b">(33b)</a></div><div class="NLM_p">In select rodent pharmacology models, <b>8a</b> was studied to understand the relationship between its <i>C</i><sub>b,u</sub> and a particular AMPAR-mediated effect, which together allowed comparison to its in vitro pharmacology values. Collectively, this strategy provided dose-dependent, temporally normalized, and assay-dependent <i>C</i><sub>b,u</sub> that could be directly compared across all in vivo models. For each species, its pharmacodynamics evaluation used the same dosing vehicle, volume, and route as its pharmacokinetics studies. For terminal assays in which brain tissue was collected from an animal undergoing the assessment (i.e., convulsion dose–response), <i>C</i><sub>b,u</sub> (nM units) was determined by measured <i>C</i><sub>b</sub>, <b>8a</b> MW (369.5 g/mol), rat <i>f</i><sub>u,b</sub>, an assumed brain tissue density of 1 g/mL, and eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a>:<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/jm-2013-01274b_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span></div><div class="NLM_p">The experimentally determined rat <i>f</i><sub>u,b</sub> was used for mouse <i>C</i><sub>b,u</sub> calculations since interspecies <i>f</i><sub>u,b</sub> are highly consistent.<a onclick="showRef(event, 'cit34c'); return false;" href="javascript:void(0);" class="ref cit34c">(34c)</a></div><div class="NLM_p">For assays (i.e., mouse cGMP and rat PPF) in which plasma or brain samples were not collected for <b>8a</b> quantification from animals undergoing pharmacodynamic evaluation, the <i>C</i><sub>b,u</sub> for each tested dose at a fixed time point was projected assuming stationary pharmacokinetics within the dose range studied either directly from the mouse SC pharmacokinetics dose-<i>C</i><sub>b</sub> data (mouse cGMP) or indirectly via eq <a class="ref internalNav" href="#eq2" aria-label="2">2</a> and the rat IV pharmacokinetics dose-derived <i>C</i><sub>p</sub>-time data (rat PPF):<span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/jm-2013-01274b_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span></div><div class="NLM_p last">Within eq <a class="ref internalNav" href="#eq2" aria-label="2">2</a>, <i>C</i><sub>b,u</sub>:<i>C</i><sub>p,u</sub> is the AUC-based interneurocompartmental relationship determined in the rat neuropharmacokinetics study that allows the projection of <i>C</i><sub>b,u</sub> from a measured <i>C</i><sub>p</sub>.<a onclick="showRef(event, 'cit33b'); return false;" href="javascript:void(0);" class="ref cit33b">(33b)</a></div></div><div id="sec4_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Convulsion Dose–Response Studies</h4><div class="NLM_p last">Compound <b>8a</b> was administered to adult male CD-1 mice (0.32 or 0.56 mg/kg, SC; <i>N</i> = 6/dose) or Sprague–Dawley rats (0.32 or 0.56 mg/kg, SC; <i>N</i> = 5/dose), which were observed for up to 1.5 h postdose. Individual animals were euthanized by CO<sub>2</sub> asphyxiation at the time of convulsion (if any), and blood and brain were collected for <b>8a</b> quantification.</div></div><div id="sec4_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Mouse Cerebellum Cyclic Guanosine Monophosphate (cGMP) Assay</h4><div class="NLM_p last">Paralleling the procedure of Ryder et al.,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> adult male CD-1 mice (25–30 g, acclimated to the vivarium 7 d before use, <i>N</i> = 5–6/dose) receiving vehicle or <b>8a</b> (0.01, 0.032, 0.1, or 0.32 mg/kg, SC) were placed in an open shoebox with sawdust bedding and observed for 0.5 h. Mice were then individually placed head first in a Plexiglas restraining device and euthanized using a beam of microwave radiation focused on the skull for 0.88 s at 100% power in a Cober Electronics microwave (Cober Electronics, Inc., Norwalk, CT). After cooling for 1 min, the cerebellum was dissected, weighed, and frozen on dry ice. Tissue cGMP levels were determined using a competitive enzyme immunoassay (EIA) using a commercially available Cyclic GMP EIA kit (Cayman Chemical Company, Ann Arbor, MI). All buffers and cGMP standards were prepared exactly as described in the package insert. Each cerebellum sample was homogenized (10 μL buffer/mg tissue) in lysis buffer (10 mM Tris HCl, 100 mM NaCl, 1 mM EDTA, and 0.3% NP-40, pH 7.4) using a tip sonicator. Homogenate was added to a 1.5 mL Eppendorf tube and centrifuged (18,000<i>g</i> for 20 min at 4 °C), and the supernatant was diluted 1:25 with EIA buffer and added in triplicate to a 96-well plate. Samples were processed according to kit directions for 12 h at 4 °C. A cGMP standard curve (0.023 to 3.0 pmol/mL) was included on each assay plate. Following incubation, plates were washed, developed using Ellman’s reagent for 2 h at rt, and then read at 420 nm on a SpectraMax Microplate Reader (Molecular Devices, LLC). Data were compiled and reduced using the SpectraMax data reduction software, which calculates sample cGMP levels via standard curve extrapolation. For each dose group, data were reported as group means ± SEM using X-fold changes in tissue cGMP levels relative to the vehicle-treated group. Doses of <b>8a</b> were compared to the concurrent vehicle control group using One-way Analysis of Variance (ANOVA) followed by Dunnett’s <i>t</i> test (SigmaStat Version 3.5; Systat Software, Inc., Chicago, IL). A value of <i>p</i> < 0.05 indicated a statistically significant effect.</div></div><div id="sec4_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Rat MK-801-Disrupted Cortical Oscillation and Paired-Pulse Facilitation (PPF) Assay</h4><div class="NLM_p last">The objective of this study was to quantify the effects of systemically administered <b>8a</b> on the cortical disruption of electroencephalogram (EEG) and paired-pulse facilitation (PPF) by the noncompetitive NMDAR antagonist MK-801 in urethane-anesthetized Sprague–Dawley rats. This is a preclinical model, which evaluates the subiculum-medial prefrontal cortex pathway, proposed for studying NMDAR hypofunction of schizophrenia. Experimental procedures were those published by Kiss et al.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> using male Sprague–Dawley rats (250 to 320 g, <i>N</i> = 5) under urethane anesthesia (1.5 mg/kg, intraparotenial). For the IV dose–response effects of <b>8a</b>, control waveform averages were first computed using 60 consecutive paired-stimuli over a 10 min period. MK-801 (0.05 mg/kg, IV; Tocris Bioscience, Bristol, U.K.) was then administered, and after a 5-min waiting period, paired-pulse averaging was again conducted over the next two consecutive 5-min time bins. The total MK-801 response was then computed by combining these two averages. At the end of the second 5-min data collection time bin (i.e., 15 min after MK-801 injection), cumulative IV administration of <b>8a</b> (0.001 and 0.03 mg/kg) was initiated. Similar to how the data were handled following MK-801 dosing, 5 min were allowed between each successive <b>8a</b> injection and the start of the subsequent averaging. If no effect was observed before the end of the second 5-min averaging period then the two 5-min averages were combined as a single value for that dose and the next IV dose was given. If an effect was observed at any point during the first two averages following a given dose, then two additional 5-min averages were combined as the data point for that dose. The reversal of the MK-801 effects by <b>8a</b> did not occur in a typical cumulative dose–response manner, but rather as an all-or-none effect with variable threshold doses between animals. Since reversal was an all-or-none effect once the threshold dose in a particular animal was reached, no additional cumulative doses of <b>8a</b> were given. Instead, responses to the paired-pulse stimulations were recorded continuously and averaged over each consecutive 10-min time-bin following a specific dose of <b>8a</b>. Mean effects in the <b>8a</b> doses were compared to both the control (vehicle) and MK-801 doses using a two-tailed Student’s <i>t</i> test (Microsoft Excel, Microsoft Corporation, Redmond, WA). A value of <i>p</i> < 0.05 indicated a statistically significant effect.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-7"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35"><a href="/doi/suppl/10.1021/jm401274b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures and characterization data for formation of <b>18</b>–<b>21</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401274b/suppl_file/jm401274b_si_001.pdf">jm401274b_si_001.pdf (212.58 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited with the Protein Data Bank for complexes of compounds <b>4</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ5">4LZ5</a>), <b>7</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ7">4LZ7</a>), and <b>11</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ8">4LZ8</a>).</p><div class="testing" data-doi="10.1021/jm401274b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayvardhan Pandit</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5339322a253221373b323d7d23323d373a271323353a2936217d303c3e"><span class="__cf_email__" data-cfemail="8ce6edf5faedfee8e4ede2a2fcede2e8e5f8ccfceae5f6e9fea2efe3e1">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. O’Donnell</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2c4f445e455f58435c44495e02460243484342424940406c5c4a4556495e024f4341"><span class="__cf_email__" data-cfemail="aecdc6dcc7dddac1dec6cbdc80c480c1cac1c0c0cbc2c2eedec8c7d4cbdc80cdc1c3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nandini C. Patel</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacob Schwarz</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinjun J. Hou</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis J. Hoover</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Longfei Xie</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anton J. Fliri</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Randall J. Gallaschun</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John T. Lazzaro</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dianne K. Bryce</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William E. Hoffmann</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ashley N. Hanks</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dina McGinnis</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric S. Marr</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Justin L. Gazard</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mihály Hajós</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Renato J. Scialis</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raymond S. Hurst</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher L. Shaffer</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research
and Development, Groton Laboratories, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1127e2572-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Jon Bordner and Dr. Brian Samas for the single-crystal X-ray structure of <b>8a</b> and Dr. Klaas Schildknegt for his radiosynthetic expertise. We also thank the Pfizer World Wide Medicinal Chemistry Analytical Group for setting up the MS and NMR assays for structure determination and Daniel Virtue and Robert Depianta for chiral separations. We are also grateful to Dr. Russell Dushin and Dr. Katherine Brighty for their review and helpful suggestions in preparing this manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i44" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i44"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i45" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i45"> Abbreviations Used</h2><tr><td class="NLM_term">DHI</td><td class="NLM_def"><p class="first last">dihydroisoxazole</p></td></tr><tr><td class="NLM_term">mES</td><td class="NLM_def"><p class="first last">mouse embryonic stem</p></td></tr><tr><td class="NLM_term">ATD</td><td class="NLM_def"><p class="first last">amino-terminal domain</p></td></tr><tr><td class="NLM_term">FLIPR</td><td class="NLM_def"><p class="first last">fluorometric imaging plate reader</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin Darby Canine Kidney</p></td></tr><tr><td class="NLM_term"><i>CL</i><sub>H</sub></td><td class="NLM_def"><p class="first last">hepatic clearance</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app,A→B</sub></td><td class="NLM_def"><p class="first last">absorptive apparent permeabilities</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app,B→A</sub></td><td class="NLM_def"><p class="first last">secretory apparent permeabilities</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>b,u</sub></td><td class="NLM_def"><p class="first last">unbound brain compound concentration</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>p,u</sub></td><td class="NLM_def"><p class="first last">unbound plasma compound concentration</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>ISF</sub></td><td class="NLM_def"><p class="first last">interstitial fluid drug concentration</p></td></tr><tr><td class="NLM_term">TI</td><td class="NLM_def"><p class="first last">therapeutic index</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein</p></td></tr><tr><td class="NLM_term">PPF</td><td class="NLM_def"><p class="first last">paired-pulse facilitation</p></td></tr><tr><td class="NLM_term">Pyr</td><td class="NLM_def"><p class="first last">pyrrolidine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Parsons, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danysz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zieglgaensberger, W.</span><span> </span><span class="NLM_article-title">Excitatory amino acid neurotransmission</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span><div class="note"><p class="first last">Anxiety and Anxiolytic Drugs</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1007%2F3-540-28082-0_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVCltb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2005&pages=249-303&author=C.+G.+Parsonsauthor=W.+Danyszauthor=W.+Zieglgaensberger&title=Excitatory+amino+acid+neurotransmission"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acid neurotransmission</span></div><div class="casAuthors">Parsons, C. G.; Danysz, W.; Zieglgaensberger, W.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">Anxiety and Anxiolytic Drugs</span>),
    <span class="NLM_cas:pages">249-303</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  In recent years great progress has been made in understanding the function of ionotropic and metabotropic glutamate receptors; their pharmacol. and potential therapeutic applications.  It should be stressed that there are already N-methyl-D-aspartate (NMDA) antagonists in clin. use, such as memantine, which proves the feasibility of their therapeutic potential.  It seems unlikely that competitive NMDA receptor antagonists and high-affinity channel blockers will find therapeutic use due to limiting side-effects, whereas agents acting at the glycineB site, NMDA receptor subtype-selective agents and moderate-affinity channel blockers are far more promising.  This is supported by the fact that there are several glycineB antagonists, NMDA moderate-affinity channel blockers and NR2B-selective agents under development.  Pos. and neg. modulators of AMPA receptors such as the AMPAkines and 2,3-benzodiazepines also show more promise than e.g. competitive antagonists.  Great progress has also been made in the field of metabotropic glutamate receptors since the discovery of novel, allosteric modulatory sites for these receptors.  Selective agents acting at these transmembrane sites have been developed that are more drug-like and have a much better access to the central nervous system than their competitive counterparts.  The chapter will critically review preclin. and scarce clin. experience in the development of new ionotropic and metabotropic glutamate receptor modulators according to the following scheme: rational, preclin. findings in animal models and finally clin. experience, where available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaBjva7_QRjbVg90H21EOLACvtfcHk0lhucJMNV-W1kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVCltb3J&md5=699bede7e35aec7cb88387e95becdf2b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2F3-540-28082-0_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F3-540-28082-0_10%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DC.%2BG.%26aulast%3DDanysz%26aufirst%3DW.%26aulast%3DZieglgaensberger%26aufirst%3DW.%26atitle%3DExcitatory%2520amino%2520acid%2520neurotransmission%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2005%26volume%3D169%26spage%3D249%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lynch, G.</span><span> </span><span class="NLM_article-title">Memory enhancement: the search for mechanism-based drugs</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1038%2Fnn935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1entLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=1035-1038&issue=Suppl&author=G.+Lynch&title=Memory+enhancement%3A+the+search+for+mechanism-based+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Memory enhancement: the search for mechanism-based drugs</span></div><div class="casAuthors">Lynch, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">Suppl.</span>),
    <span class="NLM_cas:pages">1035-1038</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rapid progress has been made in understanding the synaptic changes required for memory encoding.  Several companies are now attempting to use information about the induction and consolidation phases of this process to build memory-enhancing drugs.  These efforts have produced novel compds. that improve retention scores across a broad range of tests and species.  Initial clin. results are encouraging.  Issues now arise about appropriate applications of candidate drugs and optimal cellular targets for future development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN-gQ6I9ivB7Vg90H21EOLACvtfcHk0lg3hhADlDoMGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1entLk%253D&md5=f391c93b5e05f4c8ba19a0bbbc05ee97</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnn935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn935%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DG.%26atitle%3DMemory%2520enhancement%253A%2520the%2520search%2520for%2520mechanism-based%2520drugs%26jtitle%3DNat.%2520Neurosci.%26date%3D2002%26volume%3D5%26issue%3DSuppl%26spage%3D1035%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malinow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malenka, R. C.</span><span> </span><span class="NLM_article-title">AMPA receptor trafficking and synaptic plasticity</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1146%2Fannurev.neuro.25.112701.142758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=12052905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtF2hsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2002&pages=103-126&author=R.+Malinowauthor=R.+C.+Malenka&title=AMPA+receptor+trafficking+and+synaptic+plasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">AMPA receptor trafficking and synaptic plasticity</span></div><div class="casAuthors">Malinow, Roberto; Malenka, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103-126</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Activity-dependent changes in synaptic function are believed to underlie the formation of memories.  Two prominent examples are long-term potentiation (LTP) and long-term depression (LTD), whose mechanisms have been the subject of considerable scrutiny over the past few decades.  Here we review the growing literature that supports a crit. role for AMPA receptor trafficking in LTP and LTD, focusing on the roles proposed for specific AMPA receptor subunits and their interacting proteins.  While much work remains to understand the mol. basis for synaptic plasticity, recent results on AMPA receptor trafficking provide a clear conceptual framework for future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXbY4P375GeLVg90H21EOLACvtfcHk0lg3hhADlDoMGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtF2hsLw%253D&md5=bdf912ce2115da5d4cb87031d707d745</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.25.112701.142758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.25.112701.142758%26sid%3Dliteratum%253Aachs%26aulast%3DMalinow%26aufirst%3DR.%26aulast%3DMalenka%26aufirst%3DR.%2BC.%26atitle%3DAMPA%2520receptor%2520trafficking%2520and%2520synaptic%2520plasticity%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2002%26volume%3D25%26spage%3D103%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lynch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, C. M.</span><span> </span><span class="NLM_article-title">Ampakines and the threefold path to cognitive enhancement</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=554-562&author=G.+Lynchauthor=C.+M.+Gall&title=Ampakines+and+the+threefold+path+to+cognitive+enhancement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DG.%26aulast%3DGall%26aufirst%3DC.%2BM.%26atitle%3DAmpakines%2520and%2520the%2520threefold%2520path%2520to%2520cognitive%2520enhancement%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D554%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Morris, R. G. M.</span><span> </span><span class="NLM_article-title">Long-term potentiation and memory</span> <span class="citation_source-journal">Philos. Trans. R. Soc. London B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1098%2Frstb.2002.1230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=12740109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A280%3ADC%252BD3s3hvFCrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2003&pages=643-647&author=R.+G.+M.+Morris&title=Long-term+potentiation+and+memory"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term potentiation and memory</span></div><div class="casAuthors">Morris Richard G M</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical transactions of the Royal Society of London. Series B, Biological sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">1432</span>),
    <span class="NLM_cas:pages">643-7</span>
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    </div><div class="casAbstract">The discovery of long-term potentiation (LTP) transformed research on the neurobiology of learning and memory.  This did not happen overnight, but the discovery of an experimentally demonstrable phenomenon reflecting activity-driven neuronal and synaptic plasticity changed discussions about what might underlie learning from speculation into something much more concrete.  Equally, however, the relationship between the discovery of LTP and research on the neurobiology of learning and memory has been reciprocal; for it is also true that studies of the psychological, anatomical and neurochemical basis of memory provided a developing and critical intellectual context for the physiological discovery.  The emerging concept of multiple memory systems, from 1970 onwards, paved the way for the development of new behavioural and cognitive tasks, including the watermaze described in this paper.  The use of this task in turn provided key evidence that pharmacological interference with an LTP induction mechanism would also interfere with learning, a finding that was by no means a foregone conclusion.  This reciprocal relationship between studies of LTP and the neurobiology of memory helped the physiological phenomenon to be recognized as a major discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRumjSaqwyW3lvAgqb2vdc5fW6udTcc2eZet1ZfdNdewLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3hvFCrtA%253D%253D&md5=b9975b00a2dba770a29a392832ba549a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1098%2Frstb.2002.1230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2002.1230%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BG.%2BM.%26atitle%3DLong-term%2520potentiation%2520and%2520memory%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%2520London%2520B%26date%3D2003%26volume%3D358%26spage%3D643%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kinney, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patino, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermet-Bouvier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starrett, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribkoff, V. K.</span><span> </span><span class="NLM_article-title">Cognition-enhancing drugs increase stimulated hippocampal θ rhythm amplitude in the urethane-anesthetized rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlaksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1999&pages=99-106&author=G.+G.+Kinneyauthor=P.+Patinoauthor=Y.+Mermet-Bouvierauthor=J.+E.+Starrettauthor=V.+K.+Gribkoff&title=Cognition-enhancing+drugs+increase+stimulated+hippocampal+%CE%B8+rhythm+amplitude+in+the+urethane-anesthetized+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Cognition-enhancing drugs increase stimulated hippocampal θ rhythm amplitude in the urethane-anesthetized rat</span></div><div class="casAuthors">Kinney, Gene G.; Patino, Patricia; Mermet-Bouvier, Yvan; Starrett, John E., Jr.; Gribkoff, Valentin K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-106</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Synchronous hippocampal electroencephalog. activity occurring in a frequency range of 3 to 12 Hz (i.e., hippocampal θ rhythm) has been assocd. with mnemonic processes in vivo.  However, this link is tenuous and θ rhythm may be secondary to processes that underlie mnemonic function.  If θ rhythm is assocd. with mnemonic or cognitive function, cognition-enhancing drugs should enhance θ rhythm regardless of their primary biol. target.  In the current study, we evaluated several drugs that were shown to have cognition-enhancing properties in preclin. behavioral models and that vary with respect to their primary biol. target: 1) the nootropic piracetam (250 and 500 mg/kg); 2) the small-conductance calcium-activated potassium-channel blocker apamin (0.1 and 0.4 mg/kg); and 3) the acetylcholinesterase inhibitor donepezil (0.1-10.0 mg/kg).  All of the cognition-enhancing drugs produced dose-dependent increases in hippocampal θ rhythm amplitude elicited by stimulation of the brainstem reticular formation at doses that did not affect peak θ frequency in the urethane-anesthetized rat.  These increases were reversed by the muscarinic receptor antagonist scopolamine, suggesting a common final cholinergic action of these compds.  The use-dependent N-methyl-D-aspartate antagonist dizocilipine maleate and scopolamine reduced θ amplitude (both) and frequency (dizocilipine maleate only).  These data demonstrate that hippocampal θ rhythm is sensitive to cognition-modulating compds., suggesting that θ rhythm may be closely assocd. with cognitive function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxtwZE09Yu-LVg90H21EOLACvtfcHk0lgTjdbEE1C31w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlaksrY%253D&md5=417e6e341decf2311df8ae7821363782</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKinney%26aufirst%3DG.%2BG.%26aulast%3DPatino%26aufirst%3DP.%26aulast%3DMermet-Bouvier%26aufirst%3DY.%26aulast%3DStarrett%26aufirst%3DJ.%2BE.%26aulast%3DGribkoff%26aufirst%3DV.%2BK.%26atitle%3DCognition-enhancing%2520drugs%2520increase%2520stimulated%2520hippocampal%2520%25CE%25B8%2520rhythm%2520amplitude%2520in%2520the%2520urethane-anesthetized%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D291%26spage%3D99%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hampson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espana, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porrino, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadwyler, S. A.</span><span> </span><span class="NLM_article-title">Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1007%2Fs00213-008-1360-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=18985324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlalu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2009&pages=355-369&author=R.+E.+Hampsonauthor=R.+A.+Espanaauthor=G.+A.+Rogersauthor=L.+J.+Porrinoauthor=S.+A.+Deadwyler&title=Mechanisms+underlying+cognitive+enhancement+and+reversal+of+cognitive+deficits+in+nonhuman+primates+by+the+ampakine+CX717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717</span></div><div class="casAuthors">Hampson, R. E.; Espana, R. A.; Rogers, G. A.; Porrino, L. J.; Deadwyler, S. A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">355-369</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale: Performance of cognitive tasks in nonhuman primates (NHPs) requires specific brain regions to make decisions under different degrees of difficulty or "cognitive load.".  Objective: Local cerebral metabolic activity ([18F]FDG PET imaging) in dorsolateral prefrontal cortex (DLPFC), medial temporal lobe (MTL), and dorsal striatum (DStr) is examd. in NHPs performing a delayed-match-to-sample (DMS) task with variable degrees of cognitive load.  Materials and methods: Correlations between cognitive load and degree of brain metabolic activity were obtained with respect to the influence of the ampakine CX717 (Cortex Pharmaceuticals), using brain imaging and recordings of neuronal activity in NHPs and measures of intracellular calcium release in rat hippocampal slices.  Results: Activation of DLPFC, MTL, and DStr reflected changes in performance related to cognitive load within the DMS task and were engaged primarily on high load trials.  Similar increased activation patterns and improved performance were also obsd. following administration of CX717.  Sleep deprivation in NHPs produced impaired performance and redns. in brain activation which was reversed by CX717.  One potential basis for this facilitation of cognition by CX717 was increased firing of task-specific hippocampal cells.  Synaptic mechanisms affected by CX717 were examd. in rat hippocampal slices which showed that N-methyl-D-aspartic acid-mediated release of intracellular calcium was reduced in slices from sleep-deprived rats and reversed by application of CX717 to the bathing medium.  Conclusions: The findings provide insight into how cognition is enhanced by CX717 in terms of brain, and underlying neural, processes that are activated on high vs. low cognitive load trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgeHl-3ngiDrVg90H21EOLACvtfcHk0lgTjdbEE1C31w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlalu73K&md5=5cf11c6a76dfb3d9a172f7fe79e7b175</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1007%2Fs00213-008-1360-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-008-1360-z%26sid%3Dliteratum%253Aachs%26aulast%3DHampson%26aufirst%3DR.%2BE.%26aulast%3DEspana%26aufirst%3DR.%2BA.%26aulast%3DRogers%26aufirst%3DG.%2BA.%26aulast%3DPorrino%26aufirst%3DL.%2BJ.%26aulast%3DDeadwyler%26aufirst%3DS.%2BA.%26atitle%3DMechanisms%2520underlying%2520cognitive%2520enhancement%2520and%2520reversal%2520of%2520cognitive%2520deficits%2520in%2520nonhuman%2520primates%2520by%2520the%2520ampakine%2520CX717%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D202%26spage%3D355%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Roberts, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, S. A.</span><span> </span><span class="NLM_article-title">Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1016%2Fj.bbr.2010.03.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=20347881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFWrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2010&pages=41-48&author=B.+M.+Robertsauthor=D.+E.+Holdenauthor=C.+L.+Shafferauthor=P.+A.+Seymourauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=G.+V.+Williamsauthor=S.+A.+Castner&title=Prevention+of+ketamine-induced+working+memory+impairments+by+AMPA+potentiators+in+a+nonhuman+primate+model+of+cognitive+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction</span></div><div class="casAuthors">Roberts, Brooke M.; Holden, Daniel E.; Shaffer, Christopher L.; Seymour, Patricia A.; Menniti, Frank S.; Schmidt, Christopher J.; Williams, Graham V.; Castner, Stacy A.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Working memory impairments are a core aspect of schizophrenia, yet current medicines do not address such cognitive dysfunction.  We have developed a model of these working memory deficits by acutely disrupting glutamatergic synaptic transmission by administration of the N-methyl-3-aspartate (NMDA) antagonist ketamine in the nonhuman primate.  The current studies evaluated the effect of pos. allosteric modulators ("potentiators") of the α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors on the working memory and behavioral effects of ketamine.  AMPA receptors mediate fast excitatory synaptic transmission throughout the brain and play a crit. role in the activity-dependent regulation of NMDA receptors.  We find that pos. modulation of AMPA receptors with LY451646 (0.1-1.0 mg/kg, SC) and structurally distinct PF-4778574 (0.01 mg/kg, SC) robustly ameliorates ketamine-induced working memory impairments without altering behavioral effects of acute ketamine we consider related to pos.- and neg.-like symptoms.  These results support AMPA receptor potentiators as a potential adjunctive treatment for cognitive impairment assocd. with schizophrenia (CIAS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3Id6D1EeSrVg90H21EOLACvtfcHk0lhuxY90p4H3TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFWrsb8%253D&md5=a7e67cfd3027b0013e4ab448503219dc</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2010.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2010.03.039%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DB.%2BM.%26aulast%3DHolden%26aufirst%3DD.%2BE.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DCastner%26aufirst%3DS.%2BA.%26atitle%3DPrevention%2520of%2520ketamine-induced%2520working%2520memory%2520impairments%2520by%2520AMPA%2520potentiators%2520in%2520a%2520nonhuman%2520primate%2520model%2520of%2520cognitive%2520dysfunction%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2010%26volume%3D212%26spage%3D41%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Black, M. D.</span><span> </span><span class="NLM_article-title">Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=154-163&author=M.+D.+Black&title=Therapeutic+potential+of+positive+AMPA+modulators+and+their+relationship+to+AMPA+receptor+subunits.+A+review+of+preclinical+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DM.%2BD.%26atitle%3DTherapeutic%2520potential%2520of%2520positive%2520AMPA%2520modulators%2520and%2520their%2520relationship%2520to%2520AMPA%2520receptor%2520subunits.%2520A%2520review%2520of%2520preclinical%2520data%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D179%26spage%3D154%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Marenco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, D. R.</span><span> </span><span class="NLM_article-title">Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.2165%2F00023210-200620030-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=16529524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvF2mtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=173-185&author=S.+Marencoauthor=D.+R.+Weinberger&title=Therapeutic+potential+of+positive+AMPA+receptor+modulators+in+the+treatment+of+neuropsychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders</span></div><div class="casAuthors">Marenco, Stefano; Weinberger, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-185</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Drugs that potentiate the activity of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor cause a complex cascade of consequences in exptl. models, ranging from enhancement of long-term potentiation to induction of neurotrophic factors.  Animal studies characterizing the pharmacol. and behavioral effects of these substances have provided the rationale for several initial attempts to use these drugs in neuropsychiatric clin. settings.  Applications in schizophrenia, Alzheimer's disease and mild cognitive impairment have been initiated.  Other trials with these compds. include the treatment of Fragile X syndrome, and possible future applications may be in the field of Parkinson's disease.  The literature published to date is limited mostly to small phase I or II trials, so there is no conclusive evidence for or against the use of these drugs.  Substantial questions remain concerning which compds. to use, in what dose, for what condition and for how long.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEIFzk9iLjHLVg90H21EOLACvtfcHk0lhuxY90p4H3TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvF2mtb4%253D&md5=09378aa20043ab2a78cd6bcd0787af16</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2165%2F00023210-200620030-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200620030-00001%26sid%3Dliteratum%253Aachs%26aulast%3DMarenco%26aufirst%3DS.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DTherapeutic%2520potential%2520of%2520positive%2520AMPA%2520receptor%2520modulators%2520in%2520the%2520treatment%2520of%2520neuropsychiatric%2520disorders%26jtitle%3DCNS%2520Drugs%26date%3D2006%26volume%3D20%26spage%3D173%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleakman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisenbaum, E. S.</span><span> </span><span class="NLM_article-title">AMPA receptor potentiators for the treatment of CNS disorders</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.2174%2F1568007043337508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=15180479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=181-194&author=M.+J.+O%E2%80%99Neillauthor=D.+Bleakmanauthor=D.+M.+Zimmermanauthor=E.+S.+Nisenbaum&title=AMPA+receptor+potentiators+for+the+treatment+of+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">AMPA receptor potentiators for the treatment of CNS disorders</span></div><div class="casAuthors">O'Neill, Michael J.; Bleakman, David; Zimmerman, Dennis M.; Nisenbaum, Eric S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-194</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors mediate most of the excitatory neurotransmission in the mammalian central nervous system and also participate in forms of synaptic plasticity thought to underlie memory and learning, and the formation of neural networks during development.  Mol. cloning techniques have shown that the AMPA receptor family is composed of 4 different subunits named GluR1-4 or GluRA-D (newly termed as GluA1-GluA4) and native AMPA receptors are most likely tetramers generated by the assembly of 1 or more of these subunits, yielding homomeric or heteromeric receptors.  Addnl. complexity among AMPA receptors is conferred by alternative splicing of RNA for each subunit giving rise to flip and flop variants.  Clin. and exptl. data have suggested that pos. modulation of AMPA receptors may be therapeutically effective in the treatment of cognitive deficits.  Several classes of AMPA receptor potentiators were reported, including pyrrolidones (piracetam, aniracetam), benzothiazides (cyclothiazide), benzylpiperidines (CX-516, CX-546), and more recently biarylpropylsulfonamides (LY392098, LY404187 and LY503430).  These mols. enhance cognitive function in rodents, which appears to correlate with increased hippocampal activity.  In addn., clin. studies have suggested that AMPA receptor modulators enhance cognitive function in elderly subjects, as well as patients suffering from neurol. and psychiatric disorders.  Several independent studies have suggested that AMPA receptors can increase BDNF expression by both calcium-dependent and independent pathways.  For example, recent studies have shown that AMPA receptors interact with the protein Tyr kinase, Lyn.  Activation of Lyn can recruit the mitogen-activated protein kinase (MAPK) signalling pathway and increase the expression of BDNF.  Therefore, in addn. to directly enhancing glutamatergic synaptic transmission, AMPA receptor activation can increase the expression of BDNF in vitro and in vivo.  This may account for activity of AMPA receptor potentiators in rodent models predictive of antidepressant activity (forced swim and tail suspension tests).  The increase in neurotrophin expression also may contribute to the functional, neuroprotective, and neurotrophic actions of LY404187 and LY503430 after infusion of 6-OHDA into the substantia nigra.  In conclusion, several potent, selective and systematically active AMPA receptor potentiators were reported.  Data indicate that these mols. modulate glutamatergic transmission, enhance synaptic transmission, long-term potentiation (LTP), and increase neurotrophin expression.  Therefore, these AMPA receptor potentiators offer an exciting new class of drugs with potentials for treating (1) cognitive impairment assocd. with Alzheimer's disease and schizophrenia, (2) depression, (3) slowing the progression and potentially enhancing recovery from Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHYMd0O34_SLVg90H21EOLACvtfcHk0liUzqLNM0MtzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCgu7g%253D&md5=5d438c3c4cc13fa863608073601cc6a1</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.2174%2F1568007043337508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043337508%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DBleakman%26aufirst%3DD.%26aulast%3DZimmerman%26aufirst%3DD.%2BM.%26aulast%3DNisenbaum%26aufirst%3DE.%2BS.%26atitle%3DAMPA%2520receptor%2520potentiators%2520for%2520the%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D181%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">11047</span><span class="NLM_x">–</span> <span class="NLM_lpage">11054</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=11047-11054&author=R.+R.+Gainetdinovauthor=A.+R.+Mohnauthor=L.+M.+Bohnauthor=M.+G.+Caron&title=Glutamatergic+modulation+of+hyperactivity+in+mice+lacking+the+dopamine+transporter"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DMohn%26aufirst%3DA.%2BR.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DGlutamatergic%2520modulation%2520of%2520hyperactivity%2520in%2520mice%2520lacking%2520the%2520dopamine%2520transporter%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D11047%26epage%3D11054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollmuth, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Glutamate receptor ion channels: structure, regulation, and function</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1124%2Fpr.109.002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=20716669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+F.+Traynelisauthor=L.+P.+Wollmuthauthor=C.+J.+McBainauthor=F.+S.+Mennitiauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=K.+B.+Hansenauthor=H.+Yuanauthor=S.+J.+Myersauthor=R.+Dingledine&title=Glutamate+receptor+ion+channels%3A+structure%2C+regulation%2C+and+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor ion channels: structure, regulation, and function</span></div><div class="casAuthors">Traynelis, Stephen F.; Wollmuth, Lonnie P.; McBain, Chris J.; Menniti, Frank S.; Vance, Katie M.; Ogden, Kevin K.; Hansen, Kasper B.; Yuan, Hongjie; Myers, Scott J.; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-496</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels contg. an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore.  Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells.  These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system.  Glutamate receptors are postulated to play important roles in numerous neurol. diseases and have attracted intense scrutiny.  The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel.  In this review we discuss International Union of Basic and Clin. Pharmacol. glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacol., allosteric modulation, mechanisms of gating and permeation, roles in normal physiol. function, as well as the potential therapeutic use of pharmacol. agents acting at glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0rj4nMr5ObVg90H21EOLACvtfcHk0liUzqLNM0MtzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ&md5=5d0a7945b5ad99113adf9f6312bafe13</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002451%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWollmuth%26aufirst%3DL.%2BP.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520receptor%2520ion%2520channels%253A%2520structure%252C%2520regulation%252C%2520and%2520function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wisden, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeburg, P. H.</span><span> </span><span class="NLM_article-title">Mammalian ionotropic glutamate receptors</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=291-298&author=W.+Wisdenauthor=P.+H.+Seeburg&title=Mammalian+ionotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWisden%26aufirst%3DW.%26aulast%3DSeeburg%26aufirst%3DP.%2BH.%26atitle%3DMammalian%2520ionotropic%2520glutamate%2520receptors%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D1993%26volume%3D3%26spage%3D291%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Monyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeburg, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisden, W.</span><span> </span><span class="NLM_article-title">Glutamate-operated channels: developmentally early and mature forms arise by alternative splicing</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=799-810&author=H.+Monyerauthor=P.+H.+Seeburgauthor=W.+Wisden&title=Glutamate-operated+channels%3A+developmentally+early+and+mature+forms+arise+by+alternative+splicing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonyer%26aufirst%3DH.%26aulast%3DSeeburg%26aufirst%3DP.%2BH.%26aulast%3DWisden%26aufirst%3DW.%26atitle%3DGlutamate-operated%2520channels%253A%2520developmentally%2520early%2520and%2520mature%2520forms%2520arise%2520by%2520alternative%2520splicing%26jtitle%3DNeuron%26date%3D1991%26volume%3D6%26spage%3D799%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Pei, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, L.</span><span> </span><span class="NLM_article-title">Flip and Flop: A Molecular Determinant for AMPA Receptor Channel Opening</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3767</span><span class="NLM_x">–</span> <span class="NLM_lpage">3777</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi8015907" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=3767-3777&author=W.+Peiauthor=Z.+Huangauthor=C.+Wangauthor=Y.+Hanauthor=J.+S.+Parkauthor=L.+Niu&title=Flip+and+Flop%3A+A+Molecular+Determinant+for+AMPA+Receptor+Channel+Opening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi8015907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi8015907%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DJ.%2BS.%26aulast%3DNiu%26aufirst%3DL.%26atitle%3DFlip%2520and%2520Flop%253A%2520A%2520Molecular%2520Determinant%2520for%2520AMPA%2520Receptor%2520Channel%2520Opening%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D3767%26epage%3D3777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Structural aspects of AMPA receptor activation, desensitization and deactivation</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=281-288&author=K.+B.+Hansenauthor=H.+Yuanauthor=S.+F.+Traynelis&title=Structural+aspects+of+AMPA+receptor+activation%2C+desensitization+and+deactivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DStructural%2520aspects%2520of%2520AMPA%2520receptor%2520activation%252C%2520desensitization%2520and%2520deactivation%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2007%26volume%3D17%26spage%3D281%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mayer, M. L.</span><span> </span><span class="NLM_article-title">Glutamate receptors at atomic resolution</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=456-462&author=M.+L.+Mayer&title=Glutamate+receptors+at+atomic+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%2BL.%26atitle%3DGlutamate%2520receptors%2520at%2520atomic%2520resolution%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D456%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banke, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Structural basis for partial agonist action at ionotropic glutamate receptors</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1038%2Fnn1091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=12872125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslOisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2003&pages=803-810&author=R.+Jinauthor=T.+G.+Bankeauthor=M.+L.+Mayerauthor=S.+F.+Traynelisauthor=E.+Gouaux&title=Structural+basis+for+partial+agonist+action+at+ionotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for partial agonist action at ionotropic glutamate receptors</span></div><div class="casAuthors">Jin, Rongsheng; Banke, Tue G.; Mayer, Mark L.; Traynelis, Stephen F.; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">803-810</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">An unresolved problem in understanding neurotransmitter receptor function concerns the mechanism(s) by which full and partial agonists elicit different amplitude responses at equal receptor occupancy.  The widely held view of 'partial agonism' posits that resting and active states of the receptor are in equil., and partial agonists simply do not shift the equil. toward the active state as efficaciously as full agonists.  Here we report findings from crystallog. and electrophysiol. studies of the mechanism of activation of an AMPA-subtype glutamate receptor ion channel.  In these expts., we used 5-substituted Willardiines, a series of partial agonists that differ by only a single atom.  Our results show that the GluR2 ligand-binding core can adopt a range of ligand-dependent conformational states, which in turn control the open probability of discrete subconductance states of the intact ion channel.  Our findings thus provide a structure-based model of partial agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrppTBGXFELfrVg90H21EOLACvtfcHk0lgSD99ocanGJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslOisr8%253D&md5=45e0016d600fb6793a30547a9ccb110b</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1038%2Fnn1091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1091%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DR.%26aulast%3DBanke%26aufirst%3DT.%2BG.%26aulast%3DMayer%26aufirst%3DM.%2BL.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DStructural%2520basis%2520for%2520partial%2520agonist%2520action%2520at%2520ionotropic%2520glutamate%2520receptors%26jtitle%3DNat.%2520Neurosci.%26date%3D2003%26volume%3D6%26spage%3D803%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Partin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, M. L.</span><span> </span><span class="NLM_article-title">AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6634</span><span class="NLM_x">–</span> <span class="NLM_lpage">6647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1523%2FJNEUROSCI.16-21-06634.1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=8824304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADyaK28Xntlamu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=6634-6647&author=K.+M.+Partinauthor=M.+W.+Fleckauthor=M.+L.+Mayer&title=AMPA+receptor+flip%2Fflop+mutants+affecting+deactivation%2C+desensitization%2C+and+modulation+by+cyclothiazide%2C+aniracetam%2C+and+thiocyanate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate</span></div><div class="casAuthors">Partin, Kathryn M.; Fleck, Mark W.; Mayer, Mark L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6634-6647</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">AMPA receptor GluRA subunits with mutations at position 750, a residue shown previously to control allosteric regulation by cyclothiazide, were analyzed for modulation of deactivation and desensitization by cyclothiazide, aniracetam, and thiocyanate.  Point mutations from Ser to Asn, Ala, Asp, Gly, Gln Met, Cys, Thr, Leu, Val, and Tyr were constructed in GluRAflip.  The last four of these mutants were not functional; S750D was active only in the presence of cyclothiazide, and the remaining mutants exhibited altered rates of deactivation and desensitization four control responses to glutamate, and showed differential modulation by cyclothiazide and aniracetam.  Results from kinetic anal. are consistent with aniracetam and cyclothiazide acting via distinct mechanisms.  Our expts. demonstrate for the first time the functional importance of residue 750 in regulating intrinsic channel-gating kinetics and emphasize the biol. significance of alternative splicing in the M3-M4 extracellular loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZZeaFPhGl6LVg90H21EOLACvtfcHk0lgSD99ocanGJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xntlamu7Y%253D&md5=49660ac7e1717e59a5c263f3cf465d99</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.16-21-06634.1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.16-21-06634.1996%26sid%3Dliteratum%253Aachs%26aulast%3DPartin%26aufirst%3DK.%2BM.%26aulast%3DFleck%26aufirst%3DM.%2BW.%26aulast%3DMayer%26aufirst%3DM.%2BL.%26atitle%3DAMPA%2520receptor%2520flip%252Fflop%2520mutants%2520affecting%2520deactivation%252C%2520desensitization%252C%2520and%2520modulation%2520by%2520cyclothiazide%252C%2520aniracetam%252C%2520and%2520thiocyanate%26jtitle%3DJ.%2520Neurosci.%26date%3D1996%26volume%3D16%26spage%3D6634%26epage%3D6647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Grove, S. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclean, J. K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7271</span><span class="NLM_x">–</span> <span class="NLM_lpage">7279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1000419" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7271-7279&author=S.+J.+A.+Groveauthor=C.+Jamiesonauthor=J.+K.+F.+Macleanauthor=J.+A.+Morrowauthor=Z.+Rankovic&title=Positive+allosteric+modulators+of+the+%CE%B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic+acid+%28AMPA%29+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm1000419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1000419%26sid%3Dliteratum%253Aachs%26aulast%3DGrove%26aufirst%3DS.%2BJ.%2BA.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMaclean%26aufirst%3DJ.%2BK.%2BF.%26aulast%3DMorrow%26aufirst%3DJ.%2BA.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DPositive%2520allosteric%2520modulators%2520of%2520the%2520%25CE%25B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2520acid%2520%2528AMPA%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7271%26epage%3D7279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lynch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambros-Ingerson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schehr, R. S.</span><span> </span><span class="NLM_article-title">Psychological effects of a drug that facilitates brain AMPA receptors</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1097%2F00004850-199603000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=8732309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A280%3ADyaK28zgtFOitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1996&pages=13-19&author=G.+Lynchauthor=M.+Kesslerauthor=G.+Rogersauthor=J.+Ambros-Ingersonauthor=R.+Grangerauthor=R.+S.+Schehr&title=Psychological+effects+of+a+drug+that+facilitates+brain+AMPA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Psychological effects of a drug that facilitates brain AMPA receptors</span></div><div class="casAuthors">Lynch G; Kessler M; Rogers G; Ambros-Ingerson J; Granger R; Schehr R S</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-9</span>
        ISSN:<span class="NLM_cas:issn">0268-1315</span>.
    </div><div class="casAbstract">The effects of 1-(quinoxalin-6-ylcarbonyl)piperidine (CX516), a centrally active compound that facilitates AMPA receptor-mediated synaptic responses, were tested in human subjects.  Separate tests of delayed recall were given prior to and nearly 3 h after administration of placebo (n = 12) or drug (n = 36).  Control subjects exhibited poorer performance in the second session than in the first while subjects given 600-1200 mg of the drug did not.  There were no pre- vs post-treatment differences in immediate recall in either group.  The drug did not reliably affect self-assessment scores for any of several psychological variables but did disrupt the normally present correlations for within-subject changes in the variables.  These results suggest that AMPA receptor modulators may (1) improve memory under some circumstances and (2) produce psychological effects that are subtle or not related to specific mood states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCImjQRewJDg8IxFYvehhofW6udTcc2eYW34zi3dadNrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zgtFOitA%253D%253D&md5=e0b999d851770b7b285893786da81143</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1097%2F00004850-199603000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004850-199603000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DG.%26aulast%3DKessler%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DAmbros-Ingerson%26aufirst%3DJ.%26aulast%3DGranger%26aufirst%3DR.%26aulast%3DSchehr%26aufirst%3DR.%2BS.%26atitle%3DPsychological%2520effects%2520of%2520a%2520drug%2520that%2520facilitates%2520brain%2520AMPA%2520receptors%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D1996%26volume%3D11%26spage%3D13%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Granger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staubli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, G.</span><span> </span><span class="NLM_article-title">A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1993&pages=326-329&author=R.+Grangerauthor=U.+Staubliauthor=M.+Davisauthor=Y.+Perezauthor=L.+Nilssonauthor=G.+A.+Rogersauthor=G.+Lynch&title=A+drug+that+facilitates+glutamatergic+transmission+reduces+exploratory+activity+and+improves+performance+in+a+learning-dependent+task"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGranger%26aufirst%3DR.%26aulast%3DStaubli%26aufirst%3DU.%26aulast%3DDavis%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DY.%26aulast%3DNilsson%26aufirst%3DL.%26aulast%3DRogers%26aufirst%3DG.%2BA.%26aulast%3DLynch%26aufirst%3DG.%26atitle%3DA%2520drug%2520that%2520facilitates%2520glutamatergic%2520transmission%2520reduces%2520exploratory%2520activity%2520and%2520improves%2520performance%2520in%2520a%2520learning-dependent%2520task%26jtitle%3DSynapse%26date%3D1993%26volume%3D15%26spage%3D326%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Rosi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazia Giovannini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lestage, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Corte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepeu, G.</span><span> </span><span class="NLM_article-title">S18986, a positive modulator of AMPA receptors with cognition-enhancing properties, increases ACh release in the hippocampus of young and aged rat</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2004&pages=120-123&author=S.+Rosiauthor=M.+Grazia+Giovanniniauthor=P.+J.+Lestageauthor=C.+Munozauthor=L.+Della+Corteauthor=G.+Pepeu&title=S18986%2C+a+positive+modulator+of+AMPA+receptors+with+cognition-enhancing+properties%2C+increases+ACh+release+in+the+hippocampus+of+young+and+aged+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosi%26aufirst%3DS.%26aulast%3DGrazia%2BGiovannini%26aufirst%3DM.%26aulast%3DLestage%26aufirst%3DP.%2BJ.%26aulast%3DMunoz%26aufirst%3DC.%26aulast%3DDella%2BCorte%26aufirst%3DL.%26aulast%3DPepeu%26aufirst%3DG.%26atitle%3DS18986%252C%2520a%2520positive%2520modulator%2520of%2520AMPA%2520receptors%2520with%2520cognition-enhancing%2520properties%252C%2520increases%2520ACh%2520release%2520in%2520the%2520hippocampus%2520of%2520young%2520and%2520aged%2520rat%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D361%26spage%3D120%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldegheri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melarange, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookherjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Negro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusaf, S. P.</span><span> </span><span class="NLM_article-title">Integration of lead optimization with crystallography for a membrane-bound ion channel target: discovery of a new class of AMPA receptor positive allosteric modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100679e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=78-94&author=S.+E.+Wardauthor=M.+Harriesauthor=L.+Aldegheriauthor=N.+E.+Austinauthor=S.+Ballantineauthor=E.+Balliniauthor=D.+M.+Bradleyauthor=B.+D.+Baxauthor=B.+P.+Clarkeauthor=A.+J.+Harrisauthor=S.+A.+Harrisonauthor=R.+A.+Melarangeauthor=C.+Mookherjeeauthor=J.+Mosleyauthor=G.+Dal+Negroauthor=B.+Oliosiauthor=K.+J.+Smithauthor=K.+M.+Thewlisauthor=P.+M.+Woollardauthor=S.+P.+Yusaf&title=Integration+of+lead+optimization+with+crystallography+for+a+membrane-bound+ion+channel+target%3A+discovery+of+a+new+class+of+AMPA+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm100679e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100679e%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DHarries%26aufirst%3DM.%26aulast%3DAldegheri%26aufirst%3DL.%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DBallantine%26aufirst%3DS.%26aulast%3DBallini%26aufirst%3DE.%26aulast%3DBradley%26aufirst%3DD.%2BM.%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DClarke%26aufirst%3DB.%2BP.%26aulast%3DHarris%26aufirst%3DA.%2BJ.%26aulast%3DHarrison%26aufirst%3DS.%2BA.%26aulast%3DMelarange%26aufirst%3DR.%2BA.%26aulast%3DMookherjee%26aufirst%3DC.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DDal%2BNegro%26aufirst%3DG.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26aulast%3DYusaf%26aufirst%3DS.%2BP.%26atitle%3DIntegration%2520of%2520lead%2520optimization%2520with%2520crystallography%2520for%2520a%2520membrane-bound%2520ion%2520channel%2520target%253A%2520discovery%2520of%2520a%2520new%2520class%2520of%2520AMPA%2520receptor%2520positive%2520allosteric%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D78%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ornstein, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleisch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantrell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinmayeh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleakman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelzys, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvie, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deverill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamboj, R. K.</span><span> </span><span class="NLM_article-title">Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic acid (AMPA) receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">4354</span><span class="NLM_x">–</span> <span class="NLM_lpage">4358</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0002836" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4354-4358&issue=23&author=P.+L.+Ornsteinauthor=D.+M.+Zimmermanauthor=M.+B.+Arnoldauthor=T.+J.+Bleischauthor=B.+Cantrellauthor=R.+Simonauthor=H.+Zarrinmayehauthor=S.+R.+Bakerauthor=M.+Gatesauthor=J.+P.+Tizzanoauthor=D.+Bleakmanauthor=A.+Mandelzysauthor=K.+R.+Jarvieauthor=K.+Hoauthor=M.+Deverillauthor=R.+K.+Kamboj&title=Biarylpropylsulfonamides+as+novel%2C+potent+potentiators+of+2-amino-3-%285-methyl-3-hydroxyisoxazol-4-yl%29propanoic+acid+%28AMPA%29+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm0002836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0002836%26sid%3Dliteratum%253Aachs%26aulast%3DOrnstein%26aufirst%3DP.%2BL.%26aulast%3DZimmerman%26aufirst%3DD.%2BM.%26aulast%3DArnold%26aufirst%3DM.%2BB.%26aulast%3DBleisch%26aufirst%3DT.%2BJ.%26aulast%3DCantrell%26aufirst%3DB.%26aulast%3DSimon%26aufirst%3DR.%26aulast%3DZarrinmayeh%26aufirst%3DH.%26aulast%3DBaker%26aufirst%3DS.%2BR.%26aulast%3DGates%26aufirst%3DM.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DBleakman%26aufirst%3DD.%26aulast%3DMandelzys%26aufirst%3DA.%26aulast%3DJarvie%26aufirst%3DK.%2BR.%26aulast%3DHo%26aufirst%3DK.%26aulast%3DDeverill%26aufirst%3DM.%26aulast%3DKamboj%26aufirst%3DR.%2BK.%26atitle%3DBiarylpropylsulfonamides%2520as%2520novel%252C%2520potent%2520potentiators%2520of%25202-amino-3-%25285-methyl-3-hydroxyisoxazol-4-yl%2529propanoic%2520acid%2520%2528AMPA%2529%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D23%26spage%3D4354%26epage%3D4358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Zarrinmayeh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tromiczak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escribano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornback, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisenbaum, E. S.</span><span> </span><span class="NLM_article-title">A novel class of positive allosteric modulators of AMPA receptors: design, synthesis, and structure–activity relationships of 3-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1<i>H</i>-pyrrole-2-carboxylic acid, LY2059346</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5203</span><span class="NLM_x">–</span> <span class="NLM_lpage">5206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5203-5206&author=H.+Zarrinmayehauthor=E.+Tromiczakauthor=D.+M.+Zimmermanauthor=N.+Ranklauthor=K.+H.+Hoauthor=E.+Dominguezauthor=A.+Castanoauthor=A.+Escribanoauthor=C.+Fernandezauthor=A.+Jimenezauthor=W.+J.+Hornbackauthor=E.+S.+Nisenbaum&title=A+novel+class+of+positive+allosteric+modulators+of+AMPA+receptors%3A+design%2C+synthesis%2C+and+structure%E2%80%93activity+relationships+of+3-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1H-pyrrole-2-carboxylic+acid%2C+LY2059346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZarrinmayeh%26aufirst%3DH.%26aulast%3DTromiczak%26aufirst%3DE.%26aulast%3DZimmerman%26aufirst%3DD.%2BM.%26aulast%3DRankl%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DK.%2BH.%26aulast%3DDominguez%26aufirst%3DE.%26aulast%3DCastano%26aufirst%3DA.%26aulast%3DEscribano%26aufirst%3DA.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DJimenez%26aufirst%3DA.%26aulast%3DHornback%26aufirst%3DW.%2BJ.%26aulast%3DNisenbaum%26aufirst%3DE.%2BS.%26atitle%3DA%2520novel%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520AMPA%2520receptors%253A%2520design%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%25203-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1H-pyrrole-2-carboxylic%2520acid%252C%2520LY2059346%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5203%26epage%3D5206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldegheri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melarange, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookherjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Profeta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusaf, S. P.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(2<i>S</i>)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1<i>H</i>-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5801</span><span class="NLM_x">–</span> <span class="NLM_lpage">5812</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1005429" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5801-5812&author=S.+E.+Wardauthor=M.+Harriesauthor=L.+Aldegheriauthor=D.+Andreottiauthor=S.+Ballantineauthor=B.+D.+Baxauthor=A.+J.+Harrisauthor=A.+J.+Harkerauthor=J.+Lundauthor=R.+Melarangeauthor=A.+Mingardiauthor=C.+Mookherjeeauthor=J.+Mosleyauthor=M.+Neveauthor=B.+Oliosiauthor=R.+Profetaauthor=K.+J.+Smithauthor=P.+W.+Smithauthor=S.+Spadaauthor=K.+M.+Thewlisauthor=S.+P.+Yusaf&title=Discovery+of+N-%5B%282S%29-5-%286-fluoro-3-pyridinyl%29-2%2C3-dihydro-1H-inden-2-yl%5D-2-propanesulfonamide%2C+a+novel+clinical+AMPA+receptor+positive+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm1005429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005429%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DHarries%26aufirst%3DM.%26aulast%3DAldegheri%26aufirst%3DL.%26aulast%3DAndreotti%26aufirst%3DD.%26aulast%3DBallantine%26aufirst%3DS.%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DHarris%26aufirst%3DA.%2BJ.%26aulast%3DHarker%26aufirst%3DA.%2BJ.%26aulast%3DLund%26aufirst%3DJ.%26aulast%3DMelarange%26aufirst%3DR.%26aulast%3DMingardi%26aufirst%3DA.%26aulast%3DMookherjee%26aufirst%3DC.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNeve%26aufirst%3DM.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DProfeta%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DSpada%26aufirst%3DS.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DYusaf%26aufirst%3DS.%2BP.%26atitle%3DDiscovery%2520of%2520N-%255B%25282S%2529-5-%25286-fluoro-3-pyridinyl%2529-2%252C3-dihydro-1H-inden-2-yl%255D-2-propanesulfonamide%252C%2520a%2520novel%2520clinical%2520AMPA%2520receptor%2520positive%2520modulator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5801%26epage%3D5812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Zarrinmayeh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleakman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornstein, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKennon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnick, P.</span><span> </span><span class="NLM_article-title">[3<i>H</i>]<i>N</i>-2-(4-(<i>N</i>-benzamido)phenyl)propyl-2- propanesulfonamide: a novel AMPA receptor potentiator and radioligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000462n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=302-304&author=H.+Zarrinmayehauthor=D.+Bleakmanauthor=M.+R.+Gatesauthor=H.+Yuauthor=D.+M.+Zimmermanauthor=P.+L.+Ornsteinauthor=T.+McKennonauthor=M.+B.+Arnoldauthor=W.+J.+Wheelerauthor=P.+Skolnick&title=%5B3H%5DN-2-%284-%28N-benzamido%29phenyl%29propyl-2-+propanesulfonamide%3A+a+novel+AMPA+receptor+potentiator+and+radioligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm000462n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000462n%26sid%3Dliteratum%253Aachs%26aulast%3DZarrinmayeh%26aufirst%3DH.%26aulast%3DBleakman%26aufirst%3DD.%26aulast%3DGates%26aufirst%3DM.%2BR.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZimmerman%26aufirst%3DD.%2BM.%26aulast%3DOrnstein%26aufirst%3DP.%2BL.%26aulast%3DMcKennon%26aufirst%3DT.%26aulast%3DArnold%26aufirst%3DM.%2BB.%26aulast%3DWheeler%26aufirst%3DW.%2BJ.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3D%255B3H%255DN-2-%25284-%2528N-benzamido%2529phenyl%2529propyl-2-%2520propanesulfonamide%253A%2520a%2520novel%2520AMPA%2520receptor%2520potentiator%2520and%2520radioligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D302%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">McNeish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hambor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weibley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machacek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stice, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R.</span><span> </span><span class="NLM_article-title">High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of α-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">17209</span><span class="NLM_x">–</span> <span class="NLM_lpage">17217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=17209-17217&author=J.+McNeishauthor=M.+Roachauthor=J.+Hamborauthor=R.+J.+Matherauthor=L.+Weibleyauthor=J.+Lazzaroauthor=J.+Gazardauthor=J.+Schwarzauthor=R.+Volkmannauthor=D.+Machacekauthor=S.+Sticeauthor=L.+Zawadzkeauthor=C.+O%E2%80%99Donnellauthor=R.+Hurst&title=High-throughput+screening+in+embryonic+stem+cell-derived+neurons+identifies+potentiators+of+%CE%B1-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcNeish%26aufirst%3DJ.%26aulast%3DRoach%26aufirst%3DM.%26aulast%3DHambor%26aufirst%3DJ.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DWeibley%26aufirst%3DL.%26aulast%3DLazzaro%26aufirst%3DJ.%26aulast%3DGazard%26aufirst%3DJ.%26aulast%3DSchwarz%26aufirst%3DJ.%26aulast%3DVolkmann%26aufirst%3DR.%26aulast%3DMachacek%26aufirst%3DD.%26aulast%3DStice%26aufirst%3DS.%26aulast%3DZawadzke%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%26aulast%3DHurst%26aufirst%3DR.%26atitle%3DHigh-throughput%2520screening%2520in%2520embryonic%2520stem%2520cell-derived%2520neurons%2520identifies%2520potentiators%2520of%2520%25CE%25B1-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type%2520glutamate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D17209%26epage%3D17217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Barbachyn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, C. W.</span><span> </span><span class="NLM_article-title">Oxazolidinone structure–activity relationships leading to linezolid</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2010</span><span class="NLM_x">–</span> <span class="NLM_lpage">2023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=2010-2023&author=M.+R.+Barbachynauthor=C.+W.+Ford&title=Oxazolidinone+structure%E2%80%93activity+relationships+leading+to+linezolid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26aulast%3DFord%26aufirst%3DC.%2BW.%26atitle%3DOxazolidinone%2520structure%25E2%2580%2593activity%2520relationships%2520leading%2520to%2520linezolid%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D2010%26epage%3D2023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barbachyn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleek, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolak, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garmon, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seest, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toops, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurenko, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaadt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yagi, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slatter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oien, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaya, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wienkers, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynalda, M. A.</span><span> </span><span class="NLM_article-title">Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020248u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVemsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=284-302&author=M.+R.+Barbachynauthor=G.+J.+Cleekauthor=L.+A.+Dolakauthor=S.+A.+Garmonauthor=J.+Morrisauthor=E.+P.+Seestauthor=R.+C.+Thomasauthor=D.+S.+Toopsauthor=W.+Wattauthor=D.+G.+Wishkaauthor=C.+W.+Fordauthor=G.+E.+Zurenkoauthor=J.+C.+Hamelauthor=R.+D.+Schaadtauthor=D.+Stapertauthor=B.+H.+Yagiauthor=W.+J.+Adamsauthor=J.+M.+Friisauthor=J.+G.+Slatterauthor=J.+P.+Samsauthor=N.+L.+Oienauthor=M.+J.+Zayaauthor=L.+C.+Wienkersauthor=M.+A.+Wynalda&title=Identification+of+phenylisoxazolines+as+novel+and+viable+antibacterial+agents+active+against+Gram-positive+pathogens"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Phenylisoxazolines as Novel and Viable Antibacterial Agents Active against Gram-Positive Pathogens</span></div><div class="casAuthors">Barbachyn, Michael R.; Cleek, Gary J.; Dolak, Lester A.; Garmon, Stuart A.; Morris, Joel; Seest, Eric P.; Thomas, Richard C.; Toops, Dana S.; Watt, William; Wishka, Donn G.; Ford, Charles W.; Zurenko, Gary E.; Hamel, Judith C.; Schaadt, Ronda D.; Stapert, Douglas; Yagi, Betty H.; Adams, Wade J.; Friis, Janice M.; Slatter, J. Gregory; Sams, James P.; Oien, Nancee L.; Zaya, Matthew J.; Wienkers, Larry C.; Wynalda, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">284-302</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new and promising group of antibacterial agents, collectively known as the oxazolidinones and exemplified by linezolid, have recently emerged as important new therapeutic agents for the treatment of infections caused by Gram-pos. bacteria.  Because of their significance, extensive synthetic investigations into the structure-activity relationships of the oxazolidinones have been conducted at Pharmacia.  One facet of this research effort has focused on the identification of bioisosteric replacements for the usual oxazolidinone A-ring.  In this paper the studies leading to the identification of antibacterial agents incorporating a novel isoxazoline A-ring surrogate is presented.  In a gratifying result, the initial isoxazoline analog prepd. I (R1 = 3-methoxy-4-troponyl, R2 = R3 = H) was found to exhibit in vitro antibacterial activity approaching that of the corresponding oxazolidinone progenitor.  The synthesis and antibacterial activity profile of a preliminary series of isoxazoline analogs, (±)-, (R)-, (S)- and dehydro-I (R1 = 4-pyridinyl, morpholino, 4-hydroxyacetyl-1-piperazino, etc., R2 = H, F, R3 = H, F, Cl, X = O, S), incorporating either a C-C or N-C linkage between their B- and C-rings will be presented.  Many of the analogs exhibited interesting levels of antibacterial activity.  The piperazine deriv. (R)-I (R1 = 4-hydroxyacetyl-1-piperazino, R2 = R3 = F, X = O), derived from (R)-acetamidomethyltrifluorophenylisoxazoline, displayed esp. promising in vitro activity and in vivo efficacy comparable to the activity and efficacy of linezolid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxLAUw6yFR5bVg90H21EOLACvtfcHk0lgBo2JJzot_6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVemsr4%253D&md5=6d4c166f9c67a3188be93b0fe854613a</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1021%2Fjm020248u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020248u%26sid%3Dliteratum%253Aachs%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26aulast%3DCleek%26aufirst%3DG.%2BJ.%26aulast%3DDolak%26aufirst%3DL.%2BA.%26aulast%3DGarmon%26aufirst%3DS.%2BA.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DSeest%26aufirst%3DE.%2BP.%26aulast%3DThomas%26aufirst%3DR.%2BC.%26aulast%3DToops%26aufirst%3DD.%2BS.%26aulast%3DWatt%26aufirst%3DW.%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DFord%26aufirst%3DC.%2BW.%26aulast%3DZurenko%26aufirst%3DG.%2BE.%26aulast%3DHamel%26aufirst%3DJ.%2BC.%26aulast%3DSchaadt%26aufirst%3DR.%2BD.%26aulast%3DStapert%26aufirst%3DD.%26aulast%3DYagi%26aufirst%3DB.%2BH.%26aulast%3DAdams%26aufirst%3DW.%2BJ.%26aulast%3DFriis%26aufirst%3DJ.%2BM.%26aulast%3DSlatter%26aufirst%3DJ.%2BG.%26aulast%3DSams%26aufirst%3DJ.%2BP.%26aulast%3DOien%26aufirst%3DN.%2BL.%26aulast%3DZaya%26aufirst%3DM.%2BJ.%26aulast%3DWienkers%26aufirst%3DL.%2BC.%26aulast%3DWynalda%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520of%2520phenylisoxazolines%2520as%2520novel%2520and%2520viable%2520antibacterial%2520agents%2520active%2520against%2520Gram-positive%2520pathogens%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D284%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lhwTOMKx4gaUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lipinski, C. A.</span><span> </span><span class="NLM_article-title">Lead- and drug-like compounds: the rule-of-five revolution</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1016%2Fj.ddtec.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=24981612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=337-341&author=C.+A.+Lipinski&title=Lead-+and+drug-like+compounds%3A+the+rule-of-five+revolution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Lead- and drug-like compounds: the rule-of-five revolution</span></div><div class="casAuthors">Lipinski, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Technologies</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-341</span>CODEN:
                <span class="NLM_cas:coden">DDTTB5</span>;
        ISSN:<span class="NLM_cas:issn">1740-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Citations in CAS SciFinder to the rule-of-five (RO5) publication will exceed 1000 by year-end 2004.  Trends in the RO5 literature explosion that can be discerned are the further definitions of drug-like.  This topic is explored in terms of drug-like physicochem. features, drug-like structural features, a comparison of drug-like and non-drug-like in drug discovery and a discussion of how drug-like features relate to clin. success.  Physicochem. features of CNS drugs and features related to CNS blood-brain transporter affinity are briefly reviewed.  Recent literature on features of non-oral drugs is reviewed and how features of lead-like compds. differ from those of drug-like compds. is discussed.  Most recently, partly driven by NIH roadmap initiatives, considerations have arisen as to what tool-like means in the search for chem. tools to probe biol. space.  All these topics frame the scope of this short review/perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjiyP3CY7lLVg90H21EOLACvtfcHk0lhwTOMKx4gaUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D&md5=952c29b47003b884116d790ae9e4721f</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DLead-%2520and%2520drug-like%2520compounds%253A%2520the%2520rule-of-five%2520revolution%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2004%26volume%3D1%26spage%3D337%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duignan, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebowitz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelesky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span> </span><span class="NLM_article-title">High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.2174%2F138920008786485092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=18991580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2nsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=847-853&author=C.+E.+C.+A.+Hopauthor=M.+J.+Coleauthor=R.+E.+Davidsonauthor=D.+B.+Duignanauthor=J.+Federicoauthor=J.+S.+Janiszewskiauthor=K.+Jenkinsauthor=S.+Kruegerauthor=R.+Lebowitzauthor=T.+E.+Listonauthor=W.+Mitchellauthor=M.+Snyderauthor=S.+J.+Steynauthor=J.+R.+Sogliaauthor=C.+Taylorauthor=M.+D.+Troutmanauthor=J.+Umlandauthor=M.+Westauthor=K.+M.+Whalenauthor=V.+Zeleskyauthor=S.+X.+Zhao&title=High+throughput+ADME+screening%3A+practical+considerations%2C+impact+on+the+portfolio+and+enabler+of+in+silico+ADME+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models</span></div><div class="casAuthors">Hop, Cornelis E. C. A.; Cole, Mark J.; Davidson, Ralph E.; Duignan, David B.; Federico, James; Janiszewski, John S.; Jenkins, Kelly; Krueger, Suzanne; Lebowitz, Rebecca; Liston, Theodore E.; Mitchell, Walter; Snyder, Mark; Steyn, Stefan J.; Soglia, John R.; Taylor, Christine; Troutman, Matt D.; Umland, John; West, Michael; Whalen, Kevin M.; Zelesky, Veronica; Zhao, Sabrina X.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">847-853</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Evaluation and optimization of drug metab. and pharmacokinetic data plays an important role in drug discovery and development and several reliable in vitro ADME models are available.  Recently higher throughput in vitro ADME screening facilities have been established in order to be able to evaluate an appreciable fraction of synthesized compds.  The ADME screening process can be dissected in five distinct steps: (1) plate management of compds. in need of in vitro ADME data, (2) optimization of the MS/MS method for the compds., (3) in vitro ADME expts. and sample clean up, (4) collection and redn. of the raw LC-MS/MS data and (5) archival of the processed ADME data.  All steps will be described in detail and the value of the data on drug discovery projects will be discussed as well.  Finally, in vitro ADME screening can generate large quantities of data obtained under identical conditions to allow building of reliable in silico models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHIB4wuoFXErVg90H21EOLACvtfcHk0lhwTOMKx4gaUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2nsLk%253D&md5=69acd6725561ddb30157d22dab69e329</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F138920008786485092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008786485092%26sid%3Dliteratum%253Aachs%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26aulast%3DCole%26aufirst%3DM.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DDuignan%26aufirst%3DD.%2BB.%26aulast%3DFederico%26aufirst%3DJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DJenkins%26aufirst%3DK.%26aulast%3DKrueger%26aufirst%3DS.%26aulast%3DLebowitz%26aufirst%3DR.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DMitchell%26aufirst%3DW.%26aulast%3DSnyder%26aufirst%3DM.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DUmland%26aufirst%3DJ.%26aulast%3DWest%26aufirst%3DM.%26aulast%3DWhalen%26aufirst%3DK.%2BM.%26aulast%3DZelesky%26aufirst%3DV.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26atitle%3DHigh%2520throughput%2520ADME%2520screening%253A%2520practical%2520considerations%252C%2520impact%2520on%2520the%2520portfolio%2520and%2520enabler%2520of%2520in%2520silico%2520ADME%2520models%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D847%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benveniste, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weeks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisenbaum, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partin, K. M.</span><span> </span><span class="NLM_article-title">Structural and functional analysis of two new positive allosteric modulators of GluA2 desensitization and deactivation</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=267-280&author=D.+E.+Timmauthor=M.+Benvenisteauthor=A.+M.+Weeksauthor=E.+S.+Nisenbaumauthor=K.+M.+Partin&title=Structural+and+functional+analysis+of+two+new+positive+allosteric+modulators+of+GluA2+desensitization+and+deactivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DBenveniste%26aufirst%3DM.%26aulast%3DWeeks%26aufirst%3DA.%2BM.%26aulast%3DNisenbaum%26aufirst%3DE.%2BS.%26aulast%3DPartin%26aufirst%3DK.%2BM.%26atitle%3DStructural%2520and%2520functional%2520analysis%2520of%2520two%2520new%2520positive%2520allosteric%2520modulators%2520of%2520GluA2%2520desensitization%2520and%2520deactivation%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D80%26spage%3D267%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Mechanism of glutamate receptor desensitization</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">417</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1038%2F417245a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=12015593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjs1agtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=245-253&author=Y.+Sunauthor=R.+Olsonauthor=M.+Horningauthor=N.+Armstrongauthor=M.+Mayerauthor=E.+Gouaux&title=Mechanism+of+glutamate+receptor+desensitization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of glutamate receptor desensitization</span></div><div class="casAuthors">Sun, Yu; Olson, Rich; Horning, Michelle; Armstrong, Neali; Mayer, Mark; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">6886</span>),
    <span class="NLM_cas:pages">245-253</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ligand-gated ion channels transduce chem. signals into elec. impulses by opening a transmembrane pore in response to binding one or more neurotransmitter mols.  After activation, many ligand-gated ion channels enter a desensitized state in which the neurotransmitter remains bound but the ion channel is closed.  Although receptor desensitization is crucial to the functioning of many ligand-gated ion channels in vivo, the mol. basis of this important process has until now defied anal.  Using the GluR2 AMPA-sensitive glutamate receptor, we show here that the ligand-binding cores form dimers and that stabilization of the intradimer interface by either mutations or allosteric modulators reduces desensitization.  Perturbations that destabilize the interface enhance desensitization.  Receptor activation involves conformational changes within each subunit that result in an increase in the sepn. of portions of the receptor that are linked to the ion channel.  Our anal. defines the dimer interface in the resting and activated state, indicates how ligand binding is coupled to gating, and suggests modes of dimer-dimer interaction in the assembled tetramer.  Desensitization occurs through rearrangement of the dimer interface, which disengages the agonist-induced conformational change in the ligand-binding core from the ion channel gate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfnSz0jXyrJLVg90H21EOLACvtfcHk0liaEMSzoI1Xow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjs1agtrg%253D&md5=da6ce99323e00eeff313ce6a02d7fc01</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1038%2F417245a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F417245a%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DHorning%26aufirst%3DM.%26aulast%3DArmstrong%26aufirst%3DN.%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DMechanism%2520of%2520glutamate%2520receptor%2520desensitization%26jtitle%3DNature%26date%3D2002%26volume%3D417%26spage%3D245%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weeks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudman, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partin, K. M.</span><span> </span><span class="NLM_article-title">Mechanism of positive allosteric modulators acting on AMPA receptors</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">9027</span><span class="NLM_x">–</span> <span class="NLM_lpage">9036</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1523%2FJNEUROSCI.2567-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=16192394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOqs7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=9027-9036&author=R.+Jinauthor=S.+Clarkauthor=A.+M.+Weeksauthor=J.+T.+Dudmanauthor=E.+Gouauxauthor=K.+M.+Partin&title=Mechanism+of+positive+allosteric+modulators+acting+on+AMPA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27cR"><div class="casContent"><span class="casTitleNuber">27c</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of positive allosteric modulators acting on AMPA receptors</span></div><div class="casAuthors">Jin, Rongsheng; Clark, Suzanne; Weeks, Autumn M.; Dudman, Joshua T.; Gouaux, Eric; Partin, Kathryn M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">9027-9036</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Ligand-gated ion channels involved in the modulation of synaptic strength are the AMPA, kainate, and NMDA glutamate receptors.  Small mols. that potentiate AMPA receptor currents relieve cognitive deficits caused by neurodegenerative diseases such as Alzheimer's disease and show promise in the treatment of depression.  Previously, there has been limited understanding of the mol. mechanism of action for AMPA receptor potentiators.  Here the authors present cocrystal structures of the glutamate receptor GluR2 S1S2 ligand-binding domain in complex with aniracetam [1-(4-methoxybenzoyl)-2-pyrrolidinone] or CX614 (pyrrolidino-1,3-oxazino benzo-1,4-dioxan-10-one), two AMPA receptor potentiators that preferentially slow AMPA receptor deactivation.  Both potentiators bind within the dimer interface of the nondesensitized receptor at a common site located on the twofold axis of mol. symmetry.  Importantly, the potentiator binding site is adjacent to the "hinge" in the ligand-binding core "clamshell" that undergoes conformational rearrangement after glutamate binding.  Using rapid soln. exchange, patch-clamp electrophysiol. expts., the authors show that point mutations of residues that interact with potentiators in the cocrystal disrupt potentiator function.  The authors suggest that the potentiators slow deactivation by stabilizing the clamshell in its closed-cleft, glutamate-bound conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo15HIwmBGNTrVg90H21EOLACvtfcHk0li85clQ_eIjKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOqs7jP&md5=d035b142e3911e5e44a0ec4a825dc0a8</span></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2567-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2567-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DR.%26aulast%3DClark%26aufirst%3DS.%26aulast%3DWeeks%26aufirst%3DA.%2BM.%26aulast%3DDudman%26aufirst%3DJ.%2BT.%26aulast%3DGouaux%26aufirst%3DE.%26aulast%3DPartin%26aufirst%3DK.%2BM.%26atitle%3DMechanism%2520of%2520positive%2520allosteric%2520modulators%2520acting%2520on%2520AMPA%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D9027%26epage%3D9036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ahmed, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oswald, R. E.</span><span> </span><span class="NLM_article-title">Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2843</span><span class="NLM_x">–</span> <span class="NLM_lpage">2850</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi1000678" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=2843-2850&author=A.+H.+Ahmedauthor=C.+P.+Ptakauthor=R.+E.+Oswald&title=Molecular+mechanism+of+flop+selectivity+and+subsite+recognition+for+an+AMPA+receptor+allosteric+modulator%3A+structures+of+GluA2+and+GluA3+in+complexes+with+PEPA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27d&amp;dbid=16384&amp;doi=10.1021%2Fbi1000678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1000678%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DA.%2BH.%26aulast%3DPtak%26aufirst%3DC.%2BP.%26aulast%3DOswald%26aufirst%3DR.%2BE.%26atitle%3DMolecular%2520mechanism%2520of%2520flop%2520selectivity%2520and%2520subsite%2520recognition%2520for%2520an%2520AMPA%2520receptor%2520allosteric%2520modulator%253A%2520structures%2520of%2520GluA2%2520and%2520GluA3%2520in%2520complexes%2520with%2520PEPA%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D2843%26epage%3D2850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marrone, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luty, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. W.</span><span> </span><span class="NLM_article-title">Discovering high-affinity ligands from the computationally predicted structures and affinities of small molecules bound to a target: a virtual screening approach</span> <span class="citation_source-journal">Perspect. Drug Discovery Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1023%2FA%3A1008741308684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=209-230&author=T.+J.+Marroneauthor=B.+A.+Lutyauthor=P.+W.+Rose&title=Discovering+high-affinity+ligands+from+the+computationally+predicted+structures+and+affinities+of+small+molecules+bound+to+a+target%3A+a+virtual+screening+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering high-affinity ligands from the computationally predicted structures and affinities of small molecules bound to a target: a virtual screening approach</span></div><div class="casAuthors">Marrone, Tami J.; Luty, Brock A.; Rose, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Perspectives in Drug Discovery and Design</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-230</span>CODEN:
                <span class="NLM_cas:coden">PDDDEC</span>;
        ISSN:<span class="NLM_cas:issn">0928-2866</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">We describe a "virtual NMR screening" method to assist in the design of inhibitors that occupy different sites within a target.  We dock small mols. into the active site of an enzyme and score them.  Keeping the tightest-binding lead fixed in space, we dock and score other small mols. in its presence.  Using this approach, linker groups are used to join the compds. together to form a high-affinity inhibitor.  We present validation of our computational approach by reproducing exptl. results for FKBP and stromelysin.  Docking simulations are not subject to exptl. problems such as proteolysis, protein or compd. insoly., or enzyme size.  Because docking is fast and our scoring method can distinguish between high- and low-affinity inhibitors, this docking procedure shows promise as integral part of a drug-design strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql26ToXhh4jbVg90H21EOLACvtfcHk0li85clQ_eIjKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFSg&md5=cea3010bea46c3636970ece8ee764ae2</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008741308684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008741308684%26sid%3Dliteratum%253Aachs%26aulast%3DMarrone%26aufirst%3DT.%2BJ.%26aulast%3DLuty%26aufirst%3DB.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BW.%26atitle%3DDiscovering%2520high-affinity%2520ligands%2520from%2520the%2520computationally%2520predicted%2520structures%2520and%2520affinities%2520of%2520small%2520molecules%2520bound%2520to%2520a%2520target%253A%2520a%2520virtual%2520screening%2520approach%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D2000%26volume%3D20%26spage%3D209%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gehlhaar, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhivker, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freer, S. T.</span><span> </span><span class="NLM_article-title">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1016%2F1074-5521%2895%2990050-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=9383433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=317-324&author=D.+K.+Gehlhaarauthor=G.+M.+Verkhivkerauthor=P.+A.+Rejtoauthor=C.+J.+Shermanauthor=D.+B.+Fogelauthor=L.+J.+Fogelauthor=S.+T.+Freer&title=Molecular+recognition+of+the+inhibitor+AG-1343+by+HIV-1+protease%3A+conformationally+flexible+docking+by+evolutionary+programming"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span></div><div class="casAuthors">Gehlhaar, Daniel K.; Verkhivker, Gennady M.; Rejto, Paul A.; Sherman, Christopher J.; Fogel, David B.; Fogel, Lawrence J.; Freer, Stephan T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">317-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">An important prerequisite for computational structure-based drug design is prediction of the structures of ligand-protein complexes that have not yet been exptl. detd. by x-ray crystallog. or NMR.  For this task, docking of rigid ligands is inadequate because it assumes knowledge of the conformation of the bound ligand.  Docking of flexible ligands would be desirable, but requires one to search an enormous conformational space.  We set out to develop a strategy for flexible docking by combining a simple model of ligand-protein interactions for mol. recognition with an evolutionary programming search technique.  We have developed an intermol. energy function that incorporates steric and hydrogen-bonding terms.  The parameters in this function were obtained by docking in three different protein systems.  The effectiveness of this method was demonstrated by conformationally flexible docking of the inhibitor AG-1343, a potential new drug against AIDS, into HIV-1 protease.  For this mol., which has nine rotatable bonds, the crystal structure was reproduced within 1.5 Å rootmean-square deviation 34 times in 100 simulations, each requiring eight minutes on a Silicon Graphics R4400 workstation.  The energy function correctly evaluates the crystal structure as the global energy min.  We believe that a soln. of the docking problem may be achieved by matching a simple model of mol. recognition with an efficient search procedure.  The necessary ingredients of a mol. recognition model include only steric and hydrogen-bond interaction terms.  Although these terms are not necessarily sufficient to predict binding affinity, they describe ligand-protein interactions faithfully enough to enable a docking program to predict the structure of the bound ligand.  This docking strategy thus provides an important tool for the interdisciplinary field of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAErS8tcVx2bVg90H21EOLACvtfcHk0liHqy19flFnzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D&md5=527cfc114545ea76b64b48d0aee21856</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1016%2F1074-5521%2895%2990050-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1074-5521%252895%252990050-0%26sid%3Dliteratum%253Aachs%26aulast%3DGehlhaar%26aufirst%3DD.%2BK.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DSherman%26aufirst%3DC.%2BJ.%26aulast%3DFogel%26aufirst%3DD.%2BB.%26aulast%3DFogel%26aufirst%3DL.%2BJ.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26atitle%3DMolecular%2520recognition%2520of%2520the%2520inhibitor%2520AG-1343%2520by%2520HIV-1%2520protease%253A%2520conformationally%2520flexible%2520docking%2520by%2520evolutionary%2520programming%26jtitle%3DChem.%2520Biol.%26date%3D1995%26volume%3D2%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Linden, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinmayeh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnick, P.</span><span> </span><span class="NLM_article-title">Binding of an AMPA receptor potentiator ([3H]LY395153) to native and recombinant AMPA receptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1010</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=1010-1018&author=A.+M.+Lindenauthor=H.+Yuauthor=H.+Zarrinmayehauthor=W.+J.+Wheelerauthor=P.+Skolnick&title=Binding+of+an+AMPA+receptor+potentiator+%28%5B3H%5DLY395153%29+to+native+and+recombinant+AMPA+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLinden%26aufirst%3DA.%2BM.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZarrinmayeh%26aufirst%3DH.%26aulast%3DWheeler%26aufirst%3DW.%2BJ.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DBinding%2520of%2520an%2520AMPA%2520receptor%2520potentiator%2520%2528%255B3H%255DLY395153%2529%2520to%2520native%2520and%2520recombinant%2520AMPA%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D40%26spage%3D1010%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleo, M. D.</span><span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+a+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0liHqy19flFnzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520a%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0ljJ3EVtqU4AWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Tillement, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaumet-Riffaud, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bree, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albengres, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barre, J.</span><span> </span><span class="NLM_article-title">Blood binding and tissue uptake of drugs. Recent advances and perspectives</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1111%2Fj.1472-8206.1988.tb00634.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=3042568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADyaL1cXltVeqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1988&pages=223-238&author=J.+P.+Tillementauthor=S.+Urienauthor=P.+Chaumet-Riffaudauthor=P.+Riantauthor=F.+Breeauthor=D.+Morinauthor=E.+Albengresauthor=J.+Barre&title=Blood+binding+and+tissue+uptake+of+drugs.+Recent+advances+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Blood binding and tissue uptake of drugs.  Recent advances and perspectives</span></div><div class="casAuthors">Tillement, J. P.; Urien, S.; Chaumet-Riffaud, P.; Riant, P.; Bree, F.; Morin, D.; Albengres, E.; Barre, J.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-38</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    </div><div class="casAbstract">A review with 40 refs.  The free drug hypothesis, which states that only the unbound drug in blood is available for tissue diffusion, is discussed according to recent investigations.  In some exptl. conditions, it must be assumed that a part of the protein-bound drug in plasma is extd. during a single passage through the organ studied.  The mechanisms underlying these observations are not unequivocal and remain hypothetical.  In the liver, high-affinity binding sites for serum albumin have been demonstrated, and they would explain the high extn. by liver of endogenous and exogenous compds.  However, these expts. measure the unidirectional transfer of a drug from the vascular to the extravascular space in non-steady-state conditions.  Hence, in steady-state conditions, the free drug hypothesis cannot be ruled out because it is supported by numerous pharmacokinetic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrelrSOcPPALLVg90H21EOLACvtfcHk0ljJ3EVtqU4AWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVeqsLs%253D&md5=bc63d07fdf703eb8fcbd177986384dae</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.1988.tb00634.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.1988.tb00634.x%26sid%3Dliteratum%253Aachs%26aulast%3DTillement%26aufirst%3DJ.%2BP.%26aulast%3DUrien%26aufirst%3DS.%26aulast%3DChaumet-Riffaud%26aufirst%3DP.%26aulast%3DRiant%26aufirst%3DP.%26aulast%3DBree%26aufirst%3DF.%26aulast%3DMorin%26aufirst%3DD.%26aulast%3DAlbengres%26aufirst%3DE.%26aulast%3DBarre%26aufirst%3DJ.%26atitle%3DBlood%2520binding%2520and%2520tissue%2520uptake%2520of%2520drugs.%2520Recent%2520advances%2520and%2520perspectives%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D1988%26volume%3D2%26spage%3D223%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Shaffer, C. L.</span><span> </span><span class="NLM_article-title">Defining neuropharmacokinetic parameters in CNS drug discovery to determine cross-species pharmacologic exposure-response relationships</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=55-70&author=C.+L.+Shaffer&title=Defining+neuropharmacokinetic+parameters+in+CNS+drug+discovery+to+determine+cross-species+pharmacologic+exposure-response+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DDefining%2520neuropharmacokinetic%2520parameters%2520in%2520CNS%2520drug%2520discovery%2520to%2520determine%2520cross-species%2520pharmacologic%2520exposure-response%2520relationships%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D55%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Natta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worboys, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1124%2Fdmd.108.024125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=19116265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=787-793&author=X.+Liuauthor=K.+Van+Nattaauthor=H.+Yeoauthor=O.+Vilenskiauthor=P.+E.+Wellerauthor=P.+D.+Worboysauthor=M.+Monshouwer&title=Unbound+drug+concentration+in+brain+homogenate+and+cerebral+spinal+fluid+at+steady+state+as+a+surrogate+for+unbound+concentration+in+brain+interstitial+fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span></div><div class="casAuthors">Liu, Xingrong; Van Natta, Kristine; Yeo, Helen; Vilenski, Olga; Weller, Paul E.; Worboys, Philip D.; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present study was to examine the accuracy of using unbound brain concn. detd. by a brain homogenate method (Cub), cerebral spinal fluid concn. (CCSF), and unbound plasma concn. (Cup) as a surrogate for brain interstitial fluid concn. detd. by brain microdialysis (Cm).  Nine compds.-carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental-were selected, and each was administered as an i.v. bolus (up to 5 mg/kg) followed by a const. i.v. infusion (1-9 mg/kg/h) for 6 h in rats.  For eight of the nine compds., the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub.  The CCSFs of eight of the nine compds. were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm.  The Cups of five of the nine compds. were within 3-fold of their Cm; four compds. (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm.  In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compds. tested.  The Cups were within 3-fold of Cm for lipophilic non-P-glycoprotein (-P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates.  The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concns. within 3-fold of error in drug discovery and development settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVK_I2XYWfrrVg90H21EOLACvtfcHk0lgcMCVaBPgUvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D&md5=feb6abdcfa4e2e007c5abd44066c0e19</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVan%2BNatta%26aufirst%3DK.%26aulast%3DYeo%26aufirst%3DH.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DWeller%26aufirst%3DP.%2BE.%26aulast%3DWorboys%26aufirst%3DP.%2BD.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DUnbound%2520drug%2520concentration%2520in%2520brain%2520homogenate%2520and%2520cerebral%2520spinal%2520fluid%2520at%2520steady%2520state%2520as%2520a%2520surrogate%2520for%2520unbound%2520concentration%2520in%2520brain%2520interstitial%2520fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D787%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancuso, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span> </span><span class="NLM_article-title">An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2162</span><span class="NLM_x">–</span> <span class="NLM_lpage">2173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=2162-2173&author=A.+C.+Doranauthor=S.+M.+Osgoodauthor=J.+Y.+Mancusoauthor=C.+L.+Shaffer&title=An+evaluation+of+using+rat-derived+single-dose+neuropharmacokinetic+parameters+to+project+accurately+large+animal+unbound+brain+drug+concentrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DOsgood%26aufirst%3DS.%2BM.%26aulast%3DMancuso%26aufirst%3DJ.%2BY.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DAn%2520evaluation%2520of%2520using%2520rat-derived%2520single-dose%2520neuropharmacokinetic%2520parameters%2520to%2520project%2520accurately%2520large%2520animal%2520unbound%2520brain%2520drug%2520concentrations%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D2162%26epage%3D2173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yamada, K. A.</span><span> </span><span class="NLM_article-title">Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1006%2Fnbdi.1998.0190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=9746904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlentbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1998&pages=67-80&author=K.+A.+Yamada&title=Modulating+excitatory+synaptic+neurotransmission%3A+potential+treatment+for+neurological+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34aR"><div class="casContent"><span class="casTitleNuber">34a</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?</span></div><div class="casAuthors">Yamada, Kelvin A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-80</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review, with 84 refs.  Excitatory neurotransmission at many CNS synapses depends upon AMPA-type glutamate receptors.  Derangements in AMPA receptor-mediated synaptic transmission may be a contributing factor in neurol. and neurodegenerative diseases and could be a target for therapeutic intervention.  Drugs that pos. modulate AMPA receptors by reducing AMPA receptor desensitization and/or slowing AMPA receptor deactivation, such as thiazide derivs. (cyclothiazide, diazoxide, IDRA 21) and benzoylpiperidine derivs. (1-BCP, CX516, aniracetam), facilitate AMPA receptor-mediated processes and may have beneficial therapeutic effects.  For example, AMPA modulators facilitate long-term potentiation, which may be important for memory storage, and facilitate memory encoding in behavioral expts.  Thus, AMPA modulators might ameliorate memory deficits that occur in dementia, such as Alzheimer's disease.  However, AMPA receptor-mediated excitotoxicity may occur with excessive AMPA receptor activation such as in seizures or ischemia, and pos. AMPA modulators would promote neuronal injury under those conditions.  Regardless of the ultimate clin. utility of pos. AMPA modulators, their discovery and study have already provided significant insight into the physiol. and structural determinants of important AMPA receptor properties.  This review attempts to synthesize a variety of studies that have utilized these AMPA modulators to gain insight into fundamental as well as clin. relevant AMPA receptor-mediated processes.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfjdGogGo9LLVg90H21EOLACvtfcHk0lhNAjH-ToZ1Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlentbc%253D&md5=5f8211686883cffc773c302d8ef24877</span></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.1998.0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.1998.0190%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%2BA.%26atitle%3DModulating%2520excitatory%2520synaptic%2520neurotransmission%253A%2520potential%2520treatment%2520for%2520neurological%2520disease%253F%26jtitle%3DNeurobiol.%2520Dis.%26date%3D1998%26volume%3D5%26spage%3D67%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Garthwaite, G. G.</span><span> </span><span class="NLM_article-title">Mechanisms of AMPA neurotoxicity in rat brain slices</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">729</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1111%2Fj.1460-9568.1991.tb01669.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=12106459" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=729-736&author=G.+G.+Garthwaite&title=Mechanisms+of+AMPA+neurotoxicity+in+rat+brain+slices"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.1991.tb01669.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.1991.tb01669.x%26sid%3Dliteratum%253Aachs%26aulast%3DGarthwaite%26aufirst%3DG.%2BG.%26atitle%3DMechanisms%2520of%2520AMPA%2520neurotoxicity%2520in%2520rat%2520brain%2520slices%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1991%26volume%3D3%26spage%3D729%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span> </span><span class="NLM_article-title">Species independence in brain tissue binding using brain homogenates</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1124%2Fdmd.111.038778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=21474681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1270-1277&author=L.+Diauthor=J.+P.+Umlandauthor=G.+Changauthor=Y.+Huangauthor=Z.+Linauthor=D.+O.+Scottauthor=M.+D.+Troutmanauthor=T.+E.+Liston&title=Species+independence+in+brain+tissue+binding+using+brain+homogenates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34cR"><div class="casContent"><span class="casTitleNuber">34c</span><div class="casTitle"><span class="NLM_cas:atitle">Species independence in brain tissue binding using brain homogenates</span></div><div class="casAuthors">Di, Li; Umland, John P.; Chang, George; Huang, Youping; Lin, Zhen; Scott, Dennis O.; Troutman, Matthew D.; Liston, Theodore E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1270-1277</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Species independence of brain tissue binding was assessed with a large no. of structurally diverse compds. using equil. dialysis with brain homogenates of seven species and strains (Wistar Han rat, Sprague-Dawley rat, CD-1 mouse, Hartley guinea pig, beagle dog, cynomolgus monkey, and human).  The results showed that the fractions unbound of the seven species and strains were strongly correlated with correlation coeffs. ranging from 0.93 to 0.99.  The cross-species/strain correlations were not significantly different from the interassay correlation with the same species.  The linear correlation between Wistar Han and other species had a slope close to 1 and an intercept near 0.  Based on orthogonal statistical anal., no correction is needed for extrapolation of fraction unbound from Wistar Han rat to the other species or strains.  Hence, brain tissue binding of Wistar Han rat can be used to obtain binding of other species and strains in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoub4FiLWkAFrVg90H21EOLACvtfcHk0lhNAjH-ToZ1Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D&md5=93a51addedb22de4648e6e5ee39c6c81</span></div><a href="/servlet/linkout?suffix=cit34c&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.038778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.038778%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DListon%26aufirst%3DT.%2BE.%26atitle%3DSpecies%2520independence%2520in%2520brain%2520tissue%2520binding%2520using%2520brain%2520homogenates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1270%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotarski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span> </span><span class="NLM_article-title">Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure-response continuum of the novel potentiator PF-4778574</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1124%2Fjpet.113.204735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=23899905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=212-224&author=C.+L.+Shafferauthor=R.+S.+Hurstauthor=R.+J.+Scialisauthor=S.+M.+Osgoodauthor=D.+K.+Bryceauthor=W.+E.+Hoffmannauthor=J.+T.+Lazzaroauthor=A.+N.+Hanksauthor=S.+Lotarskiauthor=M.+L.+Weberauthor=J.+Liuauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+Haj%C3%B3s&title=Positive+allosteric+modulation+of+AMPA+receptors+from+efficacy+to+toxicity%3A+the+interspecies+exposure-response+continuum+of+the+novel+potentiator+PF-4778574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure-response continuum of the novel potentiator PF-4778574</span></div><div class="casAuthors">Shaffer, Christopher L.; Hurst, Raymond S.; Scialis, Renato J.; Osgood, Sarah M.; Bryce, Dianne K.; Hoffmann, William E.; Lazzaro, John T.; Hanks, Ashley N.; Lotarski, Susan; Weber, Mark L.; Liu, Jian Hua; Menniti, Frank S.; Schmidt, Christopher J.; Hajos, Mihaly</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-224</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) pos. allosteric modulation (i.e., "potentiation") has been proposed to overcome cognitive impairments in schizophrenia, but AMPAR overstimulation can be excitotoxic.  Thus, it is crit. to define carefully a potentiator's mechanism-based therapeutic index (TI) and to det. confidently its translatability from rodents to higher-order species.  Accordingly, the novel AMPAR potentiator N-{(3R,4S)-3-[4-(5-cyano-2-thienyl)phenyl]tetrahydro-2H-pyran-4-yl}propane-2-sulfonamide (PF-4778574) was characterized in a series of in vitro assays and single-dose animal studies evaluating AMPAR-mediated activities related to cognition and safety to afford an unbound brain compd. concn. (Cb,u)-normalized interspecies exposure-response relationship.  Because it is unknown which AMPAR subtype(s) may be selectively potentiated for an optimal TI, PF-4778574 binding affinity and functional potency were detd. in rodent tissues expected to express a native mixt. of AMPAR subunits and their assocd. proteins to afford composite pharmacol. values.  Functional activity was also quantified in recombinant cell lines stably expressing human GluA2 flip or flop homotetramers.  Procognitive effects of PF-4778574 were evaluated in both rat electrophysiol. and nonhuman primate (nhp) behavioral models of pharmacol. induced N-methyl-D-aspartate receptor hypofunction.  Safety studies assessed carebellum-based AMPAR activation (mouse) and motor coordination disruptions (mouse, dog, and nhp), as well as convulsion (mouse, rat, and dog).  The resulting empirically derived exposure-response continuum for PF-4778574 defines a single-dose-based TI of 8- to 16-fold for self-limiting tremor, a readily monitorable clin. adverse event.  Importantly, the Cb,u mediating each physiol. effect were highly consistent across species, with efficacy and convulsion occurring at just fractions of the in vitro-derived pharmacol. values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP5MdXGBbRYrVg90H21EOLACvtfcHk0lhNAjH-ToZ1Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7jE&md5=8fead71db7d49812f68c25f603132679</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.204735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.204735%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DOsgood%26aufirst%3DS.%2BM.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DLotarski%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DM.%2BL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26atitle%3DPositive%2520allosteric%2520modulation%2520of%2520AMPA%2520receptors%2520from%2520efficacy%2520to%2520toxicity%253A%2520the%2520interspecies%2520exposure-response%2520continuum%2520of%2520the%2520novel%2520potentiator%2520PF-4778574%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D212%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ryder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manro, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchant, K. M.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1124%2Fjpet.106.105734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCksLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=293-298&author=J.+W.+Ryderauthor=J.+F.+Falconeauthor=J.+R.+Manroauthor=K.+A.+Svenssonauthor=K.+M.+Merchant&title=Pharmacological+characterization+of+cGMP+regulation+by+the+biarylpropylsulfonamide+class+of+positive%2C+allosteric+modulators+of+%CE%B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic+acid+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors</span></div><div class="casAuthors">Ryder, John W.; Falcone, Julie F.; Manro, Jason R.; Svensson, Kjell A.; Merchant, Kalpana M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">293-298</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The biarylpropylsulfonamide class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) potentiators represented by N-2-(4-(4-cyanophenol)phenol)propyl-2-propanesulfonamide (LY404187) and (R)-4'-[1-fluoro-1-methyl-2-(propane-2-sulfonylamino)-ethyl]-biphenyl-4-carboxylic acid methylamide (LY503430) are pos., allosteric AMPA receptor activators, which enhance AMPA receptor-mediated neurotransmission by reducing desensitization of the ion channel.  Although these compds. have efficacy in in vivo rodent models of cognition, depression, and Parkinson's disease, little is known about biochem. pathways activated by these agents.  Given the well established regulation of the nitric oxide/cGMP pathway by excitatory neurotransmission, the current study characterized AMPA receptor potentiator-mediated cGMP response in mouse cerebellum.  Acute treatment by both LY404187 and LY503430 [2.0, 5.0, or 10 mg/kg s.c.] elevated basal cerebellar cGMP levels in a dose-dependent manner.  Pretreatment with the noncompetitive, allosteric AMPA receptor-selective antagonist 7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide, 5-(4-aminophenyl)-8,9-dihydro-N,8-dimethyl-monohydrochloride-(9CI) (GYKI 53655) [3.0 mg/kg i.p.], completely blocked the effect of LY404187, demonstrating that activation of AMPA receptors induces cGMP levels.  Interestingly, pretreatment with the N-methyl-D-aspartate (NMDA) open channel blocker dizocilpine (0.3 and 1.0 mg/kg i.p.) also abolished the AMPA receptor potentiator-mediated cGMP accumulation, indicating that activation of AMPA receptors leads to NMDA receptor-mediated transmission involved in cGMP regulation.  Pharmacol. augmentation of the endogenous glutamate tone via the alkaloid harmaline (20-60 mg/kg i.p.) synergized with AMPA potentiator activity and provided further direct evidence of in vivo allosteric activation of AMPA receptors by LY404187.  The synergism between harmaline and LY404187 was specific, since cGMP accumulation induced by foot-shock stress was not augmented by the AMPA receptor potentiator.  Taken together, these data indicate that the cGMP system may play an important role in pharmacol. efficacy of the biarylpropylsulfonamide class of AMPA receptor potentiators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeZVDKiSOi7LVg90H21EOLACvtfcHk0lgC69umSK-3sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCksLrO&md5=e1fff3ab717a74321b389e96ea575889</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.105734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.105734%26sid%3Dliteratum%253Aachs%26aulast%3DRyder%26aufirst%3DJ.%2BW.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DManro%26aufirst%3DJ.%2BR.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DMerchant%26aufirst%3DK.%2BM.%26atitle%3DPharmacological%2520characterization%2520of%2520cGMP%2520regulation%2520by%2520the%2520biarylpropylsulfonamide%2520class%2520of%2520positive%252C%2520allosteric%2520modulators%2520of%2520%25CE%25B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2520acid%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D293%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Kiss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span> </span><span class="NLM_article-title">Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1017%2FS1461145710000271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=20334724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=29-42&author=T.+Kissauthor=W.+E.+Hoffmannauthor=M.+Hajos&title=Delta+oscillation+and+short-term+plasticity+in+the+rat+medial+prefrontal+cortex%3A+modelling+NMDA+hypofunction+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia</span></div><div class="casAuthors">Kiss, Tamas; Hoffmann, William E.; Hajos, Mihaly</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-42</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Dysfunction of the prefrontal cortex (PFC) is considered to be an important factor contributing to a decrease in cognitive performance of schizophrenia patients.  The medial PFC (mPFC) is innervated by the hippocampus/subiculum, and the subiculum-mPFC pathway is known to be involved in various cognitive processes.  Glutamate-contg. subicular axons innervate cortical pyramidal neurons and interneurons where AMPA and NMDA receptors are implicated in synaptic transmission.  In our expts., properties of subiculum-mPFC interactions were studied using pathway stimulation and local field potential (LFP) recordings of the mPFC in urethane-anesthetized rats.  Changes in paired-pulse facilitation (PPF) and LFP oscillations, effects of the NMDA receptor antagonist MK-801, and the AMPAkine LY451395 were evaluated.  Effects of disruption of the thalamo-cortical loop with local microinjection of lidocaine into the mediodorsal thalamic nucleus (MD) were also studied.  Our findings demonstrate that both systemic administration of MK-801 and local MD lidocaine microinjection produce similar changes in LFP oscillations and redn. in PPF.  Specifically, it was obsd. that MK-801 (0.05 mg/kg i.v.) and intra-thalamic lidocaine changed regular, 2 Hz delta oscillation to a less regular 0.5-1.5 Hz delta rhythm.  Concurrently, PPF in response to elec. stimulation of the subiculum was significantly attenuated.  Administration of the AMPAkine LY451395 (0.01 mg/kg i.v.) reversed the MK-801- and lidocaine-induced changes, and was itself blocked by the AMPA receptor antagonist CP-465022.  Anal. of our findings suggests a crit. role of cortical interneurons in NMDA/AMPA receptor-mediated changes in thalamo-cortical oscillations and PPF, and contributes to our understanding of the NMDA hypofunction model of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5APr_ncoDP7Vg90H21EOLACvtfcHk0lgC69umSK-3sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLnO&md5=5cf78907f9690c37011f8d3e39f7b110</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1017%2FS1461145710000271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145710000271%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26atitle%3DDelta%2520oscillation%2520and%2520short-term%2520plasticity%2520in%2520the%2520rat%2520medial%2520prefrontal%2520cortex%253A%2520modelling%2520NMDA%2520hypofunction%2520of%2520schizophrenia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2011%26volume%3D14%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Olney, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomer, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, N. B.</span><span> </span><span class="NLM_article-title">NMDA receptor hypofunction model of schizophrenia</span> <span class="citation_source-journal">J. Psychiatr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1016%2FS0022-3956%2899%2900029-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=10628529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252Fpt1Wisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1999&pages=523-533&author=J.+W.+Olneyauthor=J.+W.+Newcomerauthor=N.+B.+Farber&title=NMDA+receptor+hypofunction+model+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor hypofunction model of schizophrenia</span></div><div class="casAuthors">Olney J W; Newcomer J W; Farber N B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">523-33</span>
        ISSN:<span class="NLM_cas:issn">0022-3956</span>.
    </div><div class="casAbstract">Several decades of research attempting to explain schizophrenia in terms of the dopamine hyperactivity hypothesis have produced disappointing results.  A new hypothesis focusing on hypofunction of the NMDA glutamate transmitter system is emerging as a potentially more promising concept.  In this article, we present a version of the NMDA receptor hypofunction hypothesis that has evolved from our recent studies pertaining to the neurotoxic and psychotomimetic effects of PCP and related NMDA antagonist drugs.  In this article, we examine this hypothesis in terms of its strengths and weaknesses, its therapeutic implications and ways in which it can be further tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8PJv1HPbUrDEC-75aqa5AfW6udTcc2ebLURmj8-twE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252Fpt1Wisg%253D%253D&md5=1450b1d092fbd5075e730c8aa68f1153</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0022-3956%2899%2900029-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-3956%252899%252900029-1%26sid%3Dliteratum%253Aachs%26aulast%3DOlney%26aufirst%3DJ.%2BW.%26aulast%3DNewcomer%26aufirst%3DJ.%2BW.%26aulast%3DFarber%26aufirst%3DN.%2BB.%26atitle%3DNMDA%2520receptor%2520hypofunction%2520model%2520of%2520schizophrenia%26jtitle%3DJ.%2520Psychiatr.%2520Res.%26date%3D1999%26volume%3D33%26spage%3D523%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Goldman-Rakic, P. S.</span><span> </span><span class="NLM_article-title">Working memory dysfunction in schizophrenia</span> <span class="citation_source-journal">J. Neuropsychiatry Clin. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1176%2Fjnp.6.4.348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=7841806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A280%3ADyaK2M7ktl2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1994&pages=348-357&author=P.+S.+Goldman-Rakic&title=Working+memory+dysfunction+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Working memory dysfunction in schizophrenia</span></div><div class="casAuthors">Goldman-Rakic P S</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of neuropsychiatry and clinical neurosciences</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">348-57</span>
        ISSN:<span class="NLM_cas:issn">0895-0172</span>.
    </div><div class="casAbstract">Recent advances in anatomical, behavioral, and physiological techniques have produced new information about the nature of prefrontal function, its cellular basis, and its anatomical underpinnings in nonhuman primates.  These findings are changing our views of prefrontal function and providing insight into possible bases for human mental disorder.  A major advance is the recognition that various prefrontal areas are engaged in holding information "on line" and updating past and current information on a moment-to-moment basis.  Studies of animals and of cognitive function in normal, brain-injured, and schizophrenic subjects support the theory that a defect in working memory--the ability to guide behavior by representations--may be the fundamental impairment leading to schizophrenic thought disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyESdDKBz6etTiMd2aNQVUfW6udTcc2ebs6g6EDwJV_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7ktl2mtQ%253D%253D&md5=4a864a3c0cf5268f35615668e11246c3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1176%2Fjnp.6.4.348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fjnp.6.4.348%26sid%3Dliteratum%253Aachs%26aulast%3DGoldman-Rakic%26aufirst%3DP.%2BS.%26atitle%3DWorking%2520memory%2520dysfunction%2520in%2520schizophrenia%26jtitle%3DJ.%2520Neuropsychiatry%2520Clin.%2520Neurosci.%26date%3D1994%26volume%3D6%26spage%3D348%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Moghaddam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitt, D.</span><span> </span><span class="NLM_article-title">From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1038%2Fnpp.2011.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=21956446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=4-15&author=B.+Moghaddamauthor=D.+Javitt&title=From+revolution+to+evolution%3A+the+glutamate+hypothesis+of+schizophrenia+and+its+implication+for+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment</span></div><div class="casAuthors">Moghaddam, Bita; Javitt, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glutamate is the primary excitatory neurotransmitter in mammalian brain.  Disturbances in glutamate-mediated neurotransmission have been increasingly documented in a range of neuropsychiatric disorders including schizophrenia, substance abuse, mood disorders, Alzheimer's disease, and autism-spectrum disorders.  Glutamatergic theories of schizophrenia are based on the ability of N-methyl--aspartate receptor (NMDAR) antagonists to induce schizophrenia-like symptoms, as well as emergent literature documenting disturbances of NMDAR-related gene expression and metabolic pathways in schizophrenia.  Research over the past two decades has highlighted promising new targets for drug development based on potential pre- and postsynaptic, and glial mechanisms leading to NMDAR dysfunction.  Reduced NMDAR activity on inhibitory neurons leads to disinhibition of glutamate neurons increasing synaptic activity of glutamate, esp. in the prefrontal cortex.  Based on this mechanism, normalizing excess glutamate levels by metabotropic glutamate group 2/3 receptor agonists has led to potential identification of the first non-monoaminergic target with comparable efficacy as conventional antipsychotic drugs for treating pos. and neg. symptoms of schizophrenia.  In addn., NMDAR has intrinsic modulatory sites that are active targets for drug development, several of which show promise in preclin./early clin. trials targeting both symptoms and cognition.  To date, most studies have been done with orthosteric agonists and/or antagonists at specific sites.  However, allosteric modulators, both pos. and neg., may offer superior efficacy with less danger of downregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeNMlez-A7MbVg90H21EOLACvtfcHk0lhOsov1FGsQYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N&md5=0bf82fc0e3cb5c3ad2bed91414672e6f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.181%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DB.%26aulast%3DJavitt%26aufirst%3DD.%26atitle%3DFrom%2520revolution%2520to%2520evolution%253A%2520the%2520glutamate%2520hypothesis%2520of%2520schizophrenia%2520and%2520its%2520implication%2520for%2520treatment%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D4%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism-based adverse events projecting human <i>C</i><sub>max</sub> variability after an oral dose via PBPK modeling</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1002%2Fbdd.1768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1yhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=72-84&author=C.+L.+Shafferauthor=R.+J.+Scialisauthor=H.+Rongauthor=R.+S.+Obach&title=Using+Simcyp+to+project+human+oral+pharmacokinetic+variability+in+early+drug+research+to+mitigate+mechanism-based+adverse+events+projecting+human+Cmax+variability+after+an+oral+dose+via+PBPK+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism-based adverse eventsProjecting Human Cmax Variability after an Oral Dose via PBPK ModelingC.L. SHAFFER ET AL.</span></div><div class="casAuthors">Shaffer, Christopher L.; Scialis, Renato J.; Rong, Haojing; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">72-84</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Pos. allosteric modulators ( potentiators') of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) have been shown to display a mechanism-based exposure-response continuum in preclin. species with procognitive electrophysiol. and behavioral effects ( efficacy') at low exposures and motor coordination disruptions at progressively higher exposures.  Due to the dose-capping nature of such motor coordination deficits, an exposure threshold-mediated adverse event (CAE), the adequacy of sepn. between the maximal total plasma compd. concn. (Cmax) at a predicted clin. efficacious oral dose and this adverse event (AE) was explored in early drug research with three AMPAR potentiators considered potential candidates for clin. trials.  In vitro metab. studies in human liver microsomes and human hepatocytes demonstrated the metabolic clearance for each compd. was predominately due to cytochromes P 450 (CYP).  Thus, for each compd.'s anticipated clin. efficacious dose, human Cmax variability following oral administration was assessed using Simcyp software, which combines its virtual human populations database using extensive demog., physiol. and genomic information with routinely collected compd.-specific in vitro biochem. data to simulate and predict drug disposition.  Using a combination of exptl. detd. recombinant human CYP intrinsic clearances for CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6 and CYP3A4, human binding factors, expected fraction absorbed and estd. steady-state vol. of distribution, Simcyp simulations demonstrated that two of the three potentiators had acceptable projected Cmax variability (i.e. the 95th percentile Cmax did not breach CAE).  This evaluation aided in the selection of compds. for preclin. progression, and represents a novel application of pharmacol. based pharmacokinetic (PBPK) software approaches to predict interpatient variability.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYHYc71vaExbVg90H21EOLACvtfcHk0lhOsov1FGsQYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1yhsw%253D%253D&md5=0ff126a5b34085f42606277651aa40e2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fbdd.1768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.1768%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DUsing%2520Simcyp%2520to%2520project%2520human%2520oral%2520pharmacokinetic%2520variability%2520in%2520early%2520drug%2520research%2520to%2520mitigate%2520mechanism-based%2520adverse%2520events%2520projecting%2520human%2520Cmax%2520variability%2520after%2520an%2520oral%2520dose%2520via%2520PBPK%2520modeling%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2012%26volume%3D33%26spage%3D72%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b'],'ref25':['cit25a','cit25b'],'ref26':['cit26'],'ref27':['cit27a','cit27b','cit27c','cit27d'],'ref28':['cit28a','cit28b'],'ref29':['cit29'],'ref30':['cit30a','cit30b'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33a','cit33b'],'ref34':['cit34a','cit34b','cit34c'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Virginia Spanò, Roberta Rocca, Marilia Barreca, Daniele Giallombardo, Alessandra Montalbano, Anna Carbone, Maria Valeria Raimondi, Eugenio Gaudio, Roberta Bortolozzi, Ruoli Bai, Pierfrancesco Tassone, Stefano Alcaro, Ernest Hamel, Giampietro Viola, Francesco Bertoni, <span class="NLM_string-name hlFld-ContribAuthor">Paola Barraja</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrrolo[2′,3′:3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 12023-12042. <a href="https://doi.org/10.1021/acs.jmedchem.0c01315" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01315%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrrolo%25255B2%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2%25253A3%25252C4%25255Dcyclohepta%25255B1%25252C2-d%25255D%25255B1%25252C2%25255Doxazoles%25252C%252Ba%252BNew%252BClass%252Bof%252BAntimitotic%252BAgents%252BActive%252Bagainst%252BMultiple%252BMalignant%252BCell%252BTypes%26aulast%3DSpan%25C3%25B2%26aufirst%3DVirginia%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29072020%26date%3D12102020%26date%3D28092020%26volume%3D63%26issue%3D20%26spage%3D12023%26epage%3D12042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher L.  Shaffer</span>, <span class="hlFld-ContribAuthor ">Nandini C.  Patel</span>, <span class="hlFld-ContribAuthor ">Jacob  Schwarz</span>, <span class="hlFld-ContribAuthor ">Renato J.  Scialis</span>, <span class="hlFld-ContribAuthor ">Yunjing  Wei</span>, <span class="hlFld-ContribAuthor ">Xinjun J.  Hou</span>, <span class="hlFld-ContribAuthor ">Longfei  Xie</span>, <span class="hlFld-ContribAuthor ">Kapil  Karki</span>, <span class="hlFld-ContribAuthor ">Dianne K.  Bryce</span>, <span class="hlFld-ContribAuthor ">Sarah M.  Osgood</span>, <span class="hlFld-ContribAuthor ">William E.  Hoffmann</span>, <span class="hlFld-ContribAuthor ">John T.  Lazzaro</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Dina F.  McGinnis</span>, <span class="hlFld-ContribAuthor ">Susan M.  Lotarski</span>, <span class="hlFld-ContribAuthor ">JianHua  Liu</span>, <span class="hlFld-ContribAuthor ">R. Scott  Obach</span>, <span class="hlFld-ContribAuthor ">Mark L.  Weber</span>, <span class="hlFld-ContribAuthor ">Laigao  Chen</span>, <span class="hlFld-ContribAuthor ">Kenneth R.  Zasadny</span>, <span class="hlFld-ContribAuthor ">Patricia A.  Seymour</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Mihály  Hajós</span>, <span class="hlFld-ContribAuthor ">Raymond S.  Hurst</span>, <span class="hlFld-ContribAuthor ">Jayvardhan  Pandit</span>, and <span class="hlFld-ContribAuthor ">Christopher J.  O’Donnell</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery and Characterization of the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Potentiator N-{(3S,4S)-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (10)
                                     , 4291-4308. <a href="https://doi.org/10.1021/acs.jmedchem.5b00300" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00300%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Band%252BCharacterization%252Bof%252Bthe%252B%2525CE%2525B1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic%252BAcid%252B%252528AMPA%252529%252BReceptor%252BPotentiator%252BN-%25257B%2525283S%25252C4S%252529-4-%25255B4-%2525285-Cyano-2-thienyl%252529phenoxy%25255Dtetrahydrofuran-3-yl%25257Dpropane-2-sulfonamide%252B%252528PF-04958242%252529%26aulast%3DShaffer%26aufirst%3DChristopher%2BL.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D20022015%26date%3D14052015%26date%3D28052015%26date%3D23042015%26volume%3D58%26issue%3D10%26spage%3D4291%26epage%3D4308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicola  Caldwell</span>, <span class="hlFld-ContribAuthor ">Jonathan E.  Harms</span>, <span class="hlFld-ContribAuthor ">Kathryn M.  Partin</span>, and <span class="hlFld-ContribAuthor ">Craig  Jamieson</span>  . </span><span class="cited-content_cbyCitation_article-title">Rational Design of a Novel AMPA Receptor Modulator through a Hybridization Approach. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (4)
                                     , 392-396. <a href="https://doi.org/10.1021/ml5004553" title="DOI URL">https://doi.org/10.1021/ml5004553</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml5004553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml5004553%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRational%252BDesign%252Bof%252Ba%252BNovel%252BAMPA%252BReceptor%252BModulator%252Bthrough%252Ba%252BHybridization%252BApproach%26aulast%3DCaldwell%26aufirst%3DNicola%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D04112014%26date%3D11022015%26date%3D13022015%26date%3D09042015%26date%3D11022015%26volume%3D6%26issue%3D4%26spage%3D392%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karla  Frydenvang</span>, <span class="hlFld-ContribAuthor ">Darryl S.  Pickering</span>, <span class="hlFld-ContribAuthor ">Jette Sandholm  Kastrup</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis for positive allosteric modulation of AMPA and kainate receptors. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physiology</span><span> <strong>2021,</strong> <em>53 </em><a href="https://doi.org/10.1113/JP280873" title="DOI URL">https://doi.org/10.1113/JP280873</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1113/JP280873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1113%2FJP280873%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physiology%26atitle%3DStructural%252Bbasis%252Bfor%252Bpositive%252Ballosteric%252Bmodulation%252Bof%252BAMPA%252Band%252Bkainate%252Breceptors%26aulast%3DFrydenvang%26aufirst%3DKarla%26date%3D2021%26date%3D2021%26volume%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna A.  Nazarova</span>, <span class="hlFld-ContribAuthor ">Kseniya N.  Sedenkova</span>, <span class="hlFld-ContribAuthor ">Dmitry S.  Karlov</span>, <span class="hlFld-ContribAuthor ">Mstislav I.  Lavrov</span>, <span class="hlFld-ContribAuthor ">Yuri K.  Grishin</span>, <span class="hlFld-ContribAuthor ">Tamara S.  Kuznetsova</span>, <span class="hlFld-ContribAuthor ">Vladimir L.  Zamoyski</span>, <span class="hlFld-ContribAuthor ">Vladimir V.  Grigoriev</span>, <span class="hlFld-ContribAuthor ">Elena B.  Averina</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Palyulin</span>. </span><span class="cited-content_cbyCitation_article-title">Bivalent AMPA receptor positive allosteric modulators of the bis(pyrimidine) series. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 1615-1619. <a href="https://doi.org/10.1039/C9MD00262F" title="DOI URL">https://doi.org/10.1039/C9MD00262F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00262F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00262F%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DBivalent%252BAMPA%252Breceptor%252Bpositive%252Ballosteric%252Bmodulators%252Bof%252Bthe%252Bbis%252528pyrimidine%252529%252Bseries%26aulast%3DNazarova%26aufirst%3DAnna%2BA.%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D9%26spage%3D1615%26epage%3D1619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guilherme Martins  Silva</span>, <span class="hlFld-ContribAuthor ">Mariana Pegrucci  Barcelos</span>, <span class="hlFld-ContribAuthor ">João Gabriel Curtolo  Poiani</span>, <span class="hlFld-ContribAuthor ">Lorane Izabel da Silva  Hage‐Melim</span>, <span class="hlFld-ContribAuthor ">Carlos Henrique Tomich de Paula  da Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulators of Potential Targets Related to Alzheimer's Disease: a Review. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (16)
                                     , 1467-1483. <a href="https://doi.org/10.1002/cmdc.201900299" title="DOI URL">https://doi.org/10.1002/cmdc.201900299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900299%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAllosteric%252BModulators%252Bof%252BPotential%252BTargets%252BRelated%252Bto%252BAlzheimer%252527s%252BDisease%25253A%252Ba%252BReview%26aulast%3DSilva%26aufirst%3DGuilherme%2BMartins%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D16%26spage%3D1467%26epage%3D1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher L.  Shaffer</span>, <span class="hlFld-ContribAuthor ">Jason K.  Dutra</span>, <span class="hlFld-ContribAuthor ">Wei Chou  Tseng</span>, <span class="hlFld-ContribAuthor ">Mark L.  Weber</span>, <span class="hlFld-ContribAuthor ">Luke J.  Bogart</span>, <span class="hlFld-ContribAuthor ">Katherine  Hales</span>, <span class="hlFld-ContribAuthor ">Jincheng  Pang</span>, <span class="hlFld-ContribAuthor ">Dmitri  Volfson</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, <span class="hlFld-ContribAuthor ">Michael E.  Green</span>, <span class="hlFld-ContribAuthor ">Derek L.  Buhl</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2019,</strong> <em>153 </em>, 73-81. <a href="https://doi.org/10.1016/j.neuropharm.2019.04.019" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2019.04.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2019.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2019.04.019%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DPharmacological%252Bevaluation%252Bof%252Bclinically%252Brelevant%252Bconcentrations%252Bof%252B%2525282R%25252C6R%252529-hydroxynorketamine%26aulast%3DShaffer%26aufirst%3DChristopher%2BL.%26date%3D2019%26volume%3D153%26spage%3D73%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daisuke  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Kazuishi  Makino</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Catalytic Oxygenative Difunctionalization Reactions of Carbon-Carbon Double Bond Using Molecular Oxygen in Air. </span><span class="cited-content_cbyCitation_journal-name">Journal of Synthetic Organic Chemistry, Japan</span><span> <strong>2019,</strong> <em>77 </em>
                                    (7)
                                     , 696-705. <a href="https://doi.org/10.5059/yukigoseikyokaishi.77.696" title="DOI URL">https://doi.org/10.5059/yukigoseikyokaishi.77.696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5059/yukigoseikyokaishi.77.696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5059%2Fyukigoseikyokaishi.77.696%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Synthetic%2520Organic%2520Chemistry%252C%2520Japan%26atitle%3DDevelopment%252Bof%252BCatalytic%252BOxygenative%252BDifunctionalization%252BReactions%252Bof%252BCarbon-Carbon%252BDouble%252BBond%252BUsing%252BMolecular%252BOxygen%252Bin%252BAir%26aulast%3DYamamoto%26aufirst%3DDaisuke%26date%3D2019%26volume%3D77%26issue%3D7%26spage%3D696%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akiyoshi  Kunugi</span>, <span class="hlFld-ContribAuthor ">Yasukazu  Tajima</span>, <span class="hlFld-ContribAuthor ">Haruhiko  Kuno</span>, <span class="hlFld-ContribAuthor ">Satoshi  Sogabe</span>, <span class="hlFld-ContribAuthor ">Haruhide  Kimura</span>. </span><span class="cited-content_cbyCitation_article-title">HBT1, a Novel AMPA Receptor Potentiator with Lower Agonistic Effect, Avoided Bell-Shaped Response in In Vitro BDNF Production. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2018,</strong> <em>364 </em>
                                    (3)
                                     , 377-389. <a href="https://doi.org/10.1124/jpet.117.245050" title="DOI URL">https://doi.org/10.1124/jpet.117.245050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.117.245050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.117.245050%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DHBT1%25252C%252Ba%252BNovel%252BAMPA%252BReceptor%252BPotentiator%252Bwith%252BLower%252BAgonistic%252BEffect%25252C%252BAvoided%252BBell-Shaped%252BResponse%252Bin%252BIn%252BVitro%252BBDNF%252BProduction%26aulast%3DKunugi%26aufirst%3DAkiyoshi%26date%3D2018%26date%3D2018%26volume%3D364%26issue%3D3%26spage%3D377%26epage%3D389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M  Ranganathan</span>, <span class="hlFld-ContribAuthor ">N  DeMartinis</span>, <span class="hlFld-ContribAuthor ">B  Huguenel</span>, <span class="hlFld-ContribAuthor ">F  Gaudreault</span>, <span class="hlFld-ContribAuthor ">M M  Bednar</span>, <span class="hlFld-ContribAuthor ">C L  Shaffer</span>, <span class="hlFld-ContribAuthor ">S  Gupta</span>, <span class="hlFld-ContribAuthor ">J  Cahill</span>, <span class="hlFld-ContribAuthor ">M A  Sherif</span>, <span class="hlFld-ContribAuthor ">J  Mancuso</span>, <span class="hlFld-ContribAuthor ">L  Zumpano</span>, <span class="hlFld-ContribAuthor ">D C  D’Souza</span>. </span><span class="cited-content_cbyCitation_article-title">Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242. </span><span class="cited-content_cbyCitation_journal-name">Molecular Psychiatry</span><span> <strong>2017,</strong> <em>22 </em>
                                    (11)
                                     , 1633-1640. <a href="https://doi.org/10.1038/mp.2017.6" title="DOI URL">https://doi.org/10.1038/mp.2017.6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/mp.2017.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fmp.2017.6%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Psychiatry%26atitle%3DAttenuation%252Bof%252Bketamine-induced%252Bimpairment%252Bin%252Bverbal%252Blearning%252Band%252Bmemory%252Bin%252Bhealthy%252Bvolunteers%252Bby%252Bthe%252BAMPA%252Breceptor%252Bpotentiator%252BPF-04958242%26aulast%3DRanganathan%26aufirst%3DM%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D11%26spage%3D1633%26epage%3D1640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tristan  Reuillon</span>, <span class="hlFld-ContribAuthor ">Simon E.  Ward</span>, <span class="hlFld-ContribAuthor ">Paul  Beswick</span>. </span><span class="cited-content_cbyCitation_article-title">Modulating AMPA Receptors for the Treatment of CNS Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 447-480. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12654-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12654-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12654-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12654-X%26sid%3Dliteratum%253Aachs%26atitle%3DModulating%252BAMPA%252BReceptors%252Bfor%252Bthe%252BTreatment%252Bof%252BCNS%252BDisorders%26aulast%3DReuillon%26aufirst%3DTristan%26date%3D2017%26spage%3D447%26epage%3D480%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. C. V.  Martins</span>, <span class="hlFld-ContribAuthor ">P.  de-Lima-Neto</span>, <span class="hlFld-ContribAuthor ">E. W. S.  Caetano</span>, <span class="hlFld-ContribAuthor ">V. N.  Freire</span>. </span><span class="cited-content_cbyCitation_article-title">An improved quantum biochemistry description of the glutamate–GluA2 receptor binding within an inhomogeneous dielectric function framework. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2017,</strong> <em>41 </em>
                                    (14)
                                     , 6167-6179. <a href="https://doi.org/10.1039/C6NJ03939A" title="DOI URL">https://doi.org/10.1039/C6NJ03939A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6NJ03939A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6NJ03939A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DAn%252Bimproved%252Bquantum%252Bbiochemistry%252Bdescription%252Bof%252Bthe%252Bglutamate%2525E2%252580%252593GluA2%252Breceptor%252Bbinding%252Bwithin%252Ban%252Binhomogeneous%252Bdielectric%252Bfunction%252Bframework%26aulast%3DMartins%26aufirst%3DA.%2BC.%2BV.%26date%3D2017%26date%3D2017%26volume%3D41%26issue%3D14%26spage%3D6167%26epage%3D6179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daisuke  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Takuto  Oguro</span>, <span class="hlFld-ContribAuthor ">Yuuki  Tashiro</span>, <span class="hlFld-ContribAuthor ">Masayuki  Soga</span>, <span class="hlFld-ContribAuthor ">Kazuhito  Miyashita</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Aso</span>, <span class="hlFld-ContribAuthor ">Kazuishi  Makino</span>. </span><span class="cited-content_cbyCitation_article-title">Manganese-Promoted Oxidative Cyclization of Unsaturated Oximes Using Molecular Oxygen in Air under Ambient Conditions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (31)
                                     , 5216-5219. <a href="https://doi.org/10.1002/ejoc.201600998" title="DOI URL">https://doi.org/10.1002/ejoc.201600998</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600998%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DManganese-Promoted%252BOxidative%252BCyclization%252Bof%252BUnsaturated%252BOximes%252BUsing%252BMolecular%252BOxygen%252Bin%252BAir%252Bunder%252BAmbient%252BConditions%26aulast%3DYamamoto%26aufirst%3DDaisuke%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D31%26spage%3D5216%26epage%3D5219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Virginia  Spanò</span>, <span class="hlFld-ContribAuthor ">Marzia  Pennati</span>, <span class="hlFld-ContribAuthor ">Barbara  Parrino</span>, <span class="hlFld-ContribAuthor ">Anna  Carbone</span>, <span class="hlFld-ContribAuthor ">Alessandra  Montalbano</span>, <span class="hlFld-ContribAuthor ">Alessia  Lopergolo</span>, <span class="hlFld-ContribAuthor ">Valentina  Zuco</span>, <span class="hlFld-ContribAuthor ">Denis  Cominetti</span>, <span class="hlFld-ContribAuthor ">Patrizia  Diana</span>, <span class="hlFld-ContribAuthor ">Girolamo  Cirrincione</span>, <span class="hlFld-ContribAuthor ">Nadia  Zaffaroni</span>, <span class="hlFld-ContribAuthor ">Paola  Barraja</span>. </span><span class="cited-content_cbyCitation_article-title">[1,2]Oxazolo[5,4- e ]isoindoles as promising tubulin polymerization inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>124 </em>, 840-851. <a href="https://doi.org/10.1016/j.ejmech.2016.09.013" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.09.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.09.013%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%25255B1%25252C2%25255DOxazolo%25255B5%25252C4-%252Be%252B%25255Disoindoles%252Bas%252Bpromising%252Btubulin%252Bpolymerization%252Binhibitors%26aulast%3DSpan%25C3%25B2%26aufirst%3DVirginia%26date%3D2016%26volume%3D124%26spage%3D840%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. S.  Karlov</span>, <span class="hlFld-ContribAuthor ">M. I.  Lavrov</span>, <span class="hlFld-ContribAuthor ">V. A.  Palyulin</span>, <span class="hlFld-ContribAuthor ">N. S.  Zefirov</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore analysis of positive allosteric modulators of AMPA receptors. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2016,</strong> <em>65 </em>
                                    (2)
                                     , 581-587. <a href="https://doi.org/10.1007/s11172-016-1341-z" title="DOI URL">https://doi.org/10.1007/s11172-016-1341-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-016-1341-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-016-1341-z%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DPharmacophore%252Banalysis%252Bof%252Bpositive%252Ballosteric%252Bmodulators%252Bof%252BAMPA%252Breceptors%26aulast%3DKarlov%26aufirst%3DD.%2BS.%26date%3D2016%26date%3D2016%26volume%3D65%26issue%3D2%26spage%3D581%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon E  Ward</span>, <span class="hlFld-ContribAuthor ">Lewis E  Pennicott</span>, <span class="hlFld-ContribAuthor ">Paul  Beswick</span>. </span><span class="cited-content_cbyCitation_article-title">AMPA receptor-positive allosteric modulators for the treatment of schizophrenia: an overview of recent patent applications. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (4)
                                     , 473-491. <a href="https://doi.org/10.4155/fmc.15.4" title="DOI URL">https://doi.org/10.4155/fmc.15.4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.15.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.15.4%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DAMPA%252Breceptor-positive%252Ballosteric%252Bmodulators%252Bfor%252Bthe%252Btreatment%252Bof%252Bschizophrenia%25253A%252Ban%252Boverview%252Bof%252Brecent%252Bpatent%252Bapplications%26aulast%3DWard%26aufirst%3DSimon%2BE%26date%3D2015%26volume%3D7%26issue%3D4%26spage%3D473%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative structures of AMPAR potentiator chemotypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structure of <b>7</b> (magenta) superimposed on the X-ray structure of <b>4</b> (cyan) in the symmetrical binding pocket of the human GluA2o LBD. Only one binding pose for each compound is shown for clarity. Analogous to the sulfonamide hydrogen of <b>4</b>, the amide hydrogen of <b>7</b> forms a hydrogen bond with the backbone carbonyl oxygen of Pro-494.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. A 1.85 Å resolution X-ray cocrystal structure of <b>11</b> showing the second (symmetric) hydrophobic pocket occupied by the acetamide substituent off the 3-position on the pyrrolidine ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Model of <b>16a</b> aligned with the X-ray crystal structure of <b>11</b> to demonstrate the interaction of the cyano group. Like the acetamide of <b>11</b>, the <i>ortho</i>-nitrile of <b>16a</b> optimally accessed the symmetric hydrophilic pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of the DHI Series<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NH<sub>2</sub>OH·HCl, NaOH, EtOH, 90–99%; (b) NCS, DMF, 92–99%; (c) Boc allylamine, Et<sub>3</sub>N, 85–90%; (d) TFA, DCM, 75%; (e) isopropyl sulfonyl chloride, DBU, DMAP, 45–85% yield; (f) allylisopropylsulfonamide (<b>20</b>), Et<sub>3</sub>N, DCM, RT, 20 h, 85–90%; (g) Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, toluene/EtOH/H<sub>2</sub>O, 80 °C, 20 h (Method A) or Xphos, Pd(OAc)<sub>2</sub>, KF, 1:1 MeOH/toluene (Method B), 40–75%; (h) pyrrolidine, K<sub>2</sub>CO<sub>3</sub>, 20–70%; (i) chiral separations using SFC on either Chiralpak AD-H or Chiralcel OJ-H columns, 4.6 mm × 25 cm, carbon dioxide–methanol (90:10 or 80:20, v/v) at 2.5 mL/min, 30 °C, UV detection at 254 nm.</p></p></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/medium/jm-2013-01274b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Summary of the AMPAR-mediated pharmacological characterization of <b>8a</b> in rodents. Panel A: Convulsion-causing <i>C</i><sub>b,u</sub> in CD-1 mice (<i>N</i> = 8) and rats (<i>N</i> = 6); ○, individual animal; ▲, interanimal mean. Panel B: <b>8a</b> dose-dependently increased CD-1 mouse cerebellum cGMP; single doses were administered SC with a 0.5 h pretreatment time, with data expressed as mean ± SEM with <i>N</i> = 5–6/dose; ** <i>P</i> < 0.01, one-way ANOVA followed by post hoc Dunnett’s <i>t</i> test. Panels C and D: Summary of the dose–response relationship in the rat MK-801-disrupted cortical oscillation (panel C) and paired-pulse facilitation (panel D) assay following IV administration of <b>8a</b>; * <i>P</i> = 0.05 vs control condition, <b>#</b><i>P</i> < 0.05 vs MK-801 condition, two-tailed Student’s <i>t</i> test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-22/jm401274b/production/images/large/jm-2013-01274b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401274b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80681" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80681" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Parsons, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danysz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zieglgaensberger, W.</span><span> </span><span class="NLM_article-title">Excitatory amino acid neurotransmission</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span><div class="note"><p class="first last">Anxiety and Anxiolytic Drugs</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1007%2F3-540-28082-0_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVCltb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2005&pages=249-303&author=C.+G.+Parsonsauthor=W.+Danyszauthor=W.+Zieglgaensberger&title=Excitatory+amino+acid+neurotransmission"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory amino acid neurotransmission</span></div><div class="casAuthors">Parsons, C. G.; Danysz, W.; Zieglgaensberger, W.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">Anxiety and Anxiolytic Drugs</span>),
    <span class="NLM_cas:pages">249-303</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  In recent years great progress has been made in understanding the function of ionotropic and metabotropic glutamate receptors; their pharmacol. and potential therapeutic applications.  It should be stressed that there are already N-methyl-D-aspartate (NMDA) antagonists in clin. use, such as memantine, which proves the feasibility of their therapeutic potential.  It seems unlikely that competitive NMDA receptor antagonists and high-affinity channel blockers will find therapeutic use due to limiting side-effects, whereas agents acting at the glycineB site, NMDA receptor subtype-selective agents and moderate-affinity channel blockers are far more promising.  This is supported by the fact that there are several glycineB antagonists, NMDA moderate-affinity channel blockers and NR2B-selective agents under development.  Pos. and neg. modulators of AMPA receptors such as the AMPAkines and 2,3-benzodiazepines also show more promise than e.g. competitive antagonists.  Great progress has also been made in the field of metabotropic glutamate receptors since the discovery of novel, allosteric modulatory sites for these receptors.  Selective agents acting at these transmembrane sites have been developed that are more drug-like and have a much better access to the central nervous system than their competitive counterparts.  The chapter will critically review preclin. and scarce clin. experience in the development of new ionotropic and metabotropic glutamate receptor modulators according to the following scheme: rational, preclin. findings in animal models and finally clin. experience, where available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaBjva7_QRjbVg90H21EOLACvtfcHk0lg4nnCzct9o7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVCltb3J&md5=699bede7e35aec7cb88387e95becdf2b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2F3-540-28082-0_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F3-540-28082-0_10%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DC.%2BG.%26aulast%3DDanysz%26aufirst%3DW.%26aulast%3DZieglgaensberger%26aufirst%3DW.%26atitle%3DExcitatory%2520amino%2520acid%2520neurotransmission%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2005%26volume%3D169%26spage%3D249%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lynch, G.</span><span> </span><span class="NLM_article-title">Memory enhancement: the search for mechanism-based drugs</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1038%2Fnn935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1entLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=1035-1038&issue=Suppl&author=G.+Lynch&title=Memory+enhancement%3A+the+search+for+mechanism-based+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Memory enhancement: the search for mechanism-based drugs</span></div><div class="casAuthors">Lynch, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">Suppl.</span>),
    <span class="NLM_cas:pages">1035-1038</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rapid progress has been made in understanding the synaptic changes required for memory encoding.  Several companies are now attempting to use information about the induction and consolidation phases of this process to build memory-enhancing drugs.  These efforts have produced novel compds. that improve retention scores across a broad range of tests and species.  Initial clin. results are encouraging.  Issues now arise about appropriate applications of candidate drugs and optimal cellular targets for future development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN-gQ6I9ivB7Vg90H21EOLACvtfcHk0lg4nnCzct9o7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1entLk%253D&md5=f391c93b5e05f4c8ba19a0bbbc05ee97</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnn935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn935%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DG.%26atitle%3DMemory%2520enhancement%253A%2520the%2520search%2520for%2520mechanism-based%2520drugs%26jtitle%3DNat.%2520Neurosci.%26date%3D2002%26volume%3D5%26issue%3DSuppl%26spage%3D1035%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malinow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malenka, R. C.</span><span> </span><span class="NLM_article-title">AMPA receptor trafficking and synaptic plasticity</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1146%2Fannurev.neuro.25.112701.142758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=12052905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtF2hsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2002&pages=103-126&author=R.+Malinowauthor=R.+C.+Malenka&title=AMPA+receptor+trafficking+and+synaptic+plasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">AMPA receptor trafficking and synaptic plasticity</span></div><div class="casAuthors">Malinow, Roberto; Malenka, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103-126</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Activity-dependent changes in synaptic function are believed to underlie the formation of memories.  Two prominent examples are long-term potentiation (LTP) and long-term depression (LTD), whose mechanisms have been the subject of considerable scrutiny over the past few decades.  Here we review the growing literature that supports a crit. role for AMPA receptor trafficking in LTP and LTD, focusing on the roles proposed for specific AMPA receptor subunits and their interacting proteins.  While much work remains to understand the mol. basis for synaptic plasticity, recent results on AMPA receptor trafficking provide a clear conceptual framework for future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXbY4P375GeLVg90H21EOLACvtfcHk0lg4nnCzct9o7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtF2hsLw%253D&md5=bdf912ce2115da5d4cb87031d707d745</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.25.112701.142758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.25.112701.142758%26sid%3Dliteratum%253Aachs%26aulast%3DMalinow%26aufirst%3DR.%26aulast%3DMalenka%26aufirst%3DR.%2BC.%26atitle%3DAMPA%2520receptor%2520trafficking%2520and%2520synaptic%2520plasticity%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2002%26volume%3D25%26spage%3D103%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lynch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, C. M.</span><span> </span><span class="NLM_article-title">Ampakines and the threefold path to cognitive enhancement</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=554-562&author=G.+Lynchauthor=C.+M.+Gall&title=Ampakines+and+the+threefold+path+to+cognitive+enhancement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DG.%26aulast%3DGall%26aufirst%3DC.%2BM.%26atitle%3DAmpakines%2520and%2520the%2520threefold%2520path%2520to%2520cognitive%2520enhancement%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D554%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Morris, R. G. M.</span><span> </span><span class="NLM_article-title">Long-term potentiation and memory</span> <span class="citation_source-journal">Philos. Trans. R. Soc. London B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1098%2Frstb.2002.1230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=12740109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A280%3ADC%252BD3s3hvFCrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2003&pages=643-647&author=R.+G.+M.+Morris&title=Long-term+potentiation+and+memory"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term potentiation and memory</span></div><div class="casAuthors">Morris Richard G M</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical transactions of the Royal Society of London. Series B, Biological sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">1432</span>),
    <span class="NLM_cas:pages">643-7</span>
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    </div><div class="casAbstract">The discovery of long-term potentiation (LTP) transformed research on the neurobiology of learning and memory.  This did not happen overnight, but the discovery of an experimentally demonstrable phenomenon reflecting activity-driven neuronal and synaptic plasticity changed discussions about what might underlie learning from speculation into something much more concrete.  Equally, however, the relationship between the discovery of LTP and research on the neurobiology of learning and memory has been reciprocal; for it is also true that studies of the psychological, anatomical and neurochemical basis of memory provided a developing and critical intellectual context for the physiological discovery.  The emerging concept of multiple memory systems, from 1970 onwards, paved the way for the development of new behavioural and cognitive tasks, including the watermaze described in this paper.  The use of this task in turn provided key evidence that pharmacological interference with an LTP induction mechanism would also interfere with learning, a finding that was by no means a foregone conclusion.  This reciprocal relationship between studies of LTP and the neurobiology of memory helped the physiological phenomenon to be recognized as a major discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRumjSaqwyW3lvAgqb2vdc5fW6udTcc2eb6QNBiCkuxybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3hvFCrtA%253D%253D&md5=b9975b00a2dba770a29a392832ba549a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1098%2Frstb.2002.1230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2002.1230%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BG.%2BM.%26atitle%3DLong-term%2520potentiation%2520and%2520memory%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%2520London%2520B%26date%3D2003%26volume%3D358%26spage%3D643%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kinney, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patino, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermet-Bouvier, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starrett, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribkoff, V. K.</span><span> </span><span class="NLM_article-title">Cognition-enhancing drugs increase stimulated hippocampal θ rhythm amplitude in the urethane-anesthetized rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADyaK1MXmtlaksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=1999&pages=99-106&author=G.+G.+Kinneyauthor=P.+Patinoauthor=Y.+Mermet-Bouvierauthor=J.+E.+Starrettauthor=V.+K.+Gribkoff&title=Cognition-enhancing+drugs+increase+stimulated+hippocampal+%CE%B8+rhythm+amplitude+in+the+urethane-anesthetized+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Cognition-enhancing drugs increase stimulated hippocampal θ rhythm amplitude in the urethane-anesthetized rat</span></div><div class="casAuthors">Kinney, Gene G.; Patino, Patricia; Mermet-Bouvier, Yvan; Starrett, John E., Jr.; Gribkoff, Valentin K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-106</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Synchronous hippocampal electroencephalog. activity occurring in a frequency range of 3 to 12 Hz (i.e., hippocampal θ rhythm) has been assocd. with mnemonic processes in vivo.  However, this link is tenuous and θ rhythm may be secondary to processes that underlie mnemonic function.  If θ rhythm is assocd. with mnemonic or cognitive function, cognition-enhancing drugs should enhance θ rhythm regardless of their primary biol. target.  In the current study, we evaluated several drugs that were shown to have cognition-enhancing properties in preclin. behavioral models and that vary with respect to their primary biol. target: 1) the nootropic piracetam (250 and 500 mg/kg); 2) the small-conductance calcium-activated potassium-channel blocker apamin (0.1 and 0.4 mg/kg); and 3) the acetylcholinesterase inhibitor donepezil (0.1-10.0 mg/kg).  All of the cognition-enhancing drugs produced dose-dependent increases in hippocampal θ rhythm amplitude elicited by stimulation of the brainstem reticular formation at doses that did not affect peak θ frequency in the urethane-anesthetized rat.  These increases were reversed by the muscarinic receptor antagonist scopolamine, suggesting a common final cholinergic action of these compds.  The use-dependent N-methyl-D-aspartate antagonist dizocilipine maleate and scopolamine reduced θ amplitude (both) and frequency (dizocilipine maleate only).  These data demonstrate that hippocampal θ rhythm is sensitive to cognition-modulating compds., suggesting that θ rhythm may be closely assocd. with cognitive function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxtwZE09Yu-LVg90H21EOLACvtfcHk0lglLxnn-bhTiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtlaksrY%253D&md5=417e6e341decf2311df8ae7821363782</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKinney%26aufirst%3DG.%2BG.%26aulast%3DPatino%26aufirst%3DP.%26aulast%3DMermet-Bouvier%26aufirst%3DY.%26aulast%3DStarrett%26aufirst%3DJ.%2BE.%26aulast%3DGribkoff%26aufirst%3DV.%2BK.%26atitle%3DCognition-enhancing%2520drugs%2520increase%2520stimulated%2520hippocampal%2520%25CE%25B8%2520rhythm%2520amplitude%2520in%2520the%2520urethane-anesthetized%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D291%26spage%3D99%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hampson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espana, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porrino, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadwyler, S. A.</span><span> </span><span class="NLM_article-title">Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1007%2Fs00213-008-1360-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=18985324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlalu73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2009&pages=355-369&author=R.+E.+Hampsonauthor=R.+A.+Espanaauthor=G.+A.+Rogersauthor=L.+J.+Porrinoauthor=S.+A.+Deadwyler&title=Mechanisms+underlying+cognitive+enhancement+and+reversal+of+cognitive+deficits+in+nonhuman+primates+by+the+ampakine+CX717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717</span></div><div class="casAuthors">Hampson, R. E.; Espana, R. A.; Rogers, G. A.; Porrino, L. J.; Deadwyler, S. A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">355-369</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Rationale: Performance of cognitive tasks in nonhuman primates (NHPs) requires specific brain regions to make decisions under different degrees of difficulty or "cognitive load.".  Objective: Local cerebral metabolic activity ([18F]FDG PET imaging) in dorsolateral prefrontal cortex (DLPFC), medial temporal lobe (MTL), and dorsal striatum (DStr) is examd. in NHPs performing a delayed-match-to-sample (DMS) task with variable degrees of cognitive load.  Materials and methods: Correlations between cognitive load and degree of brain metabolic activity were obtained with respect to the influence of the ampakine CX717 (Cortex Pharmaceuticals), using brain imaging and recordings of neuronal activity in NHPs and measures of intracellular calcium release in rat hippocampal slices.  Results: Activation of DLPFC, MTL, and DStr reflected changes in performance related to cognitive load within the DMS task and were engaged primarily on high load trials.  Similar increased activation patterns and improved performance were also obsd. following administration of CX717.  Sleep deprivation in NHPs produced impaired performance and redns. in brain activation which was reversed by CX717.  One potential basis for this facilitation of cognition by CX717 was increased firing of task-specific hippocampal cells.  Synaptic mechanisms affected by CX717 were examd. in rat hippocampal slices which showed that N-methyl-D-aspartic acid-mediated release of intracellular calcium was reduced in slices from sleep-deprived rats and reversed by application of CX717 to the bathing medium.  Conclusions: The findings provide insight into how cognition is enhanced by CX717 in terms of brain, and underlying neural, processes that are activated on high vs. low cognitive load trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgeHl-3ngiDrVg90H21EOLACvtfcHk0lglLxnn-bhTiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlalu73K&md5=5cf11c6a76dfb3d9a172f7fe79e7b175</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1007%2Fs00213-008-1360-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-008-1360-z%26sid%3Dliteratum%253Aachs%26aulast%3DHampson%26aufirst%3DR.%2BE.%26aulast%3DEspana%26aufirst%3DR.%2BA.%26aulast%3DRogers%26aufirst%3DG.%2BA.%26aulast%3DPorrino%26aufirst%3DL.%2BJ.%26aulast%3DDeadwyler%26aufirst%3DS.%2BA.%26atitle%3DMechanisms%2520underlying%2520cognitive%2520enhancement%2520and%2520reversal%2520of%2520cognitive%2520deficits%2520in%2520nonhuman%2520primates%2520by%2520the%2520ampakine%2520CX717%26jtitle%3DPsychopharmacology%26date%3D2009%26volume%3D202%26spage%3D355%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Roberts, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, S. A.</span><span> </span><span class="NLM_article-title">Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1016%2Fj.bbr.2010.03.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=20347881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFWrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2010&pages=41-48&author=B.+M.+Robertsauthor=D.+E.+Holdenauthor=C.+L.+Shafferauthor=P.+A.+Seymourauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=G.+V.+Williamsauthor=S.+A.+Castner&title=Prevention+of+ketamine-induced+working+memory+impairments+by+AMPA+potentiators+in+a+nonhuman+primate+model+of+cognitive+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction</span></div><div class="casAuthors">Roberts, Brooke M.; Holden, Daniel E.; Shaffer, Christopher L.; Seymour, Patricia A.; Menniti, Frank S.; Schmidt, Christopher J.; Williams, Graham V.; Castner, Stacy A.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Working memory impairments are a core aspect of schizophrenia, yet current medicines do not address such cognitive dysfunction.  We have developed a model of these working memory deficits by acutely disrupting glutamatergic synaptic transmission by administration of the N-methyl-3-aspartate (NMDA) antagonist ketamine in the nonhuman primate.  The current studies evaluated the effect of pos. allosteric modulators ("potentiators") of the α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors on the working memory and behavioral effects of ketamine.  AMPA receptors mediate fast excitatory synaptic transmission throughout the brain and play a crit. role in the activity-dependent regulation of NMDA receptors.  We find that pos. modulation of AMPA receptors with LY451646 (0.1-1.0 mg/kg, SC) and structurally distinct PF-4778574 (0.01 mg/kg, SC) robustly ameliorates ketamine-induced working memory impairments without altering behavioral effects of acute ketamine we consider related to pos.- and neg.-like symptoms.  These results support AMPA receptor potentiators as a potential adjunctive treatment for cognitive impairment assocd. with schizophrenia (CIAS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3Id6D1EeSrVg90H21EOLACvtfcHk0lglLxnn-bhTiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFWrsb8%253D&md5=a7e67cfd3027b0013e4ab448503219dc</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2010.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2010.03.039%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DB.%2BM.%26aulast%3DHolden%26aufirst%3DD.%2BE.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DCastner%26aufirst%3DS.%2BA.%26atitle%3DPrevention%2520of%2520ketamine-induced%2520working%2520memory%2520impairments%2520by%2520AMPA%2520potentiators%2520in%2520a%2520nonhuman%2520primate%2520model%2520of%2520cognitive%2520dysfunction%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2010%26volume%3D212%26spage%3D41%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Black, M. D.</span><span> </span><span class="NLM_article-title">Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=154-163&author=M.+D.+Black&title=Therapeutic+potential+of+positive+AMPA+modulators+and+their+relationship+to+AMPA+receptor+subunits.+A+review+of+preclinical+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DM.%2BD.%26atitle%3DTherapeutic%2520potential%2520of%2520positive%2520AMPA%2520modulators%2520and%2520their%2520relationship%2520to%2520AMPA%2520receptor%2520subunits.%2520A%2520review%2520of%2520preclinical%2520data%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D179%26spage%3D154%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Marenco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, D. R.</span><span> </span><span class="NLM_article-title">Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.2165%2F00023210-200620030-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=16529524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvF2mtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=173-185&author=S.+Marencoauthor=D.+R.+Weinberger&title=Therapeutic+potential+of+positive+AMPA+receptor+modulators+in+the+treatment+of+neuropsychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders</span></div><div class="casAuthors">Marenco, Stefano; Weinberger, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-185</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Drugs that potentiate the activity of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor cause a complex cascade of consequences in exptl. models, ranging from enhancement of long-term potentiation to induction of neurotrophic factors.  Animal studies characterizing the pharmacol. and behavioral effects of these substances have provided the rationale for several initial attempts to use these drugs in neuropsychiatric clin. settings.  Applications in schizophrenia, Alzheimer's disease and mild cognitive impairment have been initiated.  Other trials with these compds. include the treatment of Fragile X syndrome, and possible future applications may be in the field of Parkinson's disease.  The literature published to date is limited mostly to small phase I or II trials, so there is no conclusive evidence for or against the use of these drugs.  Substantial questions remain concerning which compds. to use, in what dose, for what condition and for how long.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEIFzk9iLjHLVg90H21EOLACvtfcHk0liLMshLYRiyRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvF2mtb4%253D&md5=09378aa20043ab2a78cd6bcd0787af16</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2165%2F00023210-200620030-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200620030-00001%26sid%3Dliteratum%253Aachs%26aulast%3DMarenco%26aufirst%3DS.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DTherapeutic%2520potential%2520of%2520positive%2520AMPA%2520receptor%2520modulators%2520in%2520the%2520treatment%2520of%2520neuropsychiatric%2520disorders%26jtitle%3DCNS%2520Drugs%26date%3D2006%26volume%3D20%26spage%3D173%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleakman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisenbaum, E. S.</span><span> </span><span class="NLM_article-title">AMPA receptor potentiators for the treatment of CNS disorders</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.2174%2F1568007043337508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=15180479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=181-194&author=M.+J.+O%E2%80%99Neillauthor=D.+Bleakmanauthor=D.+M.+Zimmermanauthor=E.+S.+Nisenbaum&title=AMPA+receptor+potentiators+for+the+treatment+of+CNS+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">AMPA receptor potentiators for the treatment of CNS disorders</span></div><div class="casAuthors">O'Neill, Michael J.; Bleakman, David; Zimmerman, Dennis M.; Nisenbaum, Eric S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-194</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors mediate most of the excitatory neurotransmission in the mammalian central nervous system and also participate in forms of synaptic plasticity thought to underlie memory and learning, and the formation of neural networks during development.  Mol. cloning techniques have shown that the AMPA receptor family is composed of 4 different subunits named GluR1-4 or GluRA-D (newly termed as GluA1-GluA4) and native AMPA receptors are most likely tetramers generated by the assembly of 1 or more of these subunits, yielding homomeric or heteromeric receptors.  Addnl. complexity among AMPA receptors is conferred by alternative splicing of RNA for each subunit giving rise to flip and flop variants.  Clin. and exptl. data have suggested that pos. modulation of AMPA receptors may be therapeutically effective in the treatment of cognitive deficits.  Several classes of AMPA receptor potentiators were reported, including pyrrolidones (piracetam, aniracetam), benzothiazides (cyclothiazide), benzylpiperidines (CX-516, CX-546), and more recently biarylpropylsulfonamides (LY392098, LY404187 and LY503430).  These mols. enhance cognitive function in rodents, which appears to correlate with increased hippocampal activity.  In addn., clin. studies have suggested that AMPA receptor modulators enhance cognitive function in elderly subjects, as well as patients suffering from neurol. and psychiatric disorders.  Several independent studies have suggested that AMPA receptors can increase BDNF expression by both calcium-dependent and independent pathways.  For example, recent studies have shown that AMPA receptors interact with the protein Tyr kinase, Lyn.  Activation of Lyn can recruit the mitogen-activated protein kinase (MAPK) signalling pathway and increase the expression of BDNF.  Therefore, in addn. to directly enhancing glutamatergic synaptic transmission, AMPA receptor activation can increase the expression of BDNF in vitro and in vivo.  This may account for activity of AMPA receptor potentiators in rodent models predictive of antidepressant activity (forced swim and tail suspension tests).  The increase in neurotrophin expression also may contribute to the functional, neuroprotective, and neurotrophic actions of LY404187 and LY503430 after infusion of 6-OHDA into the substantia nigra.  In conclusion, several potent, selective and systematically active AMPA receptor potentiators were reported.  Data indicate that these mols. modulate glutamatergic transmission, enhance synaptic transmission, long-term potentiation (LTP), and increase neurotrophin expression.  Therefore, these AMPA receptor potentiators offer an exciting new class of drugs with potentials for treating (1) cognitive impairment assocd. with Alzheimer's disease and schizophrenia, (2) depression, (3) slowing the progression and potentially enhancing recovery from Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHYMd0O34_SLVg90H21EOLACvtfcHk0liLMshLYRiyRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCgu7g%253D&md5=5d438c3c4cc13fa863608073601cc6a1</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.2174%2F1568007043337508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043337508%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DBleakman%26aufirst%3DD.%26aulast%3DZimmerman%26aufirst%3DD.%2BM.%26aulast%3DNisenbaum%26aufirst%3DE.%2BS.%26atitle%3DAMPA%2520receptor%2520potentiators%2520for%2520the%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D181%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">11047</span><span class="NLM_x">–</span> <span class="NLM_lpage">11054</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=11047-11054&author=R.+R.+Gainetdinovauthor=A.+R.+Mohnauthor=L.+M.+Bohnauthor=M.+G.+Caron&title=Glutamatergic+modulation+of+hyperactivity+in+mice+lacking+the+dopamine+transporter"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DMohn%26aufirst%3DA.%2BR.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DGlutamatergic%2520modulation%2520of%2520hyperactivity%2520in%2520mice%2520lacking%2520the%2520dopamine%2520transporter%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2001%26volume%3D98%26spage%3D11047%26epage%3D11054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wollmuth, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBain, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vance, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogden, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingledine, R.</span><span> </span><span class="NLM_article-title">Glutamate receptor ion channels: structure, regulation, and function</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1124%2Fpr.109.002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=20716669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+F.+Traynelisauthor=L.+P.+Wollmuthauthor=C.+J.+McBainauthor=F.+S.+Mennitiauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=K.+B.+Hansenauthor=H.+Yuanauthor=S.+J.+Myersauthor=R.+Dingledine&title=Glutamate+receptor+ion+channels%3A+structure%2C+regulation%2C+and+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor ion channels: structure, regulation, and function</span></div><div class="casAuthors">Traynelis, Stephen F.; Wollmuth, Lonnie P.; McBain, Chris J.; Menniti, Frank S.; Vance, Katie M.; Ogden, Kevin K.; Hansen, Kasper B.; Yuan, Hongjie; Myers, Scott J.; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-496</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels contg. an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore.  Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells.  These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system.  Glutamate receptors are postulated to play important roles in numerous neurol. diseases and have attracted intense scrutiny.  The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel.  In this review we discuss International Union of Basic and Clin. Pharmacol. glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacol., allosteric modulation, mechanisms of gating and permeation, roles in normal physiol. function, as well as the potential therapeutic use of pharmacol. agents acting at glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0rj4nMr5ObVg90H21EOLACvtfcHk0ljXnkJahETi9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ&md5=5d0a7945b5ad99113adf9f6312bafe13</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002451%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWollmuth%26aufirst%3DL.%2BP.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520receptor%2520ion%2520channels%253A%2520structure%252C%2520regulation%252C%2520and%2520function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wisden, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeburg, P. H.</span><span> </span><span class="NLM_article-title">Mammalian ionotropic glutamate receptors</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=291-298&author=W.+Wisdenauthor=P.+H.+Seeburg&title=Mammalian+ionotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWisden%26aufirst%3DW.%26aulast%3DSeeburg%26aufirst%3DP.%2BH.%26atitle%3DMammalian%2520ionotropic%2520glutamate%2520receptors%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D1993%26volume%3D3%26spage%3D291%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Monyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeburg, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisden, W.</span><span> </span><span class="NLM_article-title">Glutamate-operated channels: developmentally early and mature forms arise by alternative splicing</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=799-810&author=H.+Monyerauthor=P.+H.+Seeburgauthor=W.+Wisden&title=Glutamate-operated+channels%3A+developmentally+early+and+mature+forms+arise+by+alternative+splicing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonyer%26aufirst%3DH.%26aulast%3DSeeburg%26aufirst%3DP.%2BH.%26aulast%3DWisden%26aufirst%3DW.%26atitle%3DGlutamate-operated%2520channels%253A%2520developmentally%2520early%2520and%2520mature%2520forms%2520arise%2520by%2520alternative%2520splicing%26jtitle%3DNeuron%26date%3D1991%26volume%3D6%26spage%3D799%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Pei, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, L.</span><span> </span><span class="NLM_article-title">Flip and Flop: A Molecular Determinant for AMPA Receptor Channel Opening</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3767</span><span class="NLM_x">–</span> <span class="NLM_lpage">3777</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi8015907" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=3767-3777&author=W.+Peiauthor=Z.+Huangauthor=C.+Wangauthor=Y.+Hanauthor=J.+S.+Parkauthor=L.+Niu&title=Flip+and+Flop%3A+A+Molecular+Determinant+for+AMPA+Receptor+Channel+Opening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi8015907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi8015907%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DJ.%2BS.%26aulast%3DNiu%26aufirst%3DL.%26atitle%3DFlip%2520and%2520Flop%253A%2520A%2520Molecular%2520Determinant%2520for%2520AMPA%2520Receptor%2520Channel%2520Opening%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D3767%26epage%3D3777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span> </span><span class="NLM_article-title">Structural aspects of AMPA receptor activation, desensitization and deactivation</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">288</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=281-288&author=K.+B.+Hansenauthor=H.+Yuanauthor=S.+F.+Traynelis&title=Structural+aspects+of+AMPA+receptor+activation%2C+desensitization+and+deactivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DStructural%2520aspects%2520of%2520AMPA%2520receptor%2520activation%252C%2520desensitization%2520and%2520deactivation%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2007%26volume%3D17%26spage%3D281%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mayer, M. L.</span><span> </span><span class="NLM_article-title">Glutamate receptors at atomic resolution</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=456-462&author=M.+L.+Mayer&title=Glutamate+receptors+at+atomic+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DM.%2BL.%26atitle%3DGlutamate%2520receptors%2520at%2520atomic%2520resolution%26jtitle%3DNature%26date%3D2006%26volume%3D440%26spage%3D456%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banke, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynelis, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Structural basis for partial agonist action at ionotropic glutamate receptors</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1038%2Fnn1091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=12872125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslOisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2003&pages=803-810&author=R.+Jinauthor=T.+G.+Bankeauthor=M.+L.+Mayerauthor=S.+F.+Traynelisauthor=E.+Gouaux&title=Structural+basis+for+partial+agonist+action+at+ionotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for partial agonist action at ionotropic glutamate receptors</span></div><div class="casAuthors">Jin, Rongsheng; Banke, Tue G.; Mayer, Mark L.; Traynelis, Stephen F.; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">803-810</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">An unresolved problem in understanding neurotransmitter receptor function concerns the mechanism(s) by which full and partial agonists elicit different amplitude responses at equal receptor occupancy.  The widely held view of 'partial agonism' posits that resting and active states of the receptor are in equil., and partial agonists simply do not shift the equil. toward the active state as efficaciously as full agonists.  Here we report findings from crystallog. and electrophysiol. studies of the mechanism of activation of an AMPA-subtype glutamate receptor ion channel.  In these expts., we used 5-substituted Willardiines, a series of partial agonists that differ by only a single atom.  Our results show that the GluR2 ligand-binding core can adopt a range of ligand-dependent conformational states, which in turn control the open probability of discrete subconductance states of the intact ion channel.  Our findings thus provide a structure-based model of partial agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrppTBGXFELfrVg90H21EOLACvtfcHk0ljXnkJahETi9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslOisr8%253D&md5=45e0016d600fb6793a30547a9ccb110b</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1038%2Fnn1091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1091%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DR.%26aulast%3DBanke%26aufirst%3DT.%2BG.%26aulast%3DMayer%26aufirst%3DM.%2BL.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DStructural%2520basis%2520for%2520partial%2520agonist%2520action%2520at%2520ionotropic%2520glutamate%2520receptors%26jtitle%3DNat.%2520Neurosci.%26date%3D2003%26volume%3D6%26spage%3D803%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Partin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, M. L.</span><span> </span><span class="NLM_article-title">AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6634</span><span class="NLM_x">–</span> <span class="NLM_lpage">6647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1523%2FJNEUROSCI.16-21-06634.1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=8824304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADyaK28Xntlamu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=6634-6647&author=K.+M.+Partinauthor=M.+W.+Fleckauthor=M.+L.+Mayer&title=AMPA+receptor+flip%2Fflop+mutants+affecting+deactivation%2C+desensitization%2C+and+modulation+by+cyclothiazide%2C+aniracetam%2C+and+thiocyanate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate</span></div><div class="casAuthors">Partin, Kathryn M.; Fleck, Mark W.; Mayer, Mark L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6634-6647</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">AMPA receptor GluRA subunits with mutations at position 750, a residue shown previously to control allosteric regulation by cyclothiazide, were analyzed for modulation of deactivation and desensitization by cyclothiazide, aniracetam, and thiocyanate.  Point mutations from Ser to Asn, Ala, Asp, Gly, Gln Met, Cys, Thr, Leu, Val, and Tyr were constructed in GluRAflip.  The last four of these mutants were not functional; S750D was active only in the presence of cyclothiazide, and the remaining mutants exhibited altered rates of deactivation and desensitization four control responses to glutamate, and showed differential modulation by cyclothiazide and aniracetam.  Results from kinetic anal. are consistent with aniracetam and cyclothiazide acting via distinct mechanisms.  Our expts. demonstrate for the first time the functional importance of residue 750 in regulating intrinsic channel-gating kinetics and emphasize the biol. significance of alternative splicing in the M3-M4 extracellular loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZZeaFPhGl6LVg90H21EOLACvtfcHk0lgpH4NMPqxviA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xntlamu7Y%253D&md5=49660ac7e1717e59a5c263f3cf465d99</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.16-21-06634.1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.16-21-06634.1996%26sid%3Dliteratum%253Aachs%26aulast%3DPartin%26aufirst%3DK.%2BM.%26aulast%3DFleck%26aufirst%3DM.%2BW.%26aulast%3DMayer%26aufirst%3DM.%2BL.%26atitle%3DAMPA%2520receptor%2520flip%252Fflop%2520mutants%2520affecting%2520deactivation%252C%2520desensitization%252C%2520and%2520modulation%2520by%2520cyclothiazide%252C%2520aniracetam%252C%2520and%2520thiocyanate%26jtitle%3DJ.%2520Neurosci.%26date%3D1996%26volume%3D16%26spage%3D6634%26epage%3D6647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Grove, S. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclean, J. K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7271</span><span class="NLM_x">–</span> <span class="NLM_lpage">7279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1000419" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7271-7279&author=S.+J.+A.+Groveauthor=C.+Jamiesonauthor=J.+K.+F.+Macleanauthor=J.+A.+Morrowauthor=Z.+Rankovic&title=Positive+allosteric+modulators+of+the+%CE%B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic+acid+%28AMPA%29+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm1000419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1000419%26sid%3Dliteratum%253Aachs%26aulast%3DGrove%26aufirst%3DS.%2BJ.%2BA.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMaclean%26aufirst%3DJ.%2BK.%2BF.%26aulast%3DMorrow%26aufirst%3DJ.%2BA.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DPositive%2520allosteric%2520modulators%2520of%2520the%2520%25CE%25B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2520acid%2520%2528AMPA%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7271%26epage%3D7279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lynch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambros-Ingerson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schehr, R. S.</span><span> </span><span class="NLM_article-title">Psychological effects of a drug that facilitates brain AMPA receptors</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1097%2F00004850-199603000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=8732309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A280%3ADyaK28zgtFOitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1996&pages=13-19&author=G.+Lynchauthor=M.+Kesslerauthor=G.+Rogersauthor=J.+Ambros-Ingersonauthor=R.+Grangerauthor=R.+S.+Schehr&title=Psychological+effects+of+a+drug+that+facilitates+brain+AMPA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Psychological effects of a drug that facilitates brain AMPA receptors</span></div><div class="casAuthors">Lynch G; Kessler M; Rogers G; Ambros-Ingerson J; Granger R; Schehr R S</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-9</span>
        ISSN:<span class="NLM_cas:issn">0268-1315</span>.
    </div><div class="casAbstract">The effects of 1-(quinoxalin-6-ylcarbonyl)piperidine (CX516), a centrally active compound that facilitates AMPA receptor-mediated synaptic responses, were tested in human subjects.  Separate tests of delayed recall were given prior to and nearly 3 h after administration of placebo (n = 12) or drug (n = 36).  Control subjects exhibited poorer performance in the second session than in the first while subjects given 600-1200 mg of the drug did not.  There were no pre- vs post-treatment differences in immediate recall in either group.  The drug did not reliably affect self-assessment scores for any of several psychological variables but did disrupt the normally present correlations for within-subject changes in the variables.  These results suggest that AMPA receptor modulators may (1) improve memory under some circumstances and (2) produce psychological effects that are subtle or not related to specific mood states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCImjQRewJDg8IxFYvehhofW6udTcc2eYiHFKZA7KveLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zgtFOitA%253D%253D&md5=e0b999d851770b7b285893786da81143</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1097%2F00004850-199603000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004850-199603000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DG.%26aulast%3DKessler%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DAmbros-Ingerson%26aufirst%3DJ.%26aulast%3DGranger%26aufirst%3DR.%26aulast%3DSchehr%26aufirst%3DR.%2BS.%26atitle%3DPsychological%2520effects%2520of%2520a%2520drug%2520that%2520facilitates%2520brain%2520AMPA%2520receptors%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D1996%26volume%3D11%26spage%3D13%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Granger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staubli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, G.</span><span> </span><span class="NLM_article-title">A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1993&pages=326-329&author=R.+Grangerauthor=U.+Staubliauthor=M.+Davisauthor=Y.+Perezauthor=L.+Nilssonauthor=G.+A.+Rogersauthor=G.+Lynch&title=A+drug+that+facilitates+glutamatergic+transmission+reduces+exploratory+activity+and+improves+performance+in+a+learning-dependent+task"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGranger%26aufirst%3DR.%26aulast%3DStaubli%26aufirst%3DU.%26aulast%3DDavis%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DY.%26aulast%3DNilsson%26aufirst%3DL.%26aulast%3DRogers%26aufirst%3DG.%2BA.%26aulast%3DLynch%26aufirst%3DG.%26atitle%3DA%2520drug%2520that%2520facilitates%2520glutamatergic%2520transmission%2520reduces%2520exploratory%2520activity%2520and%2520improves%2520performance%2520in%2520a%2520learning-dependent%2520task%26jtitle%3DSynapse%26date%3D1993%26volume%3D15%26spage%3D326%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Rosi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazia Giovannini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lestage, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Corte, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepeu, G.</span><span> </span><span class="NLM_article-title">S18986, a positive modulator of AMPA receptors with cognition-enhancing properties, increases ACh release in the hippocampus of young and aged rat</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2004&pages=120-123&author=S.+Rosiauthor=M.+Grazia+Giovanniniauthor=P.+J.+Lestageauthor=C.+Munozauthor=L.+Della+Corteauthor=G.+Pepeu&title=S18986%2C+a+positive+modulator+of+AMPA+receptors+with+cognition-enhancing+properties%2C+increases+ACh+release+in+the+hippocampus+of+young+and+aged+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosi%26aufirst%3DS.%26aulast%3DGrazia%2BGiovannini%26aufirst%3DM.%26aulast%3DLestage%26aufirst%3DP.%2BJ.%26aulast%3DMunoz%26aufirst%3DC.%26aulast%3DDella%2BCorte%26aufirst%3DL.%26aulast%3DPepeu%26aufirst%3DG.%26atitle%3DS18986%252C%2520a%2520positive%2520modulator%2520of%2520AMPA%2520receptors%2520with%2520cognition-enhancing%2520properties%252C%2520increases%2520ACh%2520release%2520in%2520the%2520hippocampus%2520of%2520young%2520and%2520aged%2520rat%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D361%26spage%3D120%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldegheri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melarange, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookherjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Negro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusaf, S. P.</span><span> </span><span class="NLM_article-title">Integration of lead optimization with crystallography for a membrane-bound ion channel target: discovery of a new class of AMPA receptor positive allosteric modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100679e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=78-94&author=S.+E.+Wardauthor=M.+Harriesauthor=L.+Aldegheriauthor=N.+E.+Austinauthor=S.+Ballantineauthor=E.+Balliniauthor=D.+M.+Bradleyauthor=B.+D.+Baxauthor=B.+P.+Clarkeauthor=A.+J.+Harrisauthor=S.+A.+Harrisonauthor=R.+A.+Melarangeauthor=C.+Mookherjeeauthor=J.+Mosleyauthor=G.+Dal+Negroauthor=B.+Oliosiauthor=K.+J.+Smithauthor=K.+M.+Thewlisauthor=P.+M.+Woollardauthor=S.+P.+Yusaf&title=Integration+of+lead+optimization+with+crystallography+for+a+membrane-bound+ion+channel+target%3A+discovery+of+a+new+class+of+AMPA+receptor+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm100679e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100679e%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DHarries%26aufirst%3DM.%26aulast%3DAldegheri%26aufirst%3DL.%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DBallantine%26aufirst%3DS.%26aulast%3DBallini%26aufirst%3DE.%26aulast%3DBradley%26aufirst%3DD.%2BM.%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DClarke%26aufirst%3DB.%2BP.%26aulast%3DHarris%26aufirst%3DA.%2BJ.%26aulast%3DHarrison%26aufirst%3DS.%2BA.%26aulast%3DMelarange%26aufirst%3DR.%2BA.%26aulast%3DMookherjee%26aufirst%3DC.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DDal%2BNegro%26aufirst%3DG.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26aulast%3DYusaf%26aufirst%3DS.%2BP.%26atitle%3DIntegration%2520of%2520lead%2520optimization%2520with%2520crystallography%2520for%2520a%2520membrane-bound%2520ion%2520channel%2520target%253A%2520discovery%2520of%2520a%2520new%2520class%2520of%2520AMPA%2520receptor%2520positive%2520allosteric%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D78%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ornstein, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleisch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantrell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinmayeh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleakman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelzys, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvie, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deverill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamboj, R. K.</span><span> </span><span class="NLM_article-title">Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic acid (AMPA) receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">4354</span><span class="NLM_x">–</span> <span class="NLM_lpage">4358</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0002836" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4354-4358&issue=23&author=P.+L.+Ornsteinauthor=D.+M.+Zimmermanauthor=M.+B.+Arnoldauthor=T.+J.+Bleischauthor=B.+Cantrellauthor=R.+Simonauthor=H.+Zarrinmayehauthor=S.+R.+Bakerauthor=M.+Gatesauthor=J.+P.+Tizzanoauthor=D.+Bleakmanauthor=A.+Mandelzysauthor=K.+R.+Jarvieauthor=K.+Hoauthor=M.+Deverillauthor=R.+K.+Kamboj&title=Biarylpropylsulfonamides+as+novel%2C+potent+potentiators+of+2-amino-3-%285-methyl-3-hydroxyisoxazol-4-yl%29propanoic+acid+%28AMPA%29+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm0002836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0002836%26sid%3Dliteratum%253Aachs%26aulast%3DOrnstein%26aufirst%3DP.%2BL.%26aulast%3DZimmerman%26aufirst%3DD.%2BM.%26aulast%3DArnold%26aufirst%3DM.%2BB.%26aulast%3DBleisch%26aufirst%3DT.%2BJ.%26aulast%3DCantrell%26aufirst%3DB.%26aulast%3DSimon%26aufirst%3DR.%26aulast%3DZarrinmayeh%26aufirst%3DH.%26aulast%3DBaker%26aufirst%3DS.%2BR.%26aulast%3DGates%26aufirst%3DM.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DBleakman%26aufirst%3DD.%26aulast%3DMandelzys%26aufirst%3DA.%26aulast%3DJarvie%26aufirst%3DK.%2BR.%26aulast%3DHo%26aufirst%3DK.%26aulast%3DDeverill%26aufirst%3DM.%26aulast%3DKamboj%26aufirst%3DR.%2BK.%26atitle%3DBiarylpropylsulfonamides%2520as%2520novel%252C%2520potent%2520potentiators%2520of%25202-amino-3-%25285-methyl-3-hydroxyisoxazol-4-yl%2529propanoic%2520acid%2520%2528AMPA%2529%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D23%26spage%3D4354%26epage%3D4358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Zarrinmayeh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tromiczak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escribano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornback, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisenbaum, E. S.</span><span> </span><span class="NLM_article-title">A novel class of positive allosteric modulators of AMPA receptors: design, synthesis, and structure–activity relationships of 3-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1<i>H</i>-pyrrole-2-carboxylic acid, LY2059346</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5203</span><span class="NLM_x">–</span> <span class="NLM_lpage">5206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5203-5206&author=H.+Zarrinmayehauthor=E.+Tromiczakauthor=D.+M.+Zimmermanauthor=N.+Ranklauthor=K.+H.+Hoauthor=E.+Dominguezauthor=A.+Castanoauthor=A.+Escribanoauthor=C.+Fernandezauthor=A.+Jimenezauthor=W.+J.+Hornbackauthor=E.+S.+Nisenbaum&title=A+novel+class+of+positive+allosteric+modulators+of+AMPA+receptors%3A+design%2C+synthesis%2C+and+structure%E2%80%93activity+relationships+of+3-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1H-pyrrole-2-carboxylic+acid%2C+LY2059346"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZarrinmayeh%26aufirst%3DH.%26aulast%3DTromiczak%26aufirst%3DE.%26aulast%3DZimmerman%26aufirst%3DD.%2BM.%26aulast%3DRankl%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DK.%2BH.%26aulast%3DDominguez%26aufirst%3DE.%26aulast%3DCastano%26aufirst%3DA.%26aulast%3DEscribano%26aufirst%3DA.%26aulast%3DFernandez%26aufirst%3DC.%26aulast%3DJimenez%26aufirst%3DA.%26aulast%3DHornback%26aufirst%3DW.%2BJ.%26aulast%3DNisenbaum%26aufirst%3DE.%2BS.%26atitle%3DA%2520novel%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520AMPA%2520receptors%253A%2520design%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%25203-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1H-pyrrole-2-carboxylic%2520acid%252C%2520LY2059346%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5203%26epage%3D5206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldegheri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melarange, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookherjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Profeta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusaf, S. P.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(2<i>S</i>)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1<i>H</i>-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5801</span><span class="NLM_x">–</span> <span class="NLM_lpage">5812</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1005429" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5801-5812&author=S.+E.+Wardauthor=M.+Harriesauthor=L.+Aldegheriauthor=D.+Andreottiauthor=S.+Ballantineauthor=B.+D.+Baxauthor=A.+J.+Harrisauthor=A.+J.+Harkerauthor=J.+Lundauthor=R.+Melarangeauthor=A.+Mingardiauthor=C.+Mookherjeeauthor=J.+Mosleyauthor=M.+Neveauthor=B.+Oliosiauthor=R.+Profetaauthor=K.+J.+Smithauthor=P.+W.+Smithauthor=S.+Spadaauthor=K.+M.+Thewlisauthor=S.+P.+Yusaf&title=Discovery+of+N-%5B%282S%29-5-%286-fluoro-3-pyridinyl%29-2%2C3-dihydro-1H-inden-2-yl%5D-2-propanesulfonamide%2C+a+novel+clinical+AMPA+receptor+positive+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm1005429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005429%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DHarries%26aufirst%3DM.%26aulast%3DAldegheri%26aufirst%3DL.%26aulast%3DAndreotti%26aufirst%3DD.%26aulast%3DBallantine%26aufirst%3DS.%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DHarris%26aufirst%3DA.%2BJ.%26aulast%3DHarker%26aufirst%3DA.%2BJ.%26aulast%3DLund%26aufirst%3DJ.%26aulast%3DMelarange%26aufirst%3DR.%26aulast%3DMingardi%26aufirst%3DA.%26aulast%3DMookherjee%26aufirst%3DC.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNeve%26aufirst%3DM.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DProfeta%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DSpada%26aufirst%3DS.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DYusaf%26aufirst%3DS.%2BP.%26atitle%3DDiscovery%2520of%2520N-%255B%25282S%2529-5-%25286-fluoro-3-pyridinyl%2529-2%252C3-dihydro-1H-inden-2-yl%255D-2-propanesulfonamide%252C%2520a%2520novel%2520clinical%2520AMPA%2520receptor%2520positive%2520modulator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5801%26epage%3D5812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Zarrinmayeh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleakman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornstein, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKennon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnick, P.</span><span> </span><span class="NLM_article-title">[3<i>H</i>]<i>N</i>-2-(4-(<i>N</i>-benzamido)phenyl)propyl-2- propanesulfonamide: a novel AMPA receptor potentiator and radioligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000462n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=302-304&author=H.+Zarrinmayehauthor=D.+Bleakmanauthor=M.+R.+Gatesauthor=H.+Yuauthor=D.+M.+Zimmermanauthor=P.+L.+Ornsteinauthor=T.+McKennonauthor=M.+B.+Arnoldauthor=W.+J.+Wheelerauthor=P.+Skolnick&title=%5B3H%5DN-2-%284-%28N-benzamido%29phenyl%29propyl-2-+propanesulfonamide%3A+a+novel+AMPA+receptor+potentiator+and+radioligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm000462n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000462n%26sid%3Dliteratum%253Aachs%26aulast%3DZarrinmayeh%26aufirst%3DH.%26aulast%3DBleakman%26aufirst%3DD.%26aulast%3DGates%26aufirst%3DM.%2BR.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZimmerman%26aufirst%3DD.%2BM.%26aulast%3DOrnstein%26aufirst%3DP.%2BL.%26aulast%3DMcKennon%26aufirst%3DT.%26aulast%3DArnold%26aufirst%3DM.%2BB.%26aulast%3DWheeler%26aufirst%3DW.%2BJ.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3D%255B3H%255DN-2-%25284-%2528N-benzamido%2529phenyl%2529propyl-2-%2520propanesulfonamide%253A%2520a%2520novel%2520AMPA%2520receptor%2520potentiator%2520and%2520radioligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D302%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">McNeish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hambor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weibley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machacek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stice, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R.</span><span> </span><span class="NLM_article-title">High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of α-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">17209</span><span class="NLM_x">–</span> <span class="NLM_lpage">17217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=17209-17217&author=J.+McNeishauthor=M.+Roachauthor=J.+Hamborauthor=R.+J.+Matherauthor=L.+Weibleyauthor=J.+Lazzaroauthor=J.+Gazardauthor=J.+Schwarzauthor=R.+Volkmannauthor=D.+Machacekauthor=S.+Sticeauthor=L.+Zawadzkeauthor=C.+O%E2%80%99Donnellauthor=R.+Hurst&title=High-throughput+screening+in+embryonic+stem+cell-derived+neurons+identifies+potentiators+of+%CE%B1-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcNeish%26aufirst%3DJ.%26aulast%3DRoach%26aufirst%3DM.%26aulast%3DHambor%26aufirst%3DJ.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DWeibley%26aufirst%3DL.%26aulast%3DLazzaro%26aufirst%3DJ.%26aulast%3DGazard%26aufirst%3DJ.%26aulast%3DSchwarz%26aufirst%3DJ.%26aulast%3DVolkmann%26aufirst%3DR.%26aulast%3DMachacek%26aufirst%3DD.%26aulast%3DStice%26aufirst%3DS.%26aulast%3DZawadzke%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%26aulast%3DHurst%26aufirst%3DR.%26atitle%3DHigh-throughput%2520screening%2520in%2520embryonic%2520stem%2520cell-derived%2520neurons%2520identifies%2520potentiators%2520of%2520%25CE%25B1-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type%2520glutamate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D17209%26epage%3D17217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Barbachyn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, C. W.</span><span> </span><span class="NLM_article-title">Oxazolidinone structure–activity relationships leading to linezolid</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2010</span><span class="NLM_x">–</span> <span class="NLM_lpage">2023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=2010-2023&author=M.+R.+Barbachynauthor=C.+W.+Ford&title=Oxazolidinone+structure%E2%80%93activity+relationships+leading+to+linezolid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26aulast%3DFord%26aufirst%3DC.%2BW.%26atitle%3DOxazolidinone%2520structure%25E2%2580%2593activity%2520relationships%2520leading%2520to%2520linezolid%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D2010%26epage%3D2023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barbachyn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleek, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolak, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garmon, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seest, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toops, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurenko, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaadt, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yagi, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slatter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oien, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaya, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wienkers, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynalda, M. A.</span><span> </span><span class="NLM_article-title">Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020248u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVemsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=284-302&author=M.+R.+Barbachynauthor=G.+J.+Cleekauthor=L.+A.+Dolakauthor=S.+A.+Garmonauthor=J.+Morrisauthor=E.+P.+Seestauthor=R.+C.+Thomasauthor=D.+S.+Toopsauthor=W.+Wattauthor=D.+G.+Wishkaauthor=C.+W.+Fordauthor=G.+E.+Zurenkoauthor=J.+C.+Hamelauthor=R.+D.+Schaadtauthor=D.+Stapertauthor=B.+H.+Yagiauthor=W.+J.+Adamsauthor=J.+M.+Friisauthor=J.+G.+Slatterauthor=J.+P.+Samsauthor=N.+L.+Oienauthor=M.+J.+Zayaauthor=L.+C.+Wienkersauthor=M.+A.+Wynalda&title=Identification+of+phenylisoxazolines+as+novel+and+viable+antibacterial+agents+active+against+Gram-positive+pathogens"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Phenylisoxazolines as Novel and Viable Antibacterial Agents Active against Gram-Positive Pathogens</span></div><div class="casAuthors">Barbachyn, Michael R.; Cleek, Gary J.; Dolak, Lester A.; Garmon, Stuart A.; Morris, Joel; Seest, Eric P.; Thomas, Richard C.; Toops, Dana S.; Watt, William; Wishka, Donn G.; Ford, Charles W.; Zurenko, Gary E.; Hamel, Judith C.; Schaadt, Ronda D.; Stapert, Douglas; Yagi, Betty H.; Adams, Wade J.; Friis, Janice M.; Slatter, J. Gregory; Sams, James P.; Oien, Nancee L.; Zaya, Matthew J.; Wienkers, Larry C.; Wynalda, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">284-302</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new and promising group of antibacterial agents, collectively known as the oxazolidinones and exemplified by linezolid, have recently emerged as important new therapeutic agents for the treatment of infections caused by Gram-pos. bacteria.  Because of their significance, extensive synthetic investigations into the structure-activity relationships of the oxazolidinones have been conducted at Pharmacia.  One facet of this research effort has focused on the identification of bioisosteric replacements for the usual oxazolidinone A-ring.  In this paper the studies leading to the identification of antibacterial agents incorporating a novel isoxazoline A-ring surrogate is presented.  In a gratifying result, the initial isoxazoline analog prepd. I (R1 = 3-methoxy-4-troponyl, R2 = R3 = H) was found to exhibit in vitro antibacterial activity approaching that of the corresponding oxazolidinone progenitor.  The synthesis and antibacterial activity profile of a preliminary series of isoxazoline analogs, (±)-, (R)-, (S)- and dehydro-I (R1 = 4-pyridinyl, morpholino, 4-hydroxyacetyl-1-piperazino, etc., R2 = H, F, R3 = H, F, Cl, X = O, S), incorporating either a C-C or N-C linkage between their B- and C-rings will be presented.  Many of the analogs exhibited interesting levels of antibacterial activity.  The piperazine deriv. (R)-I (R1 = 4-hydroxyacetyl-1-piperazino, R2 = R3 = F, X = O), derived from (R)-acetamidomethyltrifluorophenylisoxazoline, displayed esp. promising in vitro activity and in vivo efficacy comparable to the activity and efficacy of linezolid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxLAUw6yFR5bVg90H21EOLACvtfcHk0lg57hptRdsJiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVemsr4%253D&md5=6d4c166f9c67a3188be93b0fe854613a</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1021%2Fjm020248u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020248u%26sid%3Dliteratum%253Aachs%26aulast%3DBarbachyn%26aufirst%3DM.%2BR.%26aulast%3DCleek%26aufirst%3DG.%2BJ.%26aulast%3DDolak%26aufirst%3DL.%2BA.%26aulast%3DGarmon%26aufirst%3DS.%2BA.%26aulast%3DMorris%26aufirst%3DJ.%26aulast%3DSeest%26aufirst%3DE.%2BP.%26aulast%3DThomas%26aufirst%3DR.%2BC.%26aulast%3DToops%26aufirst%3DD.%2BS.%26aulast%3DWatt%26aufirst%3DW.%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DFord%26aufirst%3DC.%2BW.%26aulast%3DZurenko%26aufirst%3DG.%2BE.%26aulast%3DHamel%26aufirst%3DJ.%2BC.%26aulast%3DSchaadt%26aufirst%3DR.%2BD.%26aulast%3DStapert%26aufirst%3DD.%26aulast%3DYagi%26aufirst%3DB.%2BH.%26aulast%3DAdams%26aufirst%3DW.%2BJ.%26aulast%3DFriis%26aufirst%3DJ.%2BM.%26aulast%3DSlatter%26aufirst%3DJ.%2BG.%26aulast%3DSams%26aufirst%3DJ.%2BP.%26aulast%3DOien%26aufirst%3DN.%2BL.%26aulast%3DZaya%26aufirst%3DM.%2BJ.%26aulast%3DWienkers%26aufirst%3DL.%2BC.%26aulast%3DWynalda%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520of%2520phenylisoxazolines%2520as%2520novel%2520and%2520viable%2520antibacterial%2520agents%2520active%2520against%2520Gram-positive%2520pathogens%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D284%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0liu2ARGlr9U4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lipinski, C. A.</span><span> </span><span class="NLM_article-title">Lead- and drug-like compounds: the rule-of-five revolution</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1016%2Fj.ddtec.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=24981612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=337-341&author=C.+A.+Lipinski&title=Lead-+and+drug-like+compounds%3A+the+rule-of-five+revolution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Lead- and drug-like compounds: the rule-of-five revolution</span></div><div class="casAuthors">Lipinski, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Technologies</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-341</span>CODEN:
                <span class="NLM_cas:coden">DDTTB5</span>;
        ISSN:<span class="NLM_cas:issn">1740-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Citations in CAS SciFinder to the rule-of-five (RO5) publication will exceed 1000 by year-end 2004.  Trends in the RO5 literature explosion that can be discerned are the further definitions of drug-like.  This topic is explored in terms of drug-like physicochem. features, drug-like structural features, a comparison of drug-like and non-drug-like in drug discovery and a discussion of how drug-like features relate to clin. success.  Physicochem. features of CNS drugs and features related to CNS blood-brain transporter affinity are briefly reviewed.  Recent literature on features of non-oral drugs is reviewed and how features of lead-like compds. differ from those of drug-like compds. is discussed.  Most recently, partly driven by NIH roadmap initiatives, considerations have arisen as to what tool-like means in the search for chem. tools to probe biol. space.  All these topics frame the scope of this short review/perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjiyP3CY7lLVg90H21EOLACvtfcHk0liu2ARGlr9U4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D&md5=952c29b47003b884116d790ae9e4721f</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DLead-%2520and%2520drug-like%2520compounds%253A%2520the%2520rule-of-five%2520revolution%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2004%26volume%3D1%26spage%3D337%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hop, C. E. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duignan, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federico, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebowitz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalen, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelesky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span> </span><span class="NLM_article-title">High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.2174%2F138920008786485092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=18991580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2nsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=847-853&author=C.+E.+C.+A.+Hopauthor=M.+J.+Coleauthor=R.+E.+Davidsonauthor=D.+B.+Duignanauthor=J.+Federicoauthor=J.+S.+Janiszewskiauthor=K.+Jenkinsauthor=S.+Kruegerauthor=R.+Lebowitzauthor=T.+E.+Listonauthor=W.+Mitchellauthor=M.+Snyderauthor=S.+J.+Steynauthor=J.+R.+Sogliaauthor=C.+Taylorauthor=M.+D.+Troutmanauthor=J.+Umlandauthor=M.+Westauthor=K.+M.+Whalenauthor=V.+Zeleskyauthor=S.+X.+Zhao&title=High+throughput+ADME+screening%3A+practical+considerations%2C+impact+on+the+portfolio+and+enabler+of+in+silico+ADME+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models</span></div><div class="casAuthors">Hop, Cornelis E. C. A.; Cole, Mark J.; Davidson, Ralph E.; Duignan, David B.; Federico, James; Janiszewski, John S.; Jenkins, Kelly; Krueger, Suzanne; Lebowitz, Rebecca; Liston, Theodore E.; Mitchell, Walter; Snyder, Mark; Steyn, Stefan J.; Soglia, John R.; Taylor, Christine; Troutman, Matt D.; Umland, John; West, Michael; Whalen, Kevin M.; Zelesky, Veronica; Zhao, Sabrina X.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">847-853</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Evaluation and optimization of drug metab. and pharmacokinetic data plays an important role in drug discovery and development and several reliable in vitro ADME models are available.  Recently higher throughput in vitro ADME screening facilities have been established in order to be able to evaluate an appreciable fraction of synthesized compds.  The ADME screening process can be dissected in five distinct steps: (1) plate management of compds. in need of in vitro ADME data, (2) optimization of the MS/MS method for the compds., (3) in vitro ADME expts. and sample clean up, (4) collection and redn. of the raw LC-MS/MS data and (5) archival of the processed ADME data.  All steps will be described in detail and the value of the data on drug discovery projects will be discussed as well.  Finally, in vitro ADME screening can generate large quantities of data obtained under identical conditions to allow building of reliable in silico models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHIB4wuoFXErVg90H21EOLACvtfcHk0liO3QnOGKp-Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2nsLk%253D&md5=69acd6725561ddb30157d22dab69e329</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F138920008786485092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008786485092%26sid%3Dliteratum%253Aachs%26aulast%3DHop%26aufirst%3DC.%2BE.%2BC.%2BA.%26aulast%3DCole%26aufirst%3DM.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DDuignan%26aufirst%3DD.%2BB.%26aulast%3DFederico%26aufirst%3DJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DJenkins%26aufirst%3DK.%26aulast%3DKrueger%26aufirst%3DS.%26aulast%3DLebowitz%26aufirst%3DR.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DMitchell%26aufirst%3DW.%26aulast%3DSnyder%26aufirst%3DM.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DUmland%26aufirst%3DJ.%26aulast%3DWest%26aufirst%3DM.%26aulast%3DWhalen%26aufirst%3DK.%2BM.%26aulast%3DZelesky%26aufirst%3DV.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26atitle%3DHigh%2520throughput%2520ADME%2520screening%253A%2520practical%2520considerations%252C%2520impact%2520on%2520the%2520portfolio%2520and%2520enabler%2520of%2520in%2520silico%2520ADME%2520models%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D847%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benveniste, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weeks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisenbaum, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partin, K. M.</span><span> </span><span class="NLM_article-title">Structural and functional analysis of two new positive allosteric modulators of GluA2 desensitization and deactivation</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2011&pages=267-280&author=D.+E.+Timmauthor=M.+Benvenisteauthor=A.+M.+Weeksauthor=E.+S.+Nisenbaumauthor=K.+M.+Partin&title=Structural+and+functional+analysis+of+two+new+positive+allosteric+modulators+of+GluA2+desensitization+and+deactivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DBenveniste%26aufirst%3DM.%26aulast%3DWeeks%26aufirst%3DA.%2BM.%26aulast%3DNisenbaum%26aufirst%3DE.%2BS.%26aulast%3DPartin%26aufirst%3DK.%2BM.%26atitle%3DStructural%2520and%2520functional%2520analysis%2520of%2520two%2520new%2520positive%2520allosteric%2520modulators%2520of%2520GluA2%2520desensitization%2520and%2520deactivation%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D80%26spage%3D267%26epage%3D280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span> </span><span class="NLM_article-title">Mechanism of glutamate receptor desensitization</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">417</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1038%2F417245a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=12015593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjs1agtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=245-253&author=Y.+Sunauthor=R.+Olsonauthor=M.+Horningauthor=N.+Armstrongauthor=M.+Mayerauthor=E.+Gouaux&title=Mechanism+of+glutamate+receptor+desensitization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27bR"><div class="casContent"><span class="casTitleNuber">27b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of glutamate receptor desensitization</span></div><div class="casAuthors">Sun, Yu; Olson, Rich; Horning, Michelle; Armstrong, Neali; Mayer, Mark; Gouaux, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">6886</span>),
    <span class="NLM_cas:pages">245-253</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ligand-gated ion channels transduce chem. signals into elec. impulses by opening a transmembrane pore in response to binding one or more neurotransmitter mols.  After activation, many ligand-gated ion channels enter a desensitized state in which the neurotransmitter remains bound but the ion channel is closed.  Although receptor desensitization is crucial to the functioning of many ligand-gated ion channels in vivo, the mol. basis of this important process has until now defied anal.  Using the GluR2 AMPA-sensitive glutamate receptor, we show here that the ligand-binding cores form dimers and that stabilization of the intradimer interface by either mutations or allosteric modulators reduces desensitization.  Perturbations that destabilize the interface enhance desensitization.  Receptor activation involves conformational changes within each subunit that result in an increase in the sepn. of portions of the receptor that are linked to the ion channel.  Our anal. defines the dimer interface in the resting and activated state, indicates how ligand binding is coupled to gating, and suggests modes of dimer-dimer interaction in the assembled tetramer.  Desensitization occurs through rearrangement of the dimer interface, which disengages the agonist-induced conformational change in the ligand-binding core from the ion channel gate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfnSz0jXyrJLVg90H21EOLACvtfcHk0liO3QnOGKp-Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjs1agtrg%253D&md5=da6ce99323e00eeff313ce6a02d7fc01</span></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1038%2F417245a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F417245a%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DHorning%26aufirst%3DM.%26aulast%3DArmstrong%26aufirst%3DN.%26aulast%3DMayer%26aufirst%3DM.%26aulast%3DGouaux%26aufirst%3DE.%26atitle%3DMechanism%2520of%2520glutamate%2520receptor%2520desensitization%26jtitle%3DNature%26date%3D2002%26volume%3D417%26spage%3D245%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weeks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudman, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partin, K. M.</span><span> </span><span class="NLM_article-title">Mechanism of positive allosteric modulators acting on AMPA receptors</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">9027</span><span class="NLM_x">–</span> <span class="NLM_lpage">9036</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1523%2FJNEUROSCI.2567-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=16192394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27c&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOqs7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=9027-9036&author=R.+Jinauthor=S.+Clarkauthor=A.+M.+Weeksauthor=J.+T.+Dudmanauthor=E.+Gouauxauthor=K.+M.+Partin&title=Mechanism+of+positive+allosteric+modulators+acting+on+AMPA+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27cR"><div class="casContent"><span class="casTitleNuber">27c</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of positive allosteric modulators acting on AMPA receptors</span></div><div class="casAuthors">Jin, Rongsheng; Clark, Suzanne; Weeks, Autumn M.; Dudman, Joshua T.; Gouaux, Eric; Partin, Kathryn M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">9027-9036</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Ligand-gated ion channels involved in the modulation of synaptic strength are the AMPA, kainate, and NMDA glutamate receptors.  Small mols. that potentiate AMPA receptor currents relieve cognitive deficits caused by neurodegenerative diseases such as Alzheimer's disease and show promise in the treatment of depression.  Previously, there has been limited understanding of the mol. mechanism of action for AMPA receptor potentiators.  Here the authors present cocrystal structures of the glutamate receptor GluR2 S1S2 ligand-binding domain in complex with aniracetam [1-(4-methoxybenzoyl)-2-pyrrolidinone] or CX614 (pyrrolidino-1,3-oxazino benzo-1,4-dioxan-10-one), two AMPA receptor potentiators that preferentially slow AMPA receptor deactivation.  Both potentiators bind within the dimer interface of the nondesensitized receptor at a common site located on the twofold axis of mol. symmetry.  Importantly, the potentiator binding site is adjacent to the "hinge" in the ligand-binding core "clamshell" that undergoes conformational rearrangement after glutamate binding.  Using rapid soln. exchange, patch-clamp electrophysiol. expts., the authors show that point mutations of residues that interact with potentiators in the cocrystal disrupt potentiator function.  The authors suggest that the potentiators slow deactivation by stabilizing the clamshell in its closed-cleft, glutamate-bound conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo15HIwmBGNTrVg90H21EOLACvtfcHk0liO3QnOGKp-Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOqs7jP&md5=d035b142e3911e5e44a0ec4a825dc0a8</span></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2567-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2567-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DR.%26aulast%3DClark%26aufirst%3DS.%26aulast%3DWeeks%26aufirst%3DA.%2BM.%26aulast%3DDudman%26aufirst%3DJ.%2BT.%26aulast%3DGouaux%26aufirst%3DE.%26aulast%3DPartin%26aufirst%3DK.%2BM.%26atitle%3DMechanism%2520of%2520positive%2520allosteric%2520modulators%2520acting%2520on%2520AMPA%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D9027%26epage%3D9036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Ahmed, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oswald, R. E.</span><span> </span><span class="NLM_article-title">Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2843</span><span class="NLM_x">–</span> <span class="NLM_lpage">2850</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi1000678" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=2843-2850&author=A.+H.+Ahmedauthor=C.+P.+Ptakauthor=R.+E.+Oswald&title=Molecular+mechanism+of+flop+selectivity+and+subsite+recognition+for+an+AMPA+receptor+allosteric+modulator%3A+structures+of+GluA2+and+GluA3+in+complexes+with+PEPA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27d&amp;dbid=16384&amp;doi=10.1021%2Fbi1000678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1000678%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DA.%2BH.%26aulast%3DPtak%26aufirst%3DC.%2BP.%26aulast%3DOswald%26aufirst%3DR.%2BE.%26atitle%3DMolecular%2520mechanism%2520of%2520flop%2520selectivity%2520and%2520subsite%2520recognition%2520for%2520an%2520AMPA%2520receptor%2520allosteric%2520modulator%253A%2520structures%2520of%2520GluA2%2520and%2520GluA3%2520in%2520complexes%2520with%2520PEPA%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D2843%26epage%3D2850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marrone, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luty, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. W.</span><span> </span><span class="NLM_article-title">Discovering high-affinity ligands from the computationally predicted structures and affinities of small molecules bound to a target: a virtual screening approach</span> <span class="citation_source-journal">Perspect. Drug Discovery Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1023%2FA%3A1008741308684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=209-230&author=T.+J.+Marroneauthor=B.+A.+Lutyauthor=P.+W.+Rose&title=Discovering+high-affinity+ligands+from+the+computationally+predicted+structures+and+affinities+of+small+molecules+bound+to+a+target%3A+a+virtual+screening+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering high-affinity ligands from the computationally predicted structures and affinities of small molecules bound to a target: a virtual screening approach</span></div><div class="casAuthors">Marrone, Tami J.; Luty, Brock A.; Rose, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Perspectives in Drug Discovery and Design</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-230</span>CODEN:
                <span class="NLM_cas:coden">PDDDEC</span>;
        ISSN:<span class="NLM_cas:issn">0928-2866</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">We describe a "virtual NMR screening" method to assist in the design of inhibitors that occupy different sites within a target.  We dock small mols. into the active site of an enzyme and score them.  Keeping the tightest-binding lead fixed in space, we dock and score other small mols. in its presence.  Using this approach, linker groups are used to join the compds. together to form a high-affinity inhibitor.  We present validation of our computational approach by reproducing exptl. results for FKBP and stromelysin.  Docking simulations are not subject to exptl. problems such as proteolysis, protein or compd. insoly., or enzyme size.  Because docking is fast and our scoring method can distinguish between high- and low-affinity inhibitors, this docking procedure shows promise as integral part of a drug-design strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql26ToXhh4jbVg90H21EOLACvtfcHk0lgfQIHtKqCDZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFSg&md5=cea3010bea46c3636970ece8ee764ae2</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008741308684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008741308684%26sid%3Dliteratum%253Aachs%26aulast%3DMarrone%26aufirst%3DT.%2BJ.%26aulast%3DLuty%26aufirst%3DB.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BW.%26atitle%3DDiscovering%2520high-affinity%2520ligands%2520from%2520the%2520computationally%2520predicted%2520structures%2520and%2520affinities%2520of%2520small%2520molecules%2520bound%2520to%2520a%2520target%253A%2520a%2520virtual%2520screening%2520approach%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D2000%26volume%3D20%26spage%3D209%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gehlhaar, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhivker, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freer, S. T.</span><span> </span><span class="NLM_article-title">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1016%2F1074-5521%2895%2990050-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=9383433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=317-324&author=D.+K.+Gehlhaarauthor=G.+M.+Verkhivkerauthor=P.+A.+Rejtoauthor=C.+J.+Shermanauthor=D.+B.+Fogelauthor=L.+J.+Fogelauthor=S.+T.+Freer&title=Molecular+recognition+of+the+inhibitor+AG-1343+by+HIV-1+protease%3A+conformationally+flexible+docking+by+evolutionary+programming"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span></div><div class="casAuthors">Gehlhaar, Daniel K.; Verkhivker, Gennady M.; Rejto, Paul A.; Sherman, Christopher J.; Fogel, David B.; Fogel, Lawrence J.; Freer, Stephan T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">317-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">An important prerequisite for computational structure-based drug design is prediction of the structures of ligand-protein complexes that have not yet been exptl. detd. by x-ray crystallog. or NMR.  For this task, docking of rigid ligands is inadequate because it assumes knowledge of the conformation of the bound ligand.  Docking of flexible ligands would be desirable, but requires one to search an enormous conformational space.  We set out to develop a strategy for flexible docking by combining a simple model of ligand-protein interactions for mol. recognition with an evolutionary programming search technique.  We have developed an intermol. energy function that incorporates steric and hydrogen-bonding terms.  The parameters in this function were obtained by docking in three different protein systems.  The effectiveness of this method was demonstrated by conformationally flexible docking of the inhibitor AG-1343, a potential new drug against AIDS, into HIV-1 protease.  For this mol., which has nine rotatable bonds, the crystal structure was reproduced within 1.5 Å rootmean-square deviation 34 times in 100 simulations, each requiring eight minutes on a Silicon Graphics R4400 workstation.  The energy function correctly evaluates the crystal structure as the global energy min.  We believe that a soln. of the docking problem may be achieved by matching a simple model of mol. recognition with an efficient search procedure.  The necessary ingredients of a mol. recognition model include only steric and hydrogen-bond interaction terms.  Although these terms are not necessarily sufficient to predict binding affinity, they describe ligand-protein interactions faithfully enough to enable a docking program to predict the structure of the bound ligand.  This docking strategy thus provides an important tool for the interdisciplinary field of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAErS8tcVx2bVg90H21EOLACvtfcHk0lgfQIHtKqCDZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D&md5=527cfc114545ea76b64b48d0aee21856</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1016%2F1074-5521%2895%2990050-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1074-5521%252895%252990050-0%26sid%3Dliteratum%253Aachs%26aulast%3DGehlhaar%26aufirst%3DD.%2BK.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DSherman%26aufirst%3DC.%2BJ.%26aulast%3DFogel%26aufirst%3DD.%2BB.%26aulast%3DFogel%26aufirst%3DL.%2BJ.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26atitle%3DMolecular%2520recognition%2520of%2520the%2520inhibitor%2520AG-1343%2520by%2520HIV-1%2520protease%253A%2520conformationally%2520flexible%2520docking%2520by%2520evolutionary%2520programming%26jtitle%3DChem.%2520Biol.%26date%3D1995%26volume%3D2%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Linden, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinmayeh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnick, P.</span><span> </span><span class="NLM_article-title">Binding of an AMPA receptor potentiator ([3H]LY395153) to native and recombinant AMPA receptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1010</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=1010-1018&author=A.+M.+Lindenauthor=H.+Yuauthor=H.+Zarrinmayehauthor=W.+J.+Wheelerauthor=P.+Skolnick&title=Binding+of+an+AMPA+receptor+potentiator+%28%5B3H%5DLY395153%29+to+native+and+recombinant+AMPA+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLinden%26aufirst%3DA.%2BM.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZarrinmayeh%26aufirst%3DH.%26aulast%3DWheeler%26aufirst%3DW.%2BJ.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3DBinding%2520of%2520an%2520AMPA%2520receptor%2520potentiator%2520%2528%255B3H%255DLY395153%2529%2520to%2520native%2520and%2520recombinant%2520AMPA%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2001%26volume%3D40%26spage%3D1010%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleo, M. D.</span><span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+a+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30aR"><div class="casContent"><span class="casTitleNuber">30a</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0lgfQIHtKqCDZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520a%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30b&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30bR"><div class="casContent"><span class="casTitleNuber">30b</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0lgzpmUaGTO05w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Tillement, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaumet-Riffaud, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bree, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albengres, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barre, J.</span><span> </span><span class="NLM_article-title">Blood binding and tissue uptake of drugs. Recent advances and perspectives</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1111%2Fj.1472-8206.1988.tb00634.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=3042568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADyaL1cXltVeqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1988&pages=223-238&author=J.+P.+Tillementauthor=S.+Urienauthor=P.+Chaumet-Riffaudauthor=P.+Riantauthor=F.+Breeauthor=D.+Morinauthor=E.+Albengresauthor=J.+Barre&title=Blood+binding+and+tissue+uptake+of+drugs.+Recent+advances+and+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Blood binding and tissue uptake of drugs.  Recent advances and perspectives</span></div><div class="casAuthors">Tillement, J. P.; Urien, S.; Chaumet-Riffaud, P.; Riant, P.; Bree, F.; Morin, D.; Albengres, E.; Barre, J.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-38</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    </div><div class="casAbstract">A review with 40 refs.  The free drug hypothesis, which states that only the unbound drug in blood is available for tissue diffusion, is discussed according to recent investigations.  In some exptl. conditions, it must be assumed that a part of the protein-bound drug in plasma is extd. during a single passage through the organ studied.  The mechanisms underlying these observations are not unequivocal and remain hypothetical.  In the liver, high-affinity binding sites for serum albumin have been demonstrated, and they would explain the high extn. by liver of endogenous and exogenous compds.  However, these expts. measure the unidirectional transfer of a drug from the vascular to the extravascular space in non-steady-state conditions.  Hence, in steady-state conditions, the free drug hypothesis cannot be ruled out because it is supported by numerous pharmacokinetic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrelrSOcPPALLVg90H21EOLACvtfcHk0lgzpmUaGTO05w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVeqsLs%253D&md5=bc63d07fdf703eb8fcbd177986384dae</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.1988.tb00634.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.1988.tb00634.x%26sid%3Dliteratum%253Aachs%26aulast%3DTillement%26aufirst%3DJ.%2BP.%26aulast%3DUrien%26aufirst%3DS.%26aulast%3DChaumet-Riffaud%26aufirst%3DP.%26aulast%3DRiant%26aufirst%3DP.%26aulast%3DBree%26aufirst%3DF.%26aulast%3DMorin%26aufirst%3DD.%26aulast%3DAlbengres%26aufirst%3DE.%26aulast%3DBarre%26aufirst%3DJ.%26atitle%3DBlood%2520binding%2520and%2520tissue%2520uptake%2520of%2520drugs.%2520Recent%2520advances%2520and%2520perspectives%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D1988%26volume%3D2%26spage%3D223%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Shaffer, C. L.</span><span> </span><span class="NLM_article-title">Defining neuropharmacokinetic parameters in CNS drug discovery to determine cross-species pharmacologic exposure-response relationships</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=55-70&author=C.+L.+Shaffer&title=Defining+neuropharmacokinetic+parameters+in+CNS+drug+discovery+to+determine+cross-species+pharmacologic+exposure-response+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DDefining%2520neuropharmacokinetic%2520parameters%2520in%2520CNS%2520drug%2520discovery%2520to%2520determine%2520cross-species%2520pharmacologic%2520exposure-response%2520relationships%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D55%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Natta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worboys, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1124%2Fdmd.108.024125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=19116265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=787-793&author=X.+Liuauthor=K.+Van+Nattaauthor=H.+Yeoauthor=O.+Vilenskiauthor=P.+E.+Wellerauthor=P.+D.+Worboysauthor=M.+Monshouwer&title=Unbound+drug+concentration+in+brain+homogenate+and+cerebral+spinal+fluid+at+steady+state+as+a+surrogate+for+unbound+concentration+in+brain+interstitial+fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span></div><div class="casAuthors">Liu, Xingrong; Van Natta, Kristine; Yeo, Helen; Vilenski, Olga; Weller, Paul E.; Worboys, Philip D.; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present study was to examine the accuracy of using unbound brain concn. detd. by a brain homogenate method (Cub), cerebral spinal fluid concn. (CCSF), and unbound plasma concn. (Cup) as a surrogate for brain interstitial fluid concn. detd. by brain microdialysis (Cm).  Nine compds.-carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental-were selected, and each was administered as an i.v. bolus (up to 5 mg/kg) followed by a const. i.v. infusion (1-9 mg/kg/h) for 6 h in rats.  For eight of the nine compds., the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub.  The CCSFs of eight of the nine compds. were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm.  The Cups of five of the nine compds. were within 3-fold of their Cm; four compds. (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm.  In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compds. tested.  The Cups were within 3-fold of Cm for lipophilic non-P-glycoprotein (-P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates.  The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concns. within 3-fold of error in drug discovery and development settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVK_I2XYWfrrVg90H21EOLACvtfcHk0lhuFtnMXXbkgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D&md5=feb6abdcfa4e2e007c5abd44066c0e19</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVan%2BNatta%26aufirst%3DK.%26aulast%3DYeo%26aufirst%3DH.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DWeller%26aufirst%3DP.%2BE.%26aulast%3DWorboys%26aufirst%3DP.%2BD.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DUnbound%2520drug%2520concentration%2520in%2520brain%2520homogenate%2520and%2520cerebral%2520spinal%2520fluid%2520at%2520steady%2520state%2520as%2520a%2520surrogate%2520for%2520unbound%2520concentration%2520in%2520brain%2520interstitial%2520fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D787%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancuso, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span> </span><span class="NLM_article-title">An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2162</span><span class="NLM_x">–</span> <span class="NLM_lpage">2173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=2162-2173&author=A.+C.+Doranauthor=S.+M.+Osgoodauthor=J.+Y.+Mancusoauthor=C.+L.+Shaffer&title=An+evaluation+of+using+rat-derived+single-dose+neuropharmacokinetic+parameters+to+project+accurately+large+animal+unbound+brain+drug+concentrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DOsgood%26aufirst%3DS.%2BM.%26aulast%3DMancuso%26aufirst%3DJ.%2BY.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DAn%2520evaluation%2520of%2520using%2520rat-derived%2520single-dose%2520neuropharmacokinetic%2520parameters%2520to%2520project%2520accurately%2520large%2520animal%2520unbound%2520brain%2520drug%2520concentrations%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D2162%26epage%3D2173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yamada, K. A.</span><span> </span><span class="NLM_article-title">Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1006%2Fnbdi.1998.0190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=9746904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlentbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1998&pages=67-80&author=K.+A.+Yamada&title=Modulating+excitatory+synaptic+neurotransmission%3A+potential+treatment+for+neurological+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34aR"><div class="casContent"><span class="casTitleNuber">34a</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?</span></div><div class="casAuthors">Yamada, Kelvin A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-80</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review, with 84 refs.  Excitatory neurotransmission at many CNS synapses depends upon AMPA-type glutamate receptors.  Derangements in AMPA receptor-mediated synaptic transmission may be a contributing factor in neurol. and neurodegenerative diseases and could be a target for therapeutic intervention.  Drugs that pos. modulate AMPA receptors by reducing AMPA receptor desensitization and/or slowing AMPA receptor deactivation, such as thiazide derivs. (cyclothiazide, diazoxide, IDRA 21) and benzoylpiperidine derivs. (1-BCP, CX516, aniracetam), facilitate AMPA receptor-mediated processes and may have beneficial therapeutic effects.  For example, AMPA modulators facilitate long-term potentiation, which may be important for memory storage, and facilitate memory encoding in behavioral expts.  Thus, AMPA modulators might ameliorate memory deficits that occur in dementia, such as Alzheimer's disease.  However, AMPA receptor-mediated excitotoxicity may occur with excessive AMPA receptor activation such as in seizures or ischemia, and pos. AMPA modulators would promote neuronal injury under those conditions.  Regardless of the ultimate clin. utility of pos. AMPA modulators, their discovery and study have already provided significant insight into the physiol. and structural determinants of important AMPA receptor properties.  This review attempts to synthesize a variety of studies that have utilized these AMPA modulators to gain insight into fundamental as well as clin. relevant AMPA receptor-mediated processes.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfjdGogGo9LLVg90H21EOLACvtfcHk0lhuFtnMXXbkgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlentbc%253D&md5=5f8211686883cffc773c302d8ef24877</span></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.1998.0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.1998.0190%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%2BA.%26atitle%3DModulating%2520excitatory%2520synaptic%2520neurotransmission%253A%2520potential%2520treatment%2520for%2520neurological%2520disease%253F%26jtitle%3DNeurobiol.%2520Dis.%26date%3D1998%26volume%3D5%26spage%3D67%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Garthwaite, G. G.</span><span> </span><span class="NLM_article-title">Mechanisms of AMPA neurotoxicity in rat brain slices</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">729</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1111%2Fj.1460-9568.1991.tb01669.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=12106459" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=729-736&author=G.+G.+Garthwaite&title=Mechanisms+of+AMPA+neurotoxicity+in+rat+brain+slices"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.1991.tb01669.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.1991.tb01669.x%26sid%3Dliteratum%253Aachs%26aulast%3DGarthwaite%26aufirst%3DG.%2BG.%26atitle%3DMechanisms%2520of%2520AMPA%2520neurotoxicity%2520in%2520rat%2520brain%2520slices%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1991%26volume%3D3%26spage%3D729%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span> </span><span class="NLM_article-title">Species independence in brain tissue binding using brain homogenates</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1124%2Fdmd.111.038778" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=21474681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34c&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1270-1277&author=L.+Diauthor=J.+P.+Umlandauthor=G.+Changauthor=Y.+Huangauthor=Z.+Linauthor=D.+O.+Scottauthor=M.+D.+Troutmanauthor=T.+E.+Liston&title=Species+independence+in+brain+tissue+binding+using+brain+homogenates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34cR"><div class="casContent"><span class="casTitleNuber">34c</span><div class="casTitle"><span class="NLM_cas:atitle">Species independence in brain tissue binding using brain homogenates</span></div><div class="casAuthors">Di, Li; Umland, John P.; Chang, George; Huang, Youping; Lin, Zhen; Scott, Dennis O.; Troutman, Matthew D.; Liston, Theodore E.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1270-1277</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Species independence of brain tissue binding was assessed with a large no. of structurally diverse compds. using equil. dialysis with brain homogenates of seven species and strains (Wistar Han rat, Sprague-Dawley rat, CD-1 mouse, Hartley guinea pig, beagle dog, cynomolgus monkey, and human).  The results showed that the fractions unbound of the seven species and strains were strongly correlated with correlation coeffs. ranging from 0.93 to 0.99.  The cross-species/strain correlations were not significantly different from the interassay correlation with the same species.  The linear correlation between Wistar Han and other species had a slope close to 1 and an intercept near 0.  Based on orthogonal statistical anal., no correction is needed for extrapolation of fraction unbound from Wistar Han rat to the other species or strains.  Hence, brain tissue binding of Wistar Han rat can be used to obtain binding of other species and strains in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoub4FiLWkAFrVg90H21EOLACvtfcHk0lhuFtnMXXbkgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWktrg%253D&md5=93a51addedb22de4648e6e5ee39c6c81</span></div><a href="/servlet/linkout?suffix=cit34c&amp;dbid=16384&amp;doi=10.1124%2Fdmd.111.038778&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.111.038778%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DChang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DListon%26aufirst%3DT.%2BE.%26atitle%3DSpecies%2520independence%2520in%2520brain%2520tissue%2520binding%2520using%2520brain%2520homogenates%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1270%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotarski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span> </span><span class="NLM_article-title">Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure-response continuum of the novel potentiator PF-4778574</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1124%2Fjpet.113.204735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=23899905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=212-224&author=C.+L.+Shafferauthor=R.+S.+Hurstauthor=R.+J.+Scialisauthor=S.+M.+Osgoodauthor=D.+K.+Bryceauthor=W.+E.+Hoffmannauthor=J.+T.+Lazzaroauthor=A.+N.+Hanksauthor=S.+Lotarskiauthor=M.+L.+Weberauthor=J.+Liuauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+Haj%C3%B3s&title=Positive+allosteric+modulation+of+AMPA+receptors+from+efficacy+to+toxicity%3A+the+interspecies+exposure-response+continuum+of+the+novel+potentiator+PF-4778574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure-response continuum of the novel potentiator PF-4778574</span></div><div class="casAuthors">Shaffer, Christopher L.; Hurst, Raymond S.; Scialis, Renato J.; Osgood, Sarah M.; Bryce, Dianne K.; Hoffmann, William E.; Lazzaro, John T.; Hanks, Ashley N.; Lotarski, Susan; Weber, Mark L.; Liu, Jian Hua; Menniti, Frank S.; Schmidt, Christopher J.; Hajos, Mihaly</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-224</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) pos. allosteric modulation (i.e., "potentiation") has been proposed to overcome cognitive impairments in schizophrenia, but AMPAR overstimulation can be excitotoxic.  Thus, it is crit. to define carefully a potentiator's mechanism-based therapeutic index (TI) and to det. confidently its translatability from rodents to higher-order species.  Accordingly, the novel AMPAR potentiator N-{(3R,4S)-3-[4-(5-cyano-2-thienyl)phenyl]tetrahydro-2H-pyran-4-yl}propane-2-sulfonamide (PF-4778574) was characterized in a series of in vitro assays and single-dose animal studies evaluating AMPAR-mediated activities related to cognition and safety to afford an unbound brain compd. concn. (Cb,u)-normalized interspecies exposure-response relationship.  Because it is unknown which AMPAR subtype(s) may be selectively potentiated for an optimal TI, PF-4778574 binding affinity and functional potency were detd. in rodent tissues expected to express a native mixt. of AMPAR subunits and their assocd. proteins to afford composite pharmacol. values.  Functional activity was also quantified in recombinant cell lines stably expressing human GluA2 flip or flop homotetramers.  Procognitive effects of PF-4778574 were evaluated in both rat electrophysiol. and nonhuman primate (nhp) behavioral models of pharmacol. induced N-methyl-D-aspartate receptor hypofunction.  Safety studies assessed carebellum-based AMPAR activation (mouse) and motor coordination disruptions (mouse, dog, and nhp), as well as convulsion (mouse, rat, and dog).  The resulting empirically derived exposure-response continuum for PF-4778574 defines a single-dose-based TI of 8- to 16-fold for self-limiting tremor, a readily monitorable clin. adverse event.  Importantly, the Cb,u mediating each physiol. effect were highly consistent across species, with efficacy and convulsion occurring at just fractions of the in vitro-derived pharmacol. values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP5MdXGBbRYrVg90H21EOLACvtfcHk0livpoCe59x9_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7jE&md5=8fead71db7d49812f68c25f603132679</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.204735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.204735%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DOsgood%26aufirst%3DS.%2BM.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DLotarski%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DM.%2BL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26atitle%3DPositive%2520allosteric%2520modulation%2520of%2520AMPA%2520receptors%2520from%2520efficacy%2520to%2520toxicity%253A%2520the%2520interspecies%2520exposure-response%2520continuum%2520of%2520the%2520novel%2520potentiator%2520PF-4778574%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D212%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ryder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manro, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchant, K. M.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1124%2Fjpet.106.105734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCksLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=293-298&author=J.+W.+Ryderauthor=J.+F.+Falconeauthor=J.+R.+Manroauthor=K.+A.+Svenssonauthor=K.+M.+Merchant&title=Pharmacological+characterization+of+cGMP+regulation+by+the+biarylpropylsulfonamide+class+of+positive%2C+allosteric+modulators+of+%CE%B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic+acid+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors</span></div><div class="casAuthors">Ryder, John W.; Falcone, Julie F.; Manro, Jason R.; Svensson, Kjell A.; Merchant, Kalpana M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">293-298</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The biarylpropylsulfonamide class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) potentiators represented by N-2-(4-(4-cyanophenol)phenol)propyl-2-propanesulfonamide (LY404187) and (R)-4'-[1-fluoro-1-methyl-2-(propane-2-sulfonylamino)-ethyl]-biphenyl-4-carboxylic acid methylamide (LY503430) are pos., allosteric AMPA receptor activators, which enhance AMPA receptor-mediated neurotransmission by reducing desensitization of the ion channel.  Although these compds. have efficacy in in vivo rodent models of cognition, depression, and Parkinson's disease, little is known about biochem. pathways activated by these agents.  Given the well established regulation of the nitric oxide/cGMP pathway by excitatory neurotransmission, the current study characterized AMPA receptor potentiator-mediated cGMP response in mouse cerebellum.  Acute treatment by both LY404187 and LY503430 [2.0, 5.0, or 10 mg/kg s.c.] elevated basal cerebellar cGMP levels in a dose-dependent manner.  Pretreatment with the noncompetitive, allosteric AMPA receptor-selective antagonist 7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide, 5-(4-aminophenyl)-8,9-dihydro-N,8-dimethyl-monohydrochloride-(9CI) (GYKI 53655) [3.0 mg/kg i.p.], completely blocked the effect of LY404187, demonstrating that activation of AMPA receptors induces cGMP levels.  Interestingly, pretreatment with the N-methyl-D-aspartate (NMDA) open channel blocker dizocilpine (0.3 and 1.0 mg/kg i.p.) also abolished the AMPA receptor potentiator-mediated cGMP accumulation, indicating that activation of AMPA receptors leads to NMDA receptor-mediated transmission involved in cGMP regulation.  Pharmacol. augmentation of the endogenous glutamate tone via the alkaloid harmaline (20-60 mg/kg i.p.) synergized with AMPA potentiator activity and provided further direct evidence of in vivo allosteric activation of AMPA receptors by LY404187.  The synergism between harmaline and LY404187 was specific, since cGMP accumulation induced by foot-shock stress was not augmented by the AMPA receptor potentiator.  Taken together, these data indicate that the cGMP system may play an important role in pharmacol. efficacy of the biarylpropylsulfonamide class of AMPA receptor potentiators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeZVDKiSOi7LVg90H21EOLACvtfcHk0livpoCe59x9_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCksLrO&md5=e1fff3ab717a74321b389e96ea575889</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.105734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.105734%26sid%3Dliteratum%253Aachs%26aulast%3DRyder%26aufirst%3DJ.%2BW.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DManro%26aufirst%3DJ.%2BR.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DMerchant%26aufirst%3DK.%2BM.%26atitle%3DPharmacological%2520characterization%2520of%2520cGMP%2520regulation%2520by%2520the%2520biarylpropylsulfonamide%2520class%2520of%2520positive%252C%2520allosteric%2520modulators%2520of%2520%25CE%25B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2520acid%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D293%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Kiss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span> </span><span class="NLM_article-title">Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1017%2FS1461145710000271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=20334724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=29-42&author=T.+Kissauthor=W.+E.+Hoffmannauthor=M.+Hajos&title=Delta+oscillation+and+short-term+plasticity+in+the+rat+medial+prefrontal+cortex%3A+modelling+NMDA+hypofunction+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia</span></div><div class="casAuthors">Kiss, Tamas; Hoffmann, William E.; Hajos, Mihaly</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-42</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Dysfunction of the prefrontal cortex (PFC) is considered to be an important factor contributing to a decrease in cognitive performance of schizophrenia patients.  The medial PFC (mPFC) is innervated by the hippocampus/subiculum, and the subiculum-mPFC pathway is known to be involved in various cognitive processes.  Glutamate-contg. subicular axons innervate cortical pyramidal neurons and interneurons where AMPA and NMDA receptors are implicated in synaptic transmission.  In our expts., properties of subiculum-mPFC interactions were studied using pathway stimulation and local field potential (LFP) recordings of the mPFC in urethane-anesthetized rats.  Changes in paired-pulse facilitation (PPF) and LFP oscillations, effects of the NMDA receptor antagonist MK-801, and the AMPAkine LY451395 were evaluated.  Effects of disruption of the thalamo-cortical loop with local microinjection of lidocaine into the mediodorsal thalamic nucleus (MD) were also studied.  Our findings demonstrate that both systemic administration of MK-801 and local MD lidocaine microinjection produce similar changes in LFP oscillations and redn. in PPF.  Specifically, it was obsd. that MK-801 (0.05 mg/kg i.v.) and intra-thalamic lidocaine changed regular, 2 Hz delta oscillation to a less regular 0.5-1.5 Hz delta rhythm.  Concurrently, PPF in response to elec. stimulation of the subiculum was significantly attenuated.  Administration of the AMPAkine LY451395 (0.01 mg/kg i.v.) reversed the MK-801- and lidocaine-induced changes, and was itself blocked by the AMPA receptor antagonist CP-465022.  Anal. of our findings suggests a crit. role of cortical interneurons in NMDA/AMPA receptor-mediated changes in thalamo-cortical oscillations and PPF, and contributes to our understanding of the NMDA hypofunction model of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5APr_ncoDP7Vg90H21EOLACvtfcHk0livpoCe59x9_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLnO&md5=5cf78907f9690c37011f8d3e39f7b110</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1017%2FS1461145710000271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145710000271%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26atitle%3DDelta%2520oscillation%2520and%2520short-term%2520plasticity%2520in%2520the%2520rat%2520medial%2520prefrontal%2520cortex%253A%2520modelling%2520NMDA%2520hypofunction%2520of%2520schizophrenia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2011%26volume%3D14%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Olney, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomer, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, N. B.</span><span> </span><span class="NLM_article-title">NMDA receptor hypofunction model of schizophrenia</span> <span class="citation_source-journal">J. Psychiatr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1016%2FS0022-3956%2899%2900029-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=10628529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252Fpt1Wisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1999&pages=523-533&author=J.+W.+Olneyauthor=J.+W.+Newcomerauthor=N.+B.+Farber&title=NMDA+receptor+hypofunction+model+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor hypofunction model of schizophrenia</span></div><div class="casAuthors">Olney J W; Newcomer J W; Farber N B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">523-33</span>
        ISSN:<span class="NLM_cas:issn">0022-3956</span>.
    </div><div class="casAbstract">Several decades of research attempting to explain schizophrenia in terms of the dopamine hyperactivity hypothesis have produced disappointing results.  A new hypothesis focusing on hypofunction of the NMDA glutamate transmitter system is emerging as a potentially more promising concept.  In this article, we present a version of the NMDA receptor hypofunction hypothesis that has evolved from our recent studies pertaining to the neurotoxic and psychotomimetic effects of PCP and related NMDA antagonist drugs.  In this article, we examine this hypothesis in terms of its strengths and weaknesses, its therapeutic implications and ways in which it can be further tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8PJv1HPbUrDEC-75aqa5AfW6udTcc2ebM27dPVtAH-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252Fpt1Wisg%253D%253D&md5=1450b1d092fbd5075e730c8aa68f1153</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0022-3956%2899%2900029-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-3956%252899%252900029-1%26sid%3Dliteratum%253Aachs%26aulast%3DOlney%26aufirst%3DJ.%2BW.%26aulast%3DNewcomer%26aufirst%3DJ.%2BW.%26aulast%3DFarber%26aufirst%3DN.%2BB.%26atitle%3DNMDA%2520receptor%2520hypofunction%2520model%2520of%2520schizophrenia%26jtitle%3DJ.%2520Psychiatr.%2520Res.%26date%3D1999%26volume%3D33%26spage%3D523%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Goldman-Rakic, P. S.</span><span> </span><span class="NLM_article-title">Working memory dysfunction in schizophrenia</span> <span class="citation_source-journal">J. Neuropsychiatry Clin. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1176%2Fjnp.6.4.348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=7841806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A280%3ADyaK2M7ktl2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1994&pages=348-357&author=P.+S.+Goldman-Rakic&title=Working+memory+dysfunction+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Working memory dysfunction in schizophrenia</span></div><div class="casAuthors">Goldman-Rakic P S</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of neuropsychiatry and clinical neurosciences</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">348-57</span>
        ISSN:<span class="NLM_cas:issn">0895-0172</span>.
    </div><div class="casAbstract">Recent advances in anatomical, behavioral, and physiological techniques have produced new information about the nature of prefrontal function, its cellular basis, and its anatomical underpinnings in nonhuman primates.  These findings are changing our views of prefrontal function and providing insight into possible bases for human mental disorder.  A major advance is the recognition that various prefrontal areas are engaged in holding information "on line" and updating past and current information on a moment-to-moment basis.  Studies of animals and of cognitive function in normal, brain-injured, and schizophrenic subjects support the theory that a defect in working memory--the ability to guide behavior by representations--may be the fundamental impairment leading to schizophrenic thought disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyESdDKBz6etTiMd2aNQVUfW6udTcc2ebM27dPVtAH-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7ktl2mtQ%253D%253D&md5=4a864a3c0cf5268f35615668e11246c3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1176%2Fjnp.6.4.348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fjnp.6.4.348%26sid%3Dliteratum%253Aachs%26aulast%3DGoldman-Rakic%26aufirst%3DP.%2BS.%26atitle%3DWorking%2520memory%2520dysfunction%2520in%2520schizophrenia%26jtitle%3DJ.%2520Neuropsychiatry%2520Clin.%2520Neurosci.%26date%3D1994%26volume%3D6%26spage%3D348%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Moghaddam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitt, D.</span><span> </span><span class="NLM_article-title">From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1038%2Fnpp.2011.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm401274b&amp;key=21956446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=4-15&author=B.+Moghaddamauthor=D.+Javitt&title=From+revolution+to+evolution%3A+the+glutamate+hypothesis+of+schizophrenia+and+its+implication+for+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment</span></div><div class="casAuthors">Moghaddam, Bita; Javitt, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glutamate is the primary excitatory neurotransmitter in mammalian brain.  Disturbances in glutamate-mediated neurotransmission have been increasingly documented in a range of neuropsychiatric disorders including schizophrenia, substance abuse, mood disorders, Alzheimer's disease, and autism-spectrum disorders.  Glutamatergic theories of schizophrenia are based on the ability of N-methyl--aspartate receptor (NMDAR) antagonists to induce schizophrenia-like symptoms, as well as emergent literature documenting disturbances of NMDAR-related gene expression and metabolic pathways in schizophrenia.  Research over the past two decades has highlighted promising new targets for drug development based on potential pre- and postsynaptic, and glial mechanisms leading to NMDAR dysfunction.  Reduced NMDAR activity on inhibitory neurons leads to disinhibition of glutamate neurons increasing synaptic activity of glutamate, esp. in the prefrontal cortex.  Based on this mechanism, normalizing excess glutamate levels by metabotropic glutamate group 2/3 receptor agonists has led to potential identification of the first non-monoaminergic target with comparable efficacy as conventional antipsychotic drugs for treating pos. and neg. symptoms of schizophrenia.  In addn., NMDAR has intrinsic modulatory sites that are active targets for drug development, several of which show promise in preclin./early clin. trials targeting both symptoms and cognition.  To date, most studies have been done with orthosteric agonists and/or antagonists at specific sites.  However, allosteric modulators, both pos. and neg., may offer superior efficacy with less danger of downregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeNMlez-A7MbVg90H21EOLACvtfcHk0lh7vhdrb0FM-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N&md5=0bf82fc0e3cb5c3ad2bed91414672e6f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.181%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DB.%26aulast%3DJavitt%26aufirst%3DD.%26atitle%3DFrom%2520revolution%2520to%2520evolution%253A%2520the%2520glutamate%2520hypothesis%2520of%2520schizophrenia%2520and%2520its%2520implication%2520for%2520treatment%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D4%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism-based adverse events projecting human <i>C</i><sub>max</sub> variability after an oral dose via PBPK modeling</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm401274b&amp;key=10.1002%2Fbdd.1768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm401274b&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1yhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=72-84&author=C.+L.+Shafferauthor=R.+J.+Scialisauthor=H.+Rongauthor=R.+S.+Obach&title=Using+Simcyp+to+project+human+oral+pharmacokinetic+variability+in+early+drug+research+to+mitigate+mechanism-based+adverse+events+projecting+human+Cmax+variability+after+an+oral+dose+via+PBPK+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism-based adverse eventsProjecting Human Cmax Variability after an Oral Dose via PBPK ModelingC.L. SHAFFER ET AL.</span></div><div class="casAuthors">Shaffer, Christopher L.; Scialis, Renato J.; Rong, Haojing; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">72-84</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Pos. allosteric modulators ( potentiators') of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) have been shown to display a mechanism-based exposure-response continuum in preclin. species with procognitive electrophysiol. and behavioral effects ( efficacy') at low exposures and motor coordination disruptions at progressively higher exposures.  Due to the dose-capping nature of such motor coordination deficits, an exposure threshold-mediated adverse event (CAE), the adequacy of sepn. between the maximal total plasma compd. concn. (Cmax) at a predicted clin. efficacious oral dose and this adverse event (AE) was explored in early drug research with three AMPAR potentiators considered potential candidates for clin. trials.  In vitro metab. studies in human liver microsomes and human hepatocytes demonstrated the metabolic clearance for each compd. was predominately due to cytochromes P 450 (CYP).  Thus, for each compd.'s anticipated clin. efficacious dose, human Cmax variability following oral administration was assessed using Simcyp software, which combines its virtual human populations database using extensive demog., physiol. and genomic information with routinely collected compd.-specific in vitro biochem. data to simulate and predict drug disposition.  Using a combination of exptl. detd. recombinant human CYP intrinsic clearances for CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6 and CYP3A4, human binding factors, expected fraction absorbed and estd. steady-state vol. of distribution, Simcyp simulations demonstrated that two of the three potentiators had acceptable projected Cmax variability (i.e. the 95th percentile Cmax did not breach CAE).  This evaluation aided in the selection of compds. for preclin. progression, and represents a novel application of pharmacol. based pharmacokinetic (PBPK) software approaches to predict interpatient variability.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYHYc71vaExbVg90H21EOLACvtfcHk0lh7vhdrb0FM-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1yhsw%253D%253D&md5=0ff126a5b34085f42606277651aa40e2</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fbdd.1768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.1768%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DUsing%2520Simcyp%2520to%2520project%2520human%2520oral%2520pharmacokinetic%2520variability%2520in%2520early%2520drug%2520research%2520to%2520mitigate%2520mechanism-based%2520adverse%2520events%2520projecting%2520human%2520Cmax%2520variability%2520after%2520an%2520oral%2520dose%2520via%2520PBPK%2520modeling%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2012%26volume%3D33%26spage%3D72%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ5','PDB','4LZ5'); return false;">PDB: 4LZ5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ7','PDB','4LZ7'); return false;">PDB: 4LZ7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ8','PDB','4LZ8'); return false;">PDB: 4LZ8</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-7"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i35"><a href="/doi/suppl/10.1021/jm401274b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_48721"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures and characterization data for formation of <b>18</b>–<b>21</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401274b/suppl_file/jm401274b_si_001.pdf">jm401274b_si_001.pdf (212.58 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited with the Protein Data Bank for complexes of compounds <b>4</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ5">4LZ5</a>), <b>7</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ7">4LZ7</a>), and <b>11</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ8">4LZ8</a>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401274b&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm401274b%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-22%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401274b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a5176e223d60","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
